Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,double-stranded RNA binding (GO:0003725),0.7075325550469188,2.101707918930522,0.0,0.0,0.0,18/70,5.01%,DDX60;OAS3;ZBP1;OASL;EIF2AK2;OAS2;IFIH1;DHX58;ACTN1;ADAR;DHX33;AGO2;ZFR2;TARBP2;ILF3;DHX36;HSP90AB1;TLR8
prerank,adenylyltransferase activity (GO:0070566),0.7932211057850314,1.9428916444356223,0.0,0.014891801968179007,0.023,4/21,0.82%,OAS3;OASL;OAS2;TENT4A
prerank,NAD+ ADP-ribosyltransferase activity (GO:0003950),0.7383293678211424,1.856489256624672,0.0,0.07017975640176313,0.16,6/25,4.17%,PARP14;PARP10;PARP9;PARP11;ZC3HAV1;ART4
prerank,CARD domain binding (GO:0050700),0.8079092799904528,1.85030806884506,0.0,0.05982396307906395,0.182,4/14,1.42%,IRGM;CASP4;NOD2;NOD1
prerank,glutamate receptor binding (GO:0035254),-0.6180145448583081,-1.8495137748256636,0.0,0.46687294989442374,0.374,10/17,22.44%,DLG4;HOMER1;HOMER3;SHISA6;SHANK3;NSF;GNAS;SHISA7;CAMK2A;SHANK1
prerank,CXCR chemokine receptor binding (GO:0045236),0.8521993755984291,1.843757759031899,0.0015105740181268882,0.05730776205685439,0.208,2/11,0.33%,CXCL10;CXCL9
prerank,chemokine activity (GO:0008009),0.7007144075846514,1.8402343354162067,0.002509410288582183,0.05135104126958279,0.218,6/31,5.48%,CXCL10;CXCL9;CCL7;CXCL16;CCL5;CX3CL1
prerank,single-stranded RNA binding (GO:0003727),0.6574568396152103,1.8311181576741897,0.002328288707799767,0.05193791031266373,0.252,14/43,12.58%,DDX60;IFIH1;DHX58;POLR2G;AGO2;ZFR2;ILF3;TLR8;SRA1;DHX9;EIF4H;LONP1;HNRNPA1;DDX11
prerank,pentosyltransferase activity (GO:0016763),0.676484015792947,1.7974911338624406,0.0,0.08126302280911477,0.4,6/36,4.17%,PARP14;PARP10;PARP9;PARP11;ZC3HAV1;ART4
prerank,chemokine receptor binding (GO:0042379),0.6548292117244212,1.7623952861156948,0.004842615012106538,0.11616746669430061,0.566,6/35,5.48%,CXCL10;CXCL9;CCL7;CXCL16;CCL5;CX3CL1
prerank,water transmembrane transporter activity (GO:0005372),0.8194480385713345,1.753123677530035,0.0,0.12129115947875455,0.622,3/11,9.05%,AQP11;AQP4;PDPN
prerank,channel activity (GO:0015267),0.6433504615110982,1.7454479890962011,0.0,0.12445625093155246,0.67,11/41,12.83%,TRPM5;AQP11;PANX2;ASIC4;AQP4;TMEM120B;PDPN;TMEM266;PANX1;KCNK3;TRPV4
prerank,cytokine activity (GO:0005125),0.5368766471647253,1.6633515205105889,0.0,0.3378042664850721,0.967,17/131,11.08%,CXCL10;CXCL9;WNT11;IL15;CRLF1;CCL7;WNT5A;GDF9;CXCL16;KITLG;CCL5;CX3CL1;WNT7B;CSF1;HMGB1;IL17D;CCL14
prerank,ubiquitin binding (GO:0043130),0.5583496147227588,1.6577492144324633,0.007551240560949299,0.33457178427182016,0.974,30/73,16.34%,UBE2L6;ILRUN;CXCR4;AUP1;BIRC2;UBAP1;FBXO7;RBCK1;USP25;RNFT1;MVB12A;FBXW7;UBXN1;GGA3;NBR1;N4BP1;RAE1;UCHL3;RNF19B;RNF31;UBXN2B;UBXN11;FAF2;VPS28;RNF185;USPL1;SHARPIN;ASCC2;SPRTN;OTULINL
prerank,ATP hydrolysis activity (GO:0140603),0.5903524842689697,1.6225086132534816,0.009626955475330927,0.45717098456005706,0.994,8/41,9.46%,RNF213;HSPA1B;TOR3A;CLU;KIF26A;CHD1L;DHX9;ABCD1
prerank,intracellular cyclic nucleotide activated cation channel activity (GO:0005221),0.7503123017794902,1.6120783523117392,0.01293103448275862,0.4774962157520938,0.997,1/11,0.46%,CNGB1
prerank,peptidoglycan binding (GO:0042834),0.7627581787894214,1.5958882935700092,0.016152716593245228,0.5269900610290934,1.0,5/10,15.45%,NOD2;NOD1;RNASE7;HK1;TLR2
prerank,"4 iron, 4 sulfur cluster binding (GO:0051539)",0.7102535058096899,1.5864603098274608,0.02861230329041488,0.5481270558104996,1.0,3/14,5.90%,RSAD2;EXO5;NFU1
prerank,receptor antagonist activity (GO:0048019),0.6675764890312019,1.5836781003967924,0.025885558583106268,0.532624411390617,1.0,4/17,10.75%,ESR2;CCL5;LRPAP1;DKK3
prerank,cytochrome-c oxidase activity (GO:0004129),-0.5446048954872773,-1.5792624773365551,0.0313588850174216,1.0,0.981,5/15,10.01%,CYB5A;COX15;COX10;NDUFA4;COX8A
prerank,ionotropic glutamate receptor binding (GO:0035255),-0.652094177651275,-1.5734365367542795,0.021739130434782608,1.0,0.983,8/10,27.54%,DLG4;SHISA6;SHANK3;NSF;GNAS;SHISA7;SHANK1;IGSF11
prerank,"oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen (GO:0016702)",0.6725729082407101,1.5651525947502742,0.032624113475177303,0.6058882332534248,1.0,2/16,2.10%,BCO2;ETHE1
prerank,semaphorin receptor activity (GO:0017154),0.7194188767980587,1.5516987559507682,0.03273809523809524,0.6525176814125886,1.0,4/11,4.60%,PLXNA3;PLXNB2;NRP2;PLXNB3
prerank,nucleoside-diphosphatase activity (GO:0017110),0.7007886124831219,1.5483409960715753,0.031654676258992806,0.6404208432620825,1.0,5/12,8.53%,CANT1;ENTPD3;ENTPD6;NUDT5;ENTPD5
prerank,regulatory RNA binding (GO:0061980),0.5723881850960183,1.5461251474202096,0.026378896882494004,0.6234483237775257,1.0,13/38,16.68%,PNPT1;ZC3H7A;AGO2;TARBP2;DHX9;HNRNPA2B1;ZC3H12A;HNRNPA1;MATR3;ZC3H7B;SOX2;TUT7;DICER1
prerank,alpha-actinin binding (GO:0051393),-0.46225604548429305,-1.5274076174520967,0.02252252252252252,1.0,0.994,7/24,14.63%,PDLIM5;PPARG;LDB3;RARA;PDLIM1;PKD2L1;PDLIM7
prerank,ribosomal small subunit binding (GO:0043024),0.6395772604640795,1.5274061748707404,0.039492242595204514,0.7049828170123245,1.0,11/17,20.50%,ERAL1;LARP1;MTIF3;ABCE1;EIF4H;NPM1;PIM1;EIF1B;CPEB2;EIF4B;DDX3X
prerank,outward rectifier potassium channel activity (GO:0015271),-0.585105795659168,-1.5255776294218704,0.05571847507331378,1.0,0.994,5/11,21.12%,KCND2;KCND1;KCND3;KCNT2;KCNT1
prerank,mRNA 5'-UTR binding (GO:0048027),0.5916965815616078,1.5206419514703864,0.06233766233766234,0.7145497392662444,1.0,5/24,4.83%,IGF2BP1;IGF2BP3;LARP1;RSL1D1;DHX36
prerank,miRNA binding (GO:0035198),0.5763298650599392,1.502429179724674,0.04247572815533981,0.7924492688722017,1.0,10/30,16.28%,PNPT1;ZC3H7A;AGO2;HNRNPA2B1;ZC3H12A;HNRNPA1;MATR3;ZC3H7B;SOX2;TUT7
prerank,C2H2 zinc finger domain binding (GO:0070742),0.7052228108022388,1.501036392438219,0.04354136429608128,0.7709766334613207,1.0,3/11,6.28%,THAP7;MBD2;ZXDC
prerank,cAMP-dependent protein kinase regulator activity (GO:0008603),0.7120473801220113,1.4975448373567684,0.04484304932735426,0.7631905866910437,1.0,3/10,9.80%,CXCL10;PRKAR2B;PRKAG1
prerank,G protein-coupled chemoattractant receptor activity (GO:0001637),-0.516412863984358,-1.4965614754554606,0.042071197411003236,1.0,0.995,5/15,15.71%,CCR5;CX3CR1;CCR2;CMKLR1;CCR1
prerank,transmembrane receptor protein serine/threonine kinase binding (GO:0070696),-0.5366940799799109,-1.4865671910339904,0.0707395498392283,1.0,0.996,11/13,46.37%,BMP6;SRC;BMP5;BMP3;BMP2;BMP4;CDH5;BMP7;GDF15;PYCARD;BMP8B
prerank,chemoattractant activity (GO:0042056),0.5763946232446029,1.476131140141646,0.05366492146596859,0.8709136599321241,1.0,6/26,11.22%,CXCL10;CCL5;CX3CL1;GDNF;HMGB1;VEGFD
prerank,hexosaminidase activity (GO:0015929),0.6675641639622056,1.4687986121294057,0.06367583212735166,0.8884084284750027,1.0,4/12,8.18%,SPAM1;HYAL1;HYAL4;HEXD
prerank,BMP receptor binding (GO:0070700),-0.5367231638418078,-1.4678080564941018,0.08734939759036145,1.0,0.999,11/12,46.37%,BMP6;SRC;BMP5;BMP3;BMP2;BMP4;CDH5;BMP7;GDF15;PYCARD;BMP8B
prerank,calcium activated cation channel activity (GO:0005227),0.6196422506390568,1.4666653204338354,0.04781420765027322,0.8737893182432207,1.0,2/17,0.73%,TRPM5;KCNMB3
prerank,cysteine-type endopeptidase activity involved in apoptotic process (GO:0097153),0.6759815706209406,1.4610203684883842,0.06758832565284179,0.8821777593073874,1.0,4/11,6.12%,CASP4;CASP7;CASP6;CFLAR
prerank,MHC protein binding (GO:0042287),0.6015518271522227,1.4596744231203993,0.062162162162162166,0.8633393813448605,1.0,4/20,6.76%,FCRL6;LAG3;TAPBP;ABCB9
prerank,ligand-gated calcium channel activity (GO:0099604),0.5969942974727305,1.448901798584796,0.0749665327978581,0.9054277840339224,1.0,5/19,8.96%,TRPM5;TRPM2;GRIN2D;ITPR1;P2RX4
prerank,cysteine-type endopeptidase activity involved in execution phase of apoptosis (GO:0097200),0.6843820029142662,1.4461368955895184,0.07208588957055215,0.8941122479880298,1.0,4/10,6.12%,CASP4;CASP7;CASP6;CFLAR
prerank,mRNA 3'-UTR binding (GO:0003730),0.48630759619815944,1.4377868593794876,0.021668472372697724,0.9233797523835608,1.0,21/79,17.10%,IGF2BP1;ZFP36;IGF2BP3;TARDBP;RNF40;DDX5;LARP1;RSL1D1;ILF3;DHX36;AUH;RBMS2;HNRNPA2B1;ZC3H12A;ZFP36L1;RNPS1;SECISBP2;EXOSC9;DAZAP1;MEX3D;PCBP4
prerank,flavin adenine dinucleotide binding (GO:0050660),0.5042583425419649,1.4365668804089498,0.044543429844097995,0.9052903292264837,1.0,11/53,9.58%,MTHFR;ACOXL;XDH;CYB5R2;GFER;CYBB;ACADL;CYB5R3;LDHD;DLD;GSR
prerank,microtubule minus-end binding (GO:0051011),-0.5233369913432289,-1.4355903742733722,0.07746478873239436,1.0,0.999,6/13,11.67%,MACF1;TUBGCP3;TUBGCP4;TUBGCP6;HAUS4;TUBGCP2
prerank,ion channel inhibitor activity (GO:0008200),0.5227877911489791,1.4307131921035172,0.05115712545676005,0.919211396045137,1.0,14/35,24.86%,CAMK2D;ITPR1;SLC30A1;STX7;STX8;RSC1A1;RACK1;VTI1B;SCN1B;ENSA;CALM2;WNK3;CFTR;COMMD1
prerank,four-way junction DNA binding (GO:0000400),0.5983458231376931,1.4304656290632582,0.08498583569405099,0.89669728802222,1.0,7/17,15.00%,MSH2;RAD51C;XRCC3;HMGB1;MEN1;HMGB3;GEN1
prerank,SUMO binding (GO:0032183),0.6484906997541143,1.4297689731979064,0.09483960948396095,0.8778394670366884,1.0,8/13,15.54%,PML;RNF4;USP25;HERC2;UBA2;CBX4;USPL1;TDG
prerank,N-acetyltransferase activity (GO:0008080),0.5953914788452699,1.4273939478532907,0.07734806629834254,0.8694244797353062,1.0,4/19,6.22%,SATL1;SAT1;NAA50;SMARCE1
prerank,ubiquitin-like protein ligase binding (GO:0044389),0.4501849758476588,1.4270933925639049,0.0010030090270812437,0.8500726519632009,1.0,57/269,12.74%,STAT1;STAT2;HSPA1B;PARP9;ISG15;PML;UBE2L6;DTX3L;BLZF1;TRIB3;CXCR4;AUP1;DAXX;CLU;TPI1;UBE2W;DDRGK1;CD40;CHEK2;HLTF;CUL5;FBXO7;RNF40;USP25;SUMO2;SUMO3;UBE2B;IKBKE;HSP90AB1;FBXW7;TRAF4;PSMA3;HERC2;UBXN1;GPR37;CAMLG;SLF2;DET1;SMAD2;PRKAR2B;RNF31;RBX1;HSPA8;TRAF3;ARRB2;ARIH1;SNX9;PRR7;TRAF5;FAF2;SMG5;NEK6;BAG1;PPARGC1A;MAP1LC3B;UBE2L3;RB1
prerank,protein kinase regulator activity (GO:0019887),0.4721997785623322,1.426757507308133,0.029661016949152543,0.831764604183266,1.0,24/95,13.88%,CXCL10;WNT11;TAOK3;SOCS1;DAXX;CCNL1;CCNJ;CCND2;CCNL2;CCND1;CCNT2;CAB39;MT3;CSNK2B;CNPPD1;AGAP2;GMFB;PRKAR2B;NCK1;PRKAG1;NPM1;FGF13;DUS2;CCNI
prerank,acetylcholine-gated cation-selective channel activity (GO:0022848),0.6588999783754563,1.4117325114653752,0.06983655274888559,0.8999807377112321,1.0,1/11,0.32%,CHRNA9
prerank,thyroid hormone receptor binding (GO:0046966),0.541471524509476,1.4110151617628373,0.07169811320754717,0.8833779581311956,1.0,3/28,2.03%,OASL;HMGN3;PRMT2
prerank,P-type ion transporter activity (GO:0015662),-0.536943176795245,-1.4057421862470734,0.11635220125786164,1.0,1.0,6/12,27.65%,ATP6V1E1;ATP2A2;ATP2C1;ATP2A3;ATP2B2;ATP2B4
prerank,sodium channel regulator activity (GO:0017080),0.5170052688261471,1.402072173280914,0.06625,0.9177914549400009,1.0,9/37,16.16%,CAMK2D;SGK3;SGK2;FXYD4;FXYD6;RSC1A1;FXYD5;FGF13;SCN1B
prerank,"phosphotransferase activity, alcohol group as acceptor (GO:0016773)",0.47887486488207803,1.4007070530579857,0.0397422126745435,0.9063012253287714,1.0,24/74,14.54%,ETNK1;GLYCTK;PIK3CD;TRPT1;HYKK;FCSK;PGM2L1;NOL9;IDNK;NT5C3A;FAM20B;NADK;NMRK1;PI4KB;HK1;DGKB;SPHK2;DGKK;FGGY;GNE;PIK3CB;GALK2;PANK2;FAM20C
prerank,protein serine/threonine kinase activator activity (GO:0043539),0.5217073285174278,1.3987698451546413,0.07975460122699386,0.8980313800238485,1.0,13/34,21.46%,IRGM;SPRY2;ETAA1;CCNT2;CAB39;MTCP1;MAP2K2;CALM3;CCNK;CAB39L;STK3;DDX3X;CKS2
prerank,intracellular ligand-gated ion channel activity (GO:0005217),0.6529842766678726,1.3964865481128494,0.09850746268656717,0.8927164562045011,1.0,2/11,4.64%,TRPM2;ITPR1
prerank,disordered domain specific binding (GO:0097718),0.5522311439543143,1.392358121528982,0.09171974522292993,0.8978677166964847,1.0,10/23,24.43%,TEAD2;HSP90AB1;SMAD2;RB1;FYN;HSP90AA1;CALM3;NUMA1;BCL2L2;CALM2
prerank,muscle alpha-actinin binding (GO:0051371),-0.4843845508793284,-1.3904196279104826,0.08455882352941177,1.0,1.0,5/15,14.63%,PDLIM5;LDB3;PDLIM1;PKD2L1;PDLIM7
prerank,core promoter sequence-specific DNA binding (GO:0001046),0.5042682971455055,1.3885140060515926,0.08484848484848485,0.902073471774507,1.0,9/35,12.89%,STAT1;ZBTB17;AGO2;UBTF;TBPL1;NPM1;KLF10;NR3C1;TAF1B
prerank,ubiquitination-like modification-dependent protein binding (GO:0140035),0.6425514264778881,1.3843535072815203,0.10752688172043011,0.9068996641473179,1.0,2/10,1.77%,PML;DAXX
prerank,sequence-specific mRNA binding (GO:1990825),0.6526597817889999,1.3837474890566517,0.11782477341389729,0.8926983516707202,1.0,3/10,15.27%,DHFR;DHX9;ETF1
prerank,neurexin family protein binding (GO:0042043),-0.5370627462055081,-1.3818791668574861,0.10584958217270195,1.0,1.0,4/10,14.60%,SYTL2;NLGN2;SYTL5;CPE
prerank,tumor necrosis factor receptor binding (GO:0005164),0.6385364242907552,1.3818656620141987,0.10176991150442478,0.8858732840302819,1.0,4/12,11.44%,STAT1;TRAF4;TRAF3;TRAF5
prerank,nucleotidyltransferase activity (GO:0016779),0.5712858991336555,1.3817063446269144,0.11330698287220026,0.870438187327776,1.0,7/19,16.28%,TENT4A;PNPT1;CGAS;MOCS3;NUDT5;CRPPA;TUT7
prerank,kinase activator activity (GO:0019209),0.5228058294948466,1.3809591711270388,0.09405940594059406,0.8582346210150162,1.0,7/30,13.04%,WNT11;DAXX;CAB39;MT3;AGAP2;MOB1B;FGF13
prerank,aspartic-type endopeptidase activity (GO:0004190),0.6333220275329275,1.3761627225191917,0.10174418604651163,0.8695381856124033,1.0,6/12,18.94%,SPPL2A;PSEN1;NAPSA;SPPL3;HM13;DDI2
prerank,histone methyltransferase activity (H3-K4 specific) (GO:0042800),0.5858936958630064,1.3690093028701114,0.11678832116788321,0.8922108286270878,1.0,4/15,9.78%,RBBP5;KMT2A;SETD3;WDR5
prerank,O-methyltransferase activity (GO:0008171),0.6420127123516726,1.3690045309468233,0.11332312404287902,0.8768810050727619,1.0,4/10,14.92%,BCDIN3D;MEPCE;COQ3;COMT
prerank,phosphatidylinositol 3-kinase regulator activity (GO:0035014),0.5718353940923657,1.3686142886871195,0.11804613297150611,0.8638985854807201,1.0,8/18,21.19%,SOCS1;AGAP2;SOCS5;SOCS2;WDR91;SOCS6;SOCS4;SOCS7
prerank,RNA methyltransferase activity (GO:0008173),0.5665038720028334,1.367613866760902,0.09840425531914894,0.8542930395745358,1.0,6/19,9.82%,TRMT9B;BCDIN3D;MRM2;MEPCE;TRMT13;TGS1
prerank,dicarboxylic acid transmembrane transporter activity (GO:0005310),0.5289122649856955,1.3667183970405254,0.095,0.84471621068115,1.0,8/29,14.79%,SLC25A22;ABCC2;SLC26A1;SLC46A1;SLC19A1;SLC25A10;SLC26A2;SLC25A12
prerank,filamin binding (GO:0031005),-0.5280321797794216,-1.365755657250871,0.1167192429022082,1.0,1.0,5/11,13.56%,DPYSL3;FBLIM1;NEBL;CRMP1;CEACAM1
prerank,histone methyltransferase activity (H3-K36 specific) (GO:0046975),0.6505434645186816,1.365010802055681,0.13213213213213212,0.8395729599056562,1.0,5/10,19.50%,NSD3;SETD3;ASH1L;SETD5;SMYD2
prerank,cysteine-type peptidase activity (GO:0008234),0.45956248862322946,1.3649601276727314,0.051086956521739134,0.8264746318366057,1.0,13/73,9.03%,USP18;CASP4;CASP7;CTSS;USP50;USP25;CASP6;USP21;USP15;USP40;CTSC;CTSH;USP34
prerank,polynucleotide adenylyltransferase activity (GO:0004652),0.6183180121552896,1.3611365337160721,0.11671469740634005,0.8325127093827143,1.0,4/12,13.15%,TENT4A;TENT5A;PAPOLA;TENT5C
prerank,methyl-CpG binding (GO:0008327),0.5594138771054198,1.355955979035473,0.10303830911492734,0.8461545578799898,1.0,11/22,17.85%,LRWD1;MECP2;MBD2;ZBTB38;CXXC4;CHTOP;ZBTB21;ZCWPW1;PRMT1;ZBTB4;CXXC5
prerank,phosphatidylcholine transporter activity (GO:0008525),0.5736531110895073,1.351821249172055,0.11983471074380166,0.8534387449788691,1.0,4/17,5.52%,ATP10A;ABCA1;ABCG1;PITPNM1
prerank,5'-3' exonuclease activity (GO:0008409),0.5889817308161426,1.3474826773799513,0.1352112676056338,0.8623755912792411,1.0,7/14,19.65%,XRN2;XRN1;DCP2;FEN1;DCLRE1A;TRIR;DCLRE1C
prerank,receptor ligand activity (GO:0048018),0.4225428542359264,1.3472042106589404,0.009045226130653266,0.8508867538369868,1.0,27/245,11.32%,CXCL10;CXCL9;WNT11;IL15;AGT;CRLF1;WNT5A;BDNF;GDF9;SEMA4D;KITLG;TGFA;SFRP2;CCL5;TAFA4;OSGIN1;CX3CL1;WNT7B;CSF1;NPPC;GDNF;HMGB1;LRPAP1;TAFA2;IL17D;VEGFD;FGF9
prerank,RNA cap binding (GO:0000339),0.573647356241345,1.345232155259445,0.11788617886178862,0.8483192017735076,1.0,7/16,19.48%,AGO2;LARP1;NCBP2;CYFIP1;NCBP1;DCPS;SNUPN
prerank,glycine binding (GO:0016594),-0.5141965446460124,-1.344575103816234,0.1377245508982036,1.0,1.0,5/11,11.69%,GRIN2B;SRR;GRIN1;GLRB;GLRA3
prerank,cysteine-type endopeptidase activity (GO:0004197),0.4475771688182837,1.3406563270546346,0.07435344827586207,0.8587507990142715,1.0,16/78,13.03%,USP18;CASP4;CASP7;CTSS;GPAA1;USP25;CASP6;USP15;USP40;CFLAR;CTSC;CTSH;USP34;USP14;CAPNS1;CAPN1
prerank,MHC class I protein binding (GO:0042288),0.6026224872152224,1.3402113529317707,0.13024602026049203,0.8488978050554186,1.0,8/13,29.37%,TAPBP;ABCB9;TUBB4B;TAP1;ATP5F1B;PILRA;TUBB;LILRB1
prerank,histone methyltransferase binding (GO:1990226),0.6164999929024749,1.3385372376448395,0.13303437967115098,0.8453094601879848,1.0,5/11,12.95%,HSP90AB1;CTNNB1;LCORL;LCOR;PRDM4
prerank,cGMP binding (GO:0030553),0.6312244977505284,1.3373190565720179,0.1348148148148148,0.840440685852695,1.0,2/11,8.10%,CNGB1;RAPGEF2
prerank,protein kinase activator activity (GO:0030295),0.46212086845343886,1.336358269966756,0.08183856502242152,0.83402418217684,1.0,18/60,22.78%,WNT11;IRGM;SPRY2;DAXX;ETAA1;CAB39;MT3;AGAP2;MTCP1;MAP2K2;FGF13;CALM3;CAB39L;STK3;DDX3X;STK11;ERBB3;GPRC5B
prerank,transmembrane receptor protein kinase activity (GO:0019199),0.4633598094743381,1.3344575138441497,0.08876404494382023,0.8318731749562359,1.0,12/60,9.96%,AXL;FLT1;KDR;ACVR1;EPHA4;FGFR2;RET;EPHA6;LTK;MET;INSR;ROR2
prerank,CoA-ligase activity (GO:0016405),-0.48551861714598227,-1.3324398434550462,0.14333333333333334,1.0,1.0,6/14,21.70%,ACSS3;AACS;ACSL1;ACSS1;ACSBG1;SLC27A2
prerank,RNA polymerase II-specific DNA-binding transcription factor binding (GO:0061629),0.4222805406494017,1.3302047102806998,0.025227043390514632,0.8407922201979399,1.0,44/181,17.26%,STAT1;PARP9;PITX2;TAF4B;DTX3L;DDRGK1;STAT3;RBL1;MTA3;MAD2L2;BHLHE40;NCOA1;CTNNB1;ARID1A;SMARCE1;TCF7L2;DHX9;TACC2;MDFIC;MTA2;DACT1;LMO2;MAPK14;PROX1;COMMD7;DUSP26;NPM1;SNW1;LDB2;LDB1;PPARGC1A;RB1;MIER1;RNF25;BUD31;ACTB;BBS2;PIAS1;MEF2A;PIAS2;PPARD;RBPJ;TRIP4;ANXA4
prerank,transmembrane receptor protein tyrosine kinase activity (GO:0004714),0.46146722355853353,1.3248948395861475,0.09276018099547512,0.854681395717817,1.0,12/60,9.96%,AXL;FLT1;KDR;NRP2;EPHA4;FGFR2;RET;EPHA6;LTK;MET;INSR;ROR2
prerank,serine-type endopeptidase inhibitor activity (GO:0004867),0.4804628025050647,1.323409046785034,0.12985436893203883,0.8505575804955151,1.0,4/38,9.06%,AGT;SERPINC1;SLPI;APP
prerank,cysteine-type endopeptidase inhibitor activity involved in apoptotic process (GO:0043027),0.5539842035186502,1.3233017471423658,0.16026490066225166,0.8405190436059762,1.0,5/18,15.89%,NOL3;BIRC2;MT3;BIRC3;CD27
prerank,glutathione transferase activity (GO:0004364),-0.39685993214577087,-1.323300481172406,0.10407239819004525,1.0,1.0,13/23,40.08%,LTC4S;ALOX5AP;GSTO1;GSTA3;PTGES;GSTM1;GSTA4;HPGDS;GSTM5;LANCL1;GSTT1;GSTP1;GSTT2
prerank,frizzled binding (GO:0005109),0.48914954765978613,1.3222478537183078,0.13219094247246022,0.8345442849529421,1.0,5/34,8.50%,WNT11;WNT5A;WNT7B;MYOC;BAMBI
prerank,tumor necrosis factor receptor superfamily binding (GO:0032813),0.5047156729198324,1.3217056439764348,0.13240857503152584,0.8268024815180799,1.0,6/28,11.44%,STAT1;TNFSF9;FEM1B;TRAF4;TRAF3;TRAF5
prerank,chemorepellent activity (GO:0045499),-0.4053721805431918,-1.3214535441388826,0.125,1.0,1.0,16/25,29.01%,SEMA4C;SEMA4G;SEMA4A;EPHA7;SEMA6A;SEMA4B;DPP4;SEMA3E;SEMA5B;SEMA6D;SEMA4F;NRG3;SEMA6C;SEMA6B;SEMA3B;SEMA3F
prerank,calcium-activated potassium channel activity (GO:0015269),0.6105994950808789,1.3191779268447779,0.14918759231905465,0.8280793767267649,1.0,1/11,0.73%,KCNMB3
prerank,"oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor (GO:0016646)",0.5774528337169955,1.3163823805792847,0.16165951359084407,0.8317012623939776,1.0,5/14,17.53%,MTHFR;DHFR;AASS;BLVRB;MTHFD1
prerank,ADP binding (GO:0043531),0.514868454953811,1.3152151354463701,0.13607188703465983,0.8271185575922085,1.0,11/25,19.77%,MSH2;ABCG1;ABCD1;PRKAG1;LONP1;MYO6;GLUD1;GCLC;MYH9;ERN1;TAP1
prerank,voltage-gated ion channel activity (GO:0005244),-0.458519105505956,-1.31163074194458,0.1331168831168831,0.9913901099144322,1.0,4/14,11.64%,VDAC1;KCND2;GPR89B;GPR89A
prerank,mRNA 3'-UTR AU-rich region binding (GO:0035925),0.5177444420126027,1.306113962982014,0.15,0.8591814573267677,1.0,10/22,23.54%,ZFP36;ILF3;DHX36;ZC3H12A;ZFP36L1;EXOSC9;MEX3D;CPEB2;EXOSC4;ZFP36L2
prerank,RNA polymerase II core promoter sequence-specific DNA binding (GO:0000979),0.5940192264656206,1.303333788855189,0.18262150220913106,0.86254224599492,1.0,2/12,7.62%,STAT1;TBPL1
prerank,histone deacetylase binding (GO:0042826),0.431449382919263,1.3016251702446524,0.08602150537634409,0.8606670613523545,1.0,35/88,25.28%,HSPA1B;THAP7;MEF2B;MTA3;PKN2;NACC1;DHX36;HSP90AB1;CCND1;USF1;MTA2;DACT1;SMG5;LCOR;MIER1;ZMYND15;HSP90AA1;CAMTA2;MEF2A;HDAC1;BCOR;ANKRA2;GLI3;PRDM1;HDAC2;NACC2;RAD9A;KCTD21;HDAC4;HDAC6;NCOR2;KAT2B;TFAP4;YWHAE;SIRT2
prerank,DNA polymerase binding (GO:0070182),0.5480632282714407,1.3011853823608859,0.16085790884718498,0.8529524661789678,1.0,8/18,17.23%,HSP90AB1;POLG2;CDT1;RTEL1;HMGB1;LONP1;HSP90AA1;PTGES3
prerank,kinase activity (GO:0016301),0.4305309723698303,1.3008645402247176,0.07223942208462332,0.8449611898612721,1.0,30/109,16.75%,PKMYT1;ETNK1;GLYCTK;TRIB3;PIK3CD;ITPKC;HYKK;FCSK;PKN2;PGM2L1;EPHA4;IDNK;PPIP5K1;SEPHS1;LYN;NADK;NMRK1;PI4KB;DGKB;CERKL;SPHK2;DGKK;BCKDK;PIK3CB;PANK2;MASTL;MTOR;IRAK1;STK39;DGKA
prerank,RNA 7-methylguanosine cap binding (GO:0000340),0.5950149454483723,1.2991806128613395,0.16376811594202897,0.8433552677841146,1.0,6/12,18.01%,AGO2;LARP1;NCBP2;CYFIP1;NCBP1;DCPS
prerank,histone acetyltransferase binding (GO:0035035),0.5133009737366989,1.2958293435643278,0.15958815958815958,0.8493349366557632,1.0,10/21,25.36%,STAT1;ECD;KANSL1L;MEF2A;TRIP4;CITED2;GLI3;TAF7;SIRT2;EPAS1
prerank,leucine zipper domain binding (GO:0043522),0.6121347865563584,1.2953227008350954,0.17357910906298002,0.842224056440205,1.0,2/10,7.90%,DAPK3;MRTFA
prerank,thiol-dependent deubiquitinase (GO:0004843),0.43241437581511055,1.2936379727591354,0.10118406889128095,0.8403128566293254,1.0,21/83,15.12%,USP18;USP50;USP25;USP21;USP15;OTUD3;USP40;CYLD;UCHL5;UCHL3;USP34;VCPIP1;JOSD2;ZC3H12A;OTUD1;USP14;USP39;ZRANB1;USP45;MINDY3;USP37
prerank,ligand-gated cation channel activity (GO:0099094),0.43336775630732666,1.293270960936624,0.10560344827586207,0.8330012954203257,1.0,9/75,10.12%,CHRNA9;TRPM5;TRPM2;GRIN2D;GRIK3;ASIC4;GRIA2;P2RX4;CCDC51
prerank,lipoprotein particle receptor binding (GO:0070325),0.5069953284808808,1.2916377087113553,0.15943877551020408,0.8314328172549628,1.0,11/27,26.65%,CLU;AP2A1;LDLRAP1;LRPAP1;APOE;APBB1;ANKRA2;HSP90B1;SNX17;LRP1;DNAJA1
prerank,ion channel activity (GO:0005216),0.43332457862021645,1.290387553190517,0.09600862998921252,0.8281960124759898,1.0,18/80,16.23%,TRPM5;CNGB1;TRPM2;GRIN2D;GRIK3;TMC1;TRPM6;ASIC4;GRIA2;CALHM6;TMEM120B;TRPM3;KCNK3;TRPV4;CHRNB2;TRPM7;GRID1;GRIA4
prerank,damaged DNA binding (GO:0003684),-0.33926063434800524,-1.2901956706446782,0.07586206896551724,1.0,1.0,19/44,19.73%,RPA1;RAD18;NBN;CRY2;APTX;ERCC3;XPC;ERCC2;DCLRE1B;SMC6;PNKP;OGG1;NEIL3;FANCG;RAD1;ERCC1;RPA3;XPA;POLD1
prerank,transferrin receptor binding (GO:1990459),-0.5340694173133853,-1.2898721475822346,0.17699115044247787,0.9781304365147873,1.0,3/10,7.68%,CD81;SNX4;IKBKG
prerank,ubiquitin-protein transferase activity (GO:0004842),0.4037142722007452,1.2891334009774165,0.013,0.8246341957281351,1.0,92/346,18.77%,RNF213;PML;TRIM14;IRF2BP1;UBE2L6;DTX3L;RNF214;TRIM25;TRIM45;UBE2W;BIRC2;NFX1;KLHL20;RNF4;TMEM129;HLTF;CUL5;FBXO7;RBCK1;RNF40;TRIM21;RNFT1;RNF5;BFAR;CNOT4;SIAH1;UBE2B;TNFAIP1;RNF11;UBE3A;AREL1;LRSAM1;HERC2;TRIM39;UBE2M;VPS11;RNF114;AMFR;RSPRY1;KLHL13;FBXW8;ANAPC4;RNF19B;RNF31;RBX1;UBE2E3;BARD1;PPP1R11;UBE2E1;RING1;TRAF3;ARIH1;BTRC;RNF122;RNF103-CHMP3;TRAF5;TRIM26;RNF149;SMURF1;FBXL14;KLHL9;UBE2L3;NEURL1B;NEURL3;RNF185;KCMF1;SHARPIN;MYLIP;RNF25;BIRC3;NSMCE1;UBE2Q1;DZIP3;MYCBP2;NHLRC3;RNF103;UBR4;LMO7;GID4;RNF166;MIB2;FBXL5;UBE2K;HECTD1;CBLL1;BIRC6;TRIM2;TRIM62;WWP1;RFFL;MGRN1;ASB1
prerank,NAD binding (GO:0051287),0.5123438036463693,1.2881601298059442,0.16896120150187735,0.8205791596835922,1.0,4/26,1.99%,PARP9;ZC3HAV1;SORD;GRHPR
prerank,omega peptidase activity (GO:0008242),0.4253299971995012,1.2835046208194698,0.10458911419423693,0.8323951920060713,1.0,22/89,15.12%,USP18;USP50;USP25;USP21;USP15;OTUD3;USP40;CYLD;UCHL5;UCHL3;USP34;VCPIP1;JOSD2;ZC3H12A;OTUD1;USP14;GGT7;USP39;ZRANB1;USP45;MINDY3;USP37
prerank,neuropeptide receptor binding (GO:0071855),0.5661409152860379,1.2832222312233208,0.17647058823529413,0.8252625842434651,1.0,1/14,0.59%,GAL
prerank,protein phosphatase regulator activity (GO:0019888),0.45442986944098274,1.2826192752851298,0.1373873873873874,0.8197253150309202,1.0,21/53,24.43%,EIF2AK2;RCAN1;ARPP19;ANKLE2;PPP2R5C;IGBP1;PPP6R3;PPP2R5D;PPP4R2;CALM3;PHACTR4;MGAT5;PPME1;PPP2R2A;PPP1R7;SET;PPP2R5A;PPP2R3A;CABIN1;ENSA;CALM2
prerank,3'-5' DNA helicase activity (GO:0043138),0.5444197859675473,1.2815032794304273,0.1883656509695291,0.816310386048801,1.0,5/16,7.25%,ASCC3;MCM2;MCM7;HELQ;DHX9
prerank,nucleoside-triphosphatase activity (GO:0017111),0.4013413888914219,1.2794594704651656,0.027,0.817049907516923,1.0,73/248,22.51%,RNF213;GBP4;HSPA1B;TOR3A;IRGM;GBP5;CLU;RAB8B;ATL1;GBP3;KIF26A;RAB21;KIF3C;GBP2;RHOF;GPN2;SRPRA;GSPT1;CHD1L;RHEBL1;GBP7;RRAGC;RHOJ;GNA15;GNA14;LSG1;DHX9;RAB22A;AGAP2;GFM1;RAB43;RAB11B;RAB5C;RAP1GAP;ABCD1;GCH1;DNM2;RAB14;ARL1;RAB24;MYO6;SEPTIN9;RAC1;EFTUD2;TBCC;KIF2A;HSP90AA1;GPN3;GNL2;GPN1;RAB11A;RAB32;DYNC2H1;ATAD1;HBS1L;RHOT2;MYH9;PIN1;RAP2A;RAB5B;RAB1A;RND2;DDX3X;MTG2;RIT1;MMUT;RHOH;RHEB;SMCHD1;RRAGA;RUVBL2;ENTPD7;RAB2A
prerank,single-stranded DNA helicase activity (GO:0017116),0.5326419304406116,1.2775092802746195,0.1742627345844504,0.817706081016641,1.0,6/19,11.63%,MCM2;MCM7;HELQ;RFC4;DHX9;POLQ
prerank,protein kinase A regulatory subunit binding (GO:0034237),-0.4063455295189767,-1.275631911597026,0.14746543778801843,0.9931316917943921,1.0,4/21,5.01%,ACBD3;PRRC1;AKAP1;GSKIP
prerank,"catalytic activity, acting on a tRNA (GO:0140101)",0.47829559101299507,1.2735573391245008,0.17064439140811455,0.8262627069043821,1.0,8/35,7.10%,TRMT9B;TRPT1;BCDIN3D;TRMT13;PTRH2;NT5C3A;ALKBH1;AARS1
prerank,G protein-coupled receptor binding (GO:0001664),0.41156258854193445,1.271037704486041,0.07644628099173553,0.8290480279838474,1.0,17/132,10.09%,HSPA1B;WNT11;CALCA;NPB;WNT5A;RTP4;S1PR2;CCL5;REEP2;GNA15;GNA14;WNT7B;TUB;MYOC;BAMBI;HSPA8;ARRB2
prerank,"oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor (GO:0016628)",-0.42810052785667574,-1.2701508052129207,0.17054263565891473,0.9715505407992892,1.0,3/17,2.89%,BLVRA;TECR;LBR
prerank,low-density lipoprotein particle receptor binding (GO:0050750),0.5206153612071113,1.2692693583416916,0.1742627345844504,0.8286906261854148,1.0,9/22,23.71%,CLU;AP2A1;LDLRAP1;LRPAP1;APOE;APBB1;ANKRA2;HSP90B1;SNX17
prerank,ubiquitin-like protein-specific protease activity (GO:0019783),0.5109697749394869,1.2690670217204427,0.18972332015810275,0.8218924344238464,1.0,5/20,6.96%,USP50;SENP3;USP25;USP21;SENP5
prerank,potassium channel regulator activity (GO:0015459),0.44141503757624423,1.268650482045109,0.15563298490127758,0.816217734322963,1.0,17/49,25.67%,KCNMB3;SGK3;SGK2;ARPP19;KCNS3;AKAP9;DLG1;KCNS1;ABCC9;SUMO1;ENSA;FLNA;WNK3;YWHAE;DPP10;DPP6;CHP1
prerank,acetyltransferase activity (GO:0016407),0.4838125665770674,1.264880923522355,0.16482164821648215,0.8247630786602063,1.0,5/31,6.22%,SATL1;SAT1;PAFAH1B3;NAA50;SMARCE1
prerank,DNA replication origin binding (GO:0003688),0.5024613614710179,1.261740710064543,0.1761723700887199,0.8309801294601386,1.0,7/23,12.58%,MCM2;MCM7;MCM4;MCM9;DHX9;ORC3;DDX11
prerank,ATPase binding (GO:0051117),0.42846489520039255,1.256103053294889,0.141602634467618,0.8469253877961905,1.0,11/71,6.53%,CHMP4A;NR1H2;ABCA1;TOR1AIP2;TOR1AIP1;METTL21A;ATP1B3;USP25;SNX10;ANK1;UBXN1
prerank,poly(U) RNA binding (GO:0008266),0.5160808177140269,1.2552817083188896,0.18523489932885906,0.8431750089666786,1.0,6/20,14.73%,PNPT1;HNRNPH1;RBMS2;ATXN1;DIS3L2;DAZAP1
prerank,neuropeptide receptor activity (GO:0008188),0.4901777331241508,1.2541962815787595,0.19230769230769232,0.8401120441249831,1.0,4/29,11.43%,GAL;TACR1;GPR37;GALR1
prerank,calmodulin-dependent protein kinase activity (GO:0004683),0.5003678658135727,1.2539975444031604,0.19334186939820744,0.8337087142053273,1.0,4/24,5.93%,CAMK2D;CAMK2B;PNCK;MKNK1
prerank,deubiquitinase activity (GO:0101005),0.41692305394624835,1.2505279561518818,0.12620320855614972,0.8413513966908935,1.0,21/88,15.12%,USP18;USP50;USP25;USP21;USP15;OTUD3;USP40;CYLD;UCHL5;UCHL3;USP34;VCPIP1;JOSD2;ZC3H12A;OTUD1;USP14;USP39;ZRANB1;USP45;MINDY3;USP37
prerank,voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization (GO:1902282),-0.48508383594314486,-1.249709494418887,0.19207317073170732,1.0,1.0,8/11,46.84%,KCND3;KCNH2;KCNQ1;KCNE3;KCNE4;KCNJ5;KCNJ8;KCNE2
prerank,double-stranded DNA binding (GO:0003690),0.38814221821510875,1.248576367309412,0.009,0.8425169730078335,1.0,72/531,12.97%,DDX60;STAT1;ZBP1;IRF7;PITX2;SYCP1;LMX1A;MSH2;USF2;ETV3;MEF2B;AIM2;TFAP2C;GMEB2;ESRRB;RARG;BBX;TARDBP;TEAD2;ZBTB2;NFKB2;MECP2;CGAS;BATF3;ELK3;CGGBP1;BHLHE40;NKX6-2;KLF15;JUNB;POLG2;ZNF23;SOX9;ZNF76;TCF4;ZBTB43;BCL6;USF1;ZSCAN29;NFATC2;TFAP2B;SNAI2;UBP1;DHX9;SRF;FEN1;SMAD2;MEIS3;ATF6B;HOXA9;NFIB;POU3F1;HMGB1;ELF4;IRF9;MEN1;NR2C1;PROX1;FOXK1;MAX;XBP1;HMGB3;KLF10;CUX1;TEF;MAU2;PRKDC;HOXB6;NR3C1;DDX11;PRDM4;E2F4
prerank,hexosyltransferase activity (GO:0016758),0.4143729574533191,1.2453438896526068,0.11635220125786164,0.8490154870788579,1.0,24/101,19.21%,EXT1;HAS3;HYAL1;DPY19L4;HAS1;TMTC1;POMT1;POMT2;PIGV;B4GALT4;B4GALT1;GCNT4;B4GALT5;CSGALNACT2;B3GLCT;MGAT4C;B3GALNT1;B4GALT2;TMTC4;DPY19L1;FUT9;GYG1;GBA2;PIGB
prerank,RNA binding (GO:0003723),0.3813565633281991,1.2401928754376164,0.001,0.863759035862799,1.0,341/1321,19.63%,IFIT3;DDX60;OAS3;IGF2BP1;ZBP1;OASL;EIF2AK2;PARP12;NOL3;OAS2;IFIH1;SAMHD1;HSPA1B;ZNFX1;HELZ2;IFIT1;MCAT;RPS19BP1;MOV10;ZC3HAV1;APOBEC1;IFIT2;ASCC3;BST2;DHFR;DHX58;PWP2;POLR2G;MYBBP1A;PNPT1;KNOP1;CCDC86;CPNE3;TRIM25;TRMT9B;FNDC3A;ZFP36;NFX1;HTATSF1;CSRP1;XRN2;ZC3H7A;ACTN1;EIF4A2;ADAR;DHX33;IGF2BP3;AGO2;RBM14;TARDBP;SUGP2;MECP2;HLTF;SBDS;STAT3;DDX27;DDX18;MSI1;TDRD7;ZNF106;RPL36;YTHDF1;ZC3H12C;DDX5;MAGOHB;HARS2;ZFR2;SMG7;FLNB;PKN2;DDX49;ERAL1;HNRNPH1;SUMO2;TARBP2;DYNC1H1;LARP1;RBMX;CNOT4;SRPRA;MRPS30;SRRT;RSL1D1;NOP53;MTHFSD;ILF3;DHX36;HSP90AB1;COL14A1;NCBP2;KPNB1;GSPT1;TLR8;UBTF;TCOF1;MRPL12;RPL22;MRM3;CHERP;XRN1;HNRNPK;GPATCH1;NGRN;PRPF40A;RCC1L;SLPI;RPS21;MEPCE;WDR33;PIN4;LAS1L;TRMT1;RBMS2;TRNAU1AP;TFB2M;EDF1;FNDC3B;DDX20;CFAP65;DCP2;MRPL16;ALKBH1;HNRNPM;SEPSECS;AARS1;RRS1;PPAN;MRPS35;MRPS28;CCT4;BICC1;DHX9;SRF;CISD2;NUDT5;N4BP1;HNRNPA2B1;MAPRE1;GAR1;PPIA;SF3B6;GFM1;RO60;RAE1;TUFM;UCHL5;NOLC1;YTHDF2;RPL7L1;NONO;RNMT;SLTM;CLK3;BARD1;HMGB1;SRPK1;PPP1R10;HNRNPL;HSPA8;SLIRP;SSRP1;DIMT1;DHX30;NCOA5;G3BP2;EIF4H;STAU1;DUSP14;DDX24;ZC3H12A;NPM1;ZC3H4;PUM3;CCT3;PRR3;FAM98B;SNW1;ZFP36L1;DDX50;HNRNPDL;RNPS1;RBFOX1;HDLBP;TENT5A;RALY;MRPL42;EIF3A;LONP1;ABCF1;SMG5;HMGB3;HNRNPH3;NKAP;HNRNPA1;PRRC2B;CELF6;ILF2;NOP2;PPARGC1A;PRKDC;HOXB6;TRMT10C;DDX54;MRPL4;DDX11;UBE2L3;KTN1;GTF2E2;SECISBP2;EWSR1;ZC3H11A;RACK1;RPS6;MATR3;DENR;CHTOP;ALG13;SART1;EIF4G3;MRPS23;TIAL1;ZC3H7B;SPATS2;CLNS1A;SNRPD2;SNRPD1;KRI1;DUS2;DBR1;NOP16;ADAT1;EIF1B;WDR43;EIF2S1;DHX57;EXOSC9;EFTUD2;RPN1;DUSP11;RBM45;PCF11;RBM27;PATL2;RPS11;MAP4;CFAP20;DZIP3;DAZAP1;DDX39B;RPL30;HSP90AA1;RBM15;NOA1;SNRPG;MBNL2;ZC3H13;RBFOX3;RBM39;ETF1;NCBP1;RBM3;DDX19B;PRPF40B;TUBB4B;DHX16;NUDT16;TAF15;SNTB2;GNL2;RPL32;UBA1;SRSF7;BZW1;SF3B4;PRMT1;RPL23A;MEX3D;RPL11;SRSF4;TUT7;DHX40;DHX37;ZBED4;UPF1;DDX47;RTCB;PUS7;METAP2;YARS2;DICER1;METTL14;HNRNPA3;RPL10A;NUDT4;RPP30;PCBP4;NOL4;PRKRA;RRP1;RRP1B;TLR3;DDX46;RPS15A;MRPL13;LRRFIP1;CWC22;PELP1;ZMAT3;DDX23;SRBD1;ENDOV;RPP14;MYH9;LSM5;POLR1G;CAVIN1;TBRG4;CPEB2;CAPRIN1;RBPMS;RSL24D1;RPL24;RPL37A;FASTKD2;BUD23;EIF4B;ZCCHC3;RPL3;MRPS11;ESF1;DDX19A;MRPL40;MRPL22;RC3H2;RPP25L;HNRNPF;UTP3;SNUPN;DNAJC21;RBM28;EIF5
prerank,protein phosphatase binding (GO:0019903),0.40526977647447965,1.2401512972260647,0.11372950819672131,0.8567578895554757,1.0,25/117,13.10%,MYOZ2;FCRL6;PPP1R3E;STAT3;ARPP19;ANAPC5;ANKLE2;SMG7;IKBKE;PPP1R3D;CTNNB1;ANK1;IGBP1;PPP6R3;ANAPC4;AKAP11;VRK3;MET;PPP1R11;MAPK14;TRAF3;CDC27;SMG5;RACK1;BAD
prerank,UDP-glycosyltransferase activity (GO:0008194),0.4217825801569901,1.2387722656206155,0.15285252960172227,0.855151860983758,1.0,11/70,11.70%,EXT1;HAS3;HYAL1;HAS1;B4GALT1;GCNT4;CSGALNACT2;XXYLT1;B3GLCT;MGAT4C;B3GALNT1
prerank,manganese ion binding (GO:0030145),0.43806762137364086,1.235018445120175,0.18814139110604333,0.8639602238520134,1.0,16/48,21.66%,XYLT2;SOD2;HMGCL;FEN1;B4GALT1;XXYLT1;PIM1;DYRK2;PAPOLA;FAM20C;GALNT1;NUDT16;MGAT5;GYG1;MTPAP;ABL2
prerank,monocarboxylate:sodium symporter activity (GO:0140161),-0.4833040421792619,-1.2346848094702483,0.2175141242937853,1.0,1.0,8/10,51.69%,SLC6A11;SLC10A1;SLC10A6;SLC10A3;SLC6A12;SLC6A13;SLC10A2;SLC6A1
prerank,solute:proton symporter activity (GO:0015295),0.531603947396688,1.2345941995046468,0.2157676348547718,0.8586395086042725,1.0,5/16,15.48%,MFSD3;SLC15A2;SLC11A2;CTNS;SLC2A9
prerank,ubiquitin protein ligase binding (GO:0031625),0.38959486940106974,1.231796221958118,0.05305305305305305,0.8632524158717427,1.0,51/254,13.19%,HSPA1B;ISG15;PML;UBE2L6;BLZF1;TRIB3;CXCR4;AUP1;DAXX;CLU;TPI1;UBE2W;CD40;CHEK2;HLTF;CUL5;FBXO7;RNF40;USP25;SUMO2;UBE2B;IKBKE;HSP90AB1;FBXW7;TRAF4;PSMA3;HERC2;UBXN1;GPR37;CAMLG;SLF2;DET1;SMAD2;PRKAR2B;RNF31;RBX1;HSPA8;TRAF3;ARRB2;ARIH1;SNX9;TRAF5;FAF2;SMG5;NEK6;BAG1;PPARGC1A;MAP1LC3B;UBE2L3;RB1;APBB1
prerank,galactosyltransferase activity (GO:0008378),0.5805091292179279,1.2308285707800424,0.22707423580786026,0.8600847523491945,1.0,4/11,12.33%,B4GALT4;B4GALT1;B4GALT5;B4GALT2
prerank,"steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (GO:0033764)",0.5201555443930385,1.229296093784446,0.2077028885832187,0.8593392982491388,1.0,3/18,11.73%,HSD17B7;HSD11B1;DHRS11
prerank,phosphatidylinositol-5-phosphate binding (GO:0010314),0.5286761896831085,1.2285277462263657,0.23931623931623933,0.8558803393462731,1.0,5/15,19.67%,SAP30L;RUBCNL;SH3PXD2B;PHLDA3;PLA2G4E
prerank,1-phosphatidylinositol-3-kinase regulator activity (GO:0046935),0.5331750575381279,1.2265721154446498,0.23529411764705882,0.8568803831851709,1.0,6/15,21.19%,SOCS1;SOCS5;SOCS2;SOCS6;SOCS4;SOCS7
prerank,DNA-binding transcription factor binding (GO:0140297),0.38961717953621844,1.2258426505693008,0.09292929292929293,0.8532154638480492,1.0,48/189,19.43%,STAT1;PITX2;DAPK3;USF2;ZBTB17;DDRGK1;STAT3;RBL1;MTA3;CGGBP1;MAD2L2;BHLHE40;CTNNB1;TCF7L2;DDX20;USF1;DHX9;SRF;MTA2;SMAD2;DACT1;LMO2;SCX;HMGB1;CRTC1;DUSP26;NPM1;SIK1;NEK6;LDB2;LDB1;RB1;MIER1;CRTC3;BBS2;PIAS1;MEF2A;PIAS2;PPARD;RBPJ;CHCHD2;ZBTB49;CXXC5;HDAC1;PRRX1;CTBP1;PSMD9;BEX1
prerank,lipid phosphatase activity (GO:0042577),0.5458249690242383,1.2255533792504474,0.22517482517482518,0.8476871889578821,1.0,9/14,25.45%,SGPP2;EPHX2;INPP5K;PLPP2;PLPP7;PLPPR2;PLPPR1;PLPP6;PLPP1
prerank,N-methyltransferase activity (GO:0008170),0.49803565227565233,1.2250996581729414,0.21510883482714468,0.8428940230622785,1.0,8/20,16.55%,ZCCHC4;TRMT1;TFB2M;SETD3;RNMT;DIMT1;PRMT1;METTL15
prerank,adenyl-nucleotide exchange factor activity (GO:0000774),-0.47661035816499514,-1.224676692728465,0.22653721682847897,0.9969241393259667,1.0,8/11,24.37%,HSPH1;SIL1;GRPEL1;BAG4;BAG5;BAG3;GRPEL2;BAG2
prerank,adenyl nucleotide binding (GO:0030554),-0.47661035816499514,-1.224676692728465,0.22653721682847897,0.9969241393259667,1.0,8/11,24.37%,HSPH1;SIL1;GRPEL1;BAG4;BAG5;BAG3;GRPEL2;BAG2
prerank,nuclear receptor binding (GO:0016922),0.39603963174906615,1.2236002390334295,0.15772870662460567,0.8421959791251498,1.0,19/111,13.61%,STAT1;OASL;HMGN3;DAXX;PRMT2;DDX5;NCOA1;CTNNB1;ARID1A;SMARCE1;TCF7L2;TACC2;MED12;PROX1;SNW1;PPARGC1A;DDX54;LCOR;BUD31
prerank,insulin-like growth factor receptor binding (GO:0005159),0.5513632116647085,1.2209306284900199,0.23216783216783216,0.8463732675780288,1.0,4/12,12.42%,IRS1;SOCS1;INSR;SOCS2
prerank,NAD+ binding (GO:0070403),0.5600952813016497,1.2196511012227096,0.23487031700288186,0.8453684329841361,1.0,2/12,0.64%,PARP9;ZC3HAV1
prerank,ribosomal large subunit binding (GO:0043023),0.5693650258431081,1.2161800079117806,0.22633136094674555,0.8521229826082916,1.0,5/11,18.41%,DHX33;NPM1;EIF6;RBM3;CPEB2
prerank,chloride channel inhibitor activity (GO:0019869),0.5636834787260442,1.2144238056401728,0.25194401244167963,0.8527822113897318,1.0,5/10,24.80%,STX7;STX8;VTI1B;WNK3;CFTR
prerank,mannose binding (GO:0005537),-0.47400628395804395,-1.2142311801534271,0.23174603174603176,1.0,1.0,4/12,23.47%,CLN5;CLEC4D;LMAN2L;CLEC6A
prerank,syntaxin binding (GO:0019905),0.4197603471935,1.21256053292104,0.18101545253863136,0.8539715645643493,1.0,20/61,16.46%,ABCA1;CPLX1;STX7;VPS11;VPS54;BAIAP3;CACNA1A;SYT3;STX8;STX16;TMED10;VAMP1;SCFD1;VPS52;VAMP2;NAPB;NAPA;SNAP23;RAB11A;STXBP5L
prerank,protein homodimerization activity (GO:0042803),0.3753793157373479,1.212498239570868,0.015,0.8479768614983771,1.0,152/589,22.28%,STAT1;GBP4;TPST1;CLTRN;PML;CHMP4A;CHMP4B;TRIM14;AGXT;EXT1;MSH2;GBP5;BST2;DAPK3;USF2;PPCS;CAMK2D;XDH;NOD1;SPPL2A;DPY30;ABCG1;TPI1;GRHPR;PRMT2;B2M;CAMK2B;ACTN1;GBP3;CHEK2;CANT1;ACVR1;STAT3;RNF40;TRIM21;PAFAH1B3;GBP2;TARBP2;BHLHE40;ZHX3;PEX7;GOLGA5;CCL5;MZF1;HSP90AB1;DCK;TNNC1;KMT2A;FGFR2;SH3GLB1;ZBTB38;WDR54;USF1;TFAP2B;ABCB9;DUSP29;CSF1;IDH1;CPQ;SRF;ST6GAL1;CISD2;NUDT5;TPD52L1;CCDC88A;HSD11B1;CST7;GDNF;BANF1;NFS1;BARD1;RAP1GAP;VAPB;MKLN1;TMEM266;ABCD1;HOOK1;GCH1;SNX9;NPM1;ATIC;NECTIN3;IL17D;CEP131;SRGAP2;STARD3;LDB1;EPHX2;APOE;ENPP1;RACK1;MASP1;SHMT1;SPPL3;CRPPA;HSP90AA1;GEN1;STK25;BMPR1A;CCDC66;NRBP1;NUDT16;TDG;PGRMC1;DSCAML1;MIGA2;IRAK1;ZBTB4;YARS2;SNX1;BAX;PRKRA;LRRFIP1;CLCN1;GLB1;ABCB7;HM13;MYH9;ACOX1;TARS2;GYG1;PSMD7;RBPMS;TERF2;ERN1;TAP1;RIPK2;TYROBP;POU3F3;ABCG2;PSMF1;RPE;APPL2;TKT;LHPP;ZDHHC3;MCL1;MMUT;TPD52;MTPAP;GADD45A;TENM4;SMCHD1;S100A13;PON3;CHMP1A;SNX2;TSG101;STUB1;RRAGA;HMGCS1;IDE
prerank,ATPase activator activity (GO:0001671),0.494148699177268,1.209777681118819,0.2516469038208169,0.8523755646018532,1.0,5/20,9.80%,TOR1AIP2;TOR1AIP1;ATP1B3;DNAJB4;DNAJB6
prerank,anion transmembrane transporter activity (GO:0008509),0.5579903331101143,1.2096429731508123,0.2543103448275862,0.8468667008918824,1.0,5/12,20.39%,ABCC2;SLC19A1;SLC4A2;ABCG2;ABCC5
prerank,polyubiquitin modification-dependent protein binding (GO:0031593),0.4287025321013338,1.2086401239213633,0.2022857142857143,0.8451944362834862,1.0,25/49,25.93%,PARP10;UBQLN2;IKBKE;UBXN1;UBQLN1;TNIP1;ZRANB3;SHARPIN;ZRANB1;TNIP2;DZIP3;SPRTN;TNIP3;BABAM2;TAB3;ATRIP;ZFAND6;OPTN;UBQLN4;PSMD4;VCP;HDAC6;UBL7;RAD23A;ABRAXAS2
prerank,E-box binding (GO:0070888),0.45077106935030975,1.2055113850020012,0.2246376811594203,0.851313473757396,1.0,7/34,11.42%,CIART;BHLHE40;TCF4;SNAI2;SCX;MAX;MITF
prerank,CCR chemokine receptor binding (GO:0048020),0.45934979819908756,1.2050436827343511,0.2534854245880862,0.8472203613099768,1.0,5/28,13.93%,CCL7;CCL5;CX3CL1;CCL14;NARS1
prerank,NAD-retinol dehydrogenase activity (GO:0004745),0.5346657169186255,1.2044679652661634,0.2482758620689655,0.8434408528528973,1.0,4/14,29.21%,RDH11;RDH10;AKR1A1;DHRS3
prerank,protein serine/threonine phosphatase activity (GO:0004722),-0.2873252307191956,-1.2021854473810742,0.13793103448275862,1.0,1.0,12/60,11.32%,TAB1;PPP3R1;PPM1E;PPM1G;CTDSPL2;PPP4C;CTDNEP1;LRRC40;PPM1L;LRRK1;CTDP1;CTDSPL
prerank,mannosyltransferase activity (GO:0000030),0.4922945590062722,1.2010721643925457,0.23655913978494625,0.8508548807768884,1.0,8/21,19.21%,DPY19L4;TMTC1;POMT1;POMT2;PIGV;TMTC4;DPY19L1;PIGB
prerank,DNA-directed DNA polymerase activity (GO:0003887),0.4861043797984552,1.1993129430592793,0.24503311258278146,0.851540952033983,1.0,6/21,11.63%,POLD4;POLE2;POLM;POLB;POLK;POLQ
prerank,translation initiation factor activity (GO:0003743),0.45358193831490795,1.1974340796539975,0.22262773722627738,0.8530979925528811,1.0,17/36,27.56%,EIF4A2;AGO2;MTIF3;EIF2B2;EIF3A;EIF4G3;EIF1B;EIF2S1;EIF3K;EIF2B5;EIF2B3;EIF5;EIF3I;EIF3C;EIF4E;EIF4E2;EIF2B4
prerank,growth factor activity (GO:0008083),0.4035926258958404,1.196320480955796,0.1939799331103679,0.8513655676001762,1.0,8/74,11.32%,AGT;BDNF;TGFA;OSGIN1;CSF1;GDNF;VEGFD;FGF9
prerank,nuclease activity (GO:0004518),0.41955827633863285,1.1952913138188261,0.21839080459770116,0.8497115387314212,1.0,12/52,14.12%,SAMHD1;XRN2;AEN;RNASEH2A;FEN1;N4BP1;RNASE7;ZC3H12A;ENPP1;RNASE1;DIS3L2;REXO1
prerank,cysteine-type endopeptidase activator activity involved in apoptotic process (GO:0008656),0.5360575075637721,1.1952900853260287,0.2710144927536232,0.8440536419453809,1.0,4/12,13.10%,NOD1;CTSH;RACK1;BAD
prerank,carboxylic acid transmembrane transporter activity (GO:0046943),0.42084684371997794,1.1937808389772815,0.22630992196209587,0.8442519272464599,1.0,14/55,16.65%,SLC38A2;SLC38A1;SLC46A1;SLC19A1;SLC38A3;SLC25A10;SLC38A6;PDPN;SLC7A6;ABCC1;SLC16A13;SLC16A14;SLC16A6;SLC36A4
prerank,lysine-acetylated histone binding (GO:0070577),0.4917142640469263,1.1914090498124743,0.2680683311432326,0.8420026880696282,1.0,7/20,16.79%,THAP7;BRD2;PSME4;KMT2A;PHIP;MLLT3;BRD7
prerank,acetylation-dependent protein binding (GO:0140033),0.4917142640469263,1.1914090498124743,0.2680683311432326,0.8420026880696282,1.0,7/20,16.79%,THAP7;BRD2;PSME4;KMT2A;PHIP;MLLT3;BRD7
prerank,tau-protein kinase activity (GO:0050321),-0.3763197937112746,-1.1894573108739868,0.23318385650224216,1.0,1.0,6/20,14.29%,DYRK1A;ROCK1;MARK4;GSK3B;TTBK1;TTBK2
prerank,DNA polymerase activity (GO:0034061),0.4785557991410182,1.1892063045719252,0.2513157894736842,0.8452581461965287,1.0,6/22,11.63%,POLD4;POLE2;POLM;POLB;POLK;POLQ
prerank,protein phosphatase 2A binding (GO:0051721),0.47066165365081875,1.1821839072218165,0.2653846153846154,0.8667393172224678,1.0,13/23,28.11%,ARPP19;ANKLE2;SMG7;IGBP1;SMG5;MASTL;PPME1;MFHAS1;STRN3;ENSA;GRIN3A;BOD1;CTTNBP2NL
prerank,chloride transmembrane transporter activity (GO:0015108),0.5015907243800193,1.1819154442618391,0.2460881934566145,0.8621576490489773,1.0,5/16,15.71%,SLC26A1;SLC12A5;CLCN6;SLC26A2;CLCN7
prerank,guanyl ribonucleotide binding (GO:0032561),0.37511492111863987,1.181092241305657,0.14631685166498487,0.8599369660148808,1.0,43/196,16.74%,GBP4;CNGB1;GBP5;TUBD1;ARF3;TUBB2B;RAB8B;ATL1;GBP3;RAB21;GBP2;RHOF;RHEBL1;GBP7;RAB12;SLC19A1;RRAGC;RHOJ;LSG1;ARF5;RAB22A;AGAP2;RAB11B;RAPGEF2;SEPHS1;RAB5C;EIF2B2;INSR;TUBE1;GCH1;DNM2;RAB14;ARL1;ARL5C;RAC1;NOA1;TUBB4B;NUDT16;GNL2;GLUD1;ARF4;RAB32;RANBP17
prerank,"2 iron, 2 sulfur cluster binding (GO:0051537)",0.5502898374102171,1.1807612550535902,0.2727272727272727,0.8557683528235004,1.0,3/12,7.47%,XDH;FXN;CISD2
prerank,alkali metal ion binding (GO:0031420),-0.43613700670759564,-1.1787044751412925,0.22697368421052633,1.0,1.0,2/13,1.80%,CAPN3;DRG1
prerank,phosphoric ester hydrolase activity (GO:0042578),0.4187096518755006,1.1781551689723238,0.2243958573072497,0.8605788591734659,1.0,14/49,21.41%,SAMHD1;DUSP3;PDXP;SBF1;DUSP28;EPHX2;DUSP10;DUSP16;DUSP11;ENPP6;DUSP8;SACM1L;LHPP;PGAM5
prerank,monovalent cation:proton antiporter activity (GO:0005451),-0.45539918065274443,-1.1776891767475874,0.25227963525835867,1.0,1.0,4/12,23.88%,SLC9A9;LETM1;SLC9A8;SLC9B2
prerank,cytokine receptor binding (GO:0005126),0.39320187500909887,1.1692838778825043,0.23504273504273504,0.8889186187772716,1.0,18/83,18.75%,CRLF1;TNFSF9;KITLG;USP15;CCL5;IL27;ERAP1;CSF1;SMAD2;TIMM50;VEGFD;SOCS2;JAK2;IL1RAP;PIBF1;IL18;CD300LF;SPRED1
prerank,phosphatidylinositol binding (GO:0035091),0.39068448454289656,1.1687802249544008,0.20873269435569755,0.885502458861756,1.0,34/91,24.25%,GPAA1;THY1;PLEKHN1;GAP43;ITPR1;GRAMD2A;PITPNM1;SNX10;DENND1A;RUBCNL;CCDC88A;PLEKHF2;WDFY1;SNX9;ANKFY1;RUBCN;SNAP91;RPH3A;SNX1;SNX24;TULP3;NUMA1;DENND1B;PIGK;APPL2;TNFAIP8L3;SNX2;ESYT2;ZFYVE1;PITPNA;EEA1;SNX17;SNX12;WDFY3
prerank,ubiquitin-like protein ligase activity (GO:0061659),0.369114018209617,1.1684816126540982,0.1419939577039275,0.8812028870902145,1.0,71/232,23.20%,TRIM14;IRF2BP1;DTX3L;TRIM25;BIRC2;NFX1;TMEM129;HLTF;TRIM21;RNFT1;RNF5;BFAR;SIAH1;RNF11;UBE3A;AREL1;LRSAM1;HERC2;TRIM39;VPS11;RNF114;AMFR;RNF19B;RBX1;PPP1R11;RING1;ARIH1;RNF122;CBX4;TRIM26;RNF149;SMURF1;NEURL1B;NEURL3;RNF185;KCMF1;MYLIP;RNF25;BIRC3;NSMCE2;NSMCE1;MYCBP2;NHLRC3;UBR4;PIAS1;PIAS2;GID4;RNF166;HECTD1;CBLL1;TRIM2;TRIM62;WWP1;RFFL;MGRN1;ASB1;RC3H2;RNFT2;VPS18;MKRN2;RNF180;TRIM13;MKRN1;RNF216;HUWE1;SMURF2;STUB1;UBR2;CUL3;PELI1;XIAP
prerank,bHLH transcription factor binding (GO:0043425),0.48243953189155536,1.1674876767171984,0.27770360480640854,0.8795267732346419,1.0,5/19,9.10%,USF2;BHLHE40;USF1;LMO2;SCX
prerank,tRNA methyltransferase activity (GO:0008175),0.500810394137667,1.1673948414237443,0.28317373461012313,0.8745583313978434,1.0,7/16,22.65%,TRMT9B;BCDIN3D;TRMT13;THUMPD3;TYW3;TARBP1;TRDMT1
prerank,WW domain binding (GO:0050699),0.45086261316339277,1.1672482761743386,0.25851197982345525,0.8698119466830675,1.0,6/26,12.78%,DAZAP2;PMEPA1;TRAF4;RAPGEF2;TCEAL3;TCEAL6
prerank,DNA binding (GO:0003677),0.3613158808880476,1.1665114849819538,0.033,0.8672695920637165,1.0,136/694,17.97%,DDX60;STAT1;ZBP1;OASL;IRF7;SAMHD1;SYCP1;SIM1;TAF4B;NR1H2;MSH2;ESR2;USF2;AIM2;POLR2G;MYBBP1A;TFAP2C;MCM2;ESRRB;RARG;TIMELESS;SAP30L;ZFPL1;RNF4;TARDBP;MECP2;STAT3;CGAS;TIGD2;ARID5B;SPATA24;CGGBP1;MCM7;NKX6-2;SRRT;ILF3;DHX36;TIPIN;RNF11;JUNB;TLR8;MCM4;POLG2;RFC1;SOX9;XRN1;ARID1A;SLPI;ZNF76;CDT1;TCF7L2;TCF4;BCL6;MCM9;BRIP1;USF1;NFATC2;TFAP2B;RAD51C;SNAI2;DHX9;FEN1;SMAD2;MEIS3;ERCC4;GTF3C5;DNMT3A;MPG;SLTM;NFIB;JRKL;POU3F1;BANF1;APP;SCX;DNMT1;HMGB1;ZMYM3;MEN1;BPTF;POGK;LIN9;NR2C1;TWNK;RORA;PROX1;ZC3H12A;MAX;CTCF;RYBP;XBP1;LONP1;POLQ;HMGB3;ZNF423;CUX1;TRIM26;HNRNPA1;ILF2;PPARGC1A;MAU2;PRKDC;DDX11;DNASE2;E2F4;ZNF35;STN1;ZBTB21;SMARCA1;IKZF1;SOX2;POU6F1;DCLRE1A;RTF2;CAMTA2;ERF;TDG;NHEJ1;MEF2A;SPRTN;CARF;ZMYM6;PPARD;GTF3C3;DENND4A;SREBF1;ZBTB4;RBPJ;CHCHD2;HMBOX1;LRRFIP1;ZBTB49;POU2F2;CXXC5;ZNF513;ENDOV
prerank,LRR domain binding (GO:0030275),0.5090452310228446,1.1650273734628342,0.3032904148783977,0.867666552172802,1.0,3/14,7.90%,DAPK3;ZXDC;MRTFA
prerank,peptidase activator activity involved in apoptotic process (GO:0016505),0.508193036075184,1.1636387156430852,0.3091168091168091,0.8678264842367504,1.0,4/14,13.10%,NOD1;CTSH;RACK1;BAD
prerank,methylation-dependent protein binding (GO:0140034),0.4091710917026794,1.1631275513094315,0.2502844141069397,0.8646117629147801,1.0,18/57,23.70%,THAP7;LRWD1;RBBP5;MORC3;BPTF;WDR5;NCAPG2;CDYL;PYGO1;KDM8;ZCWPW1;KDM7A;KAT8;SGF29;SPIN1;ZCWPW2;ING5;CHD8
prerank,ATP binding (GO:0005524),0.3633171993402464,1.1621655238158901,0.1282565130260521,0.8630478886694187,1.0,64/266,21.17%,OAS3;OAS2;HSPA1B;MSH2;ABCA1;DAPK3;ABCG1;MLKL;ACVR1;HASPIN;STK38L;DHX36;HSP90AB1;PEAK1;NOL9;PFKM;MKNK1;RTEL1;PPIP5K1;ABCB9;AARS1;DHX9;AGAP2;ABCE1;EIF2B2;P2RX4;UBA2;INSR;SRPK1;ABCD1;HSPA8;PRKAG1;NUAK2;HSPA4;BCKDK;SIK1;LONP1;PIM1;ABCF1;NEK6;DYRK2;ENPP1;PAPOLA;HSP90AA1;MINK1;BMPR1A;TDG;OXSR1;TBCK;YARS2;SNRK;MYH9;HSPA14;MARK1;BRSK1;STK3;ERN1;TAP1;ACVRL1;ABCD4;TLK2;MAP4K2;MTPAP;STK11
prerank,RNA polymerase II complex binding (GO:0000993),0.44169189426973016,1.1609854064247809,0.2740740740740741,0.8624752724486429,1.0,11/32,16.92%,ESRRB;AGO2;UVSSA;SCAF1;DHX9;ELP2;WAC;WDR43;PCF11;RECQL5;ELOF1
prerank,chloride channel regulator activity (GO:0017081),0.5014189877429266,1.1568330747854731,0.28865979381443296,0.8728781358132512,1.0,4/14,13.50%,SGK3;STX7;STX8;VTI1B
prerank,cyclin-dependent protein serine/threonine kinase regulator activity (GO:0016538),0.4177913389613918,1.1554144288455483,0.2638888888888889,0.872878653534463,1.0,8/42,7.51%,CCNL1;CCNJ;CCND2;CCNL2;CDKN2D;CCND1;CCNT2;CNPPD1
prerank,zinc ion binding (GO:0008270),0.3634166063381966,1.1542476734889058,0.13494461228600202,0.8721708750804484,1.0,62/293,15.95%,IFIH1;SAMHD1;TNFSF10;ADAM33;DHX58;GALT;SORD;BIRC2;CSRP1;SAP30L;ZFPL1;ADAMTS3;ITGB1BP2;ASAH2;ZFP37;ADAM8;ENPP3;RNF5;SIAH1;RNF11;KPNB1;ZDHHC20;ZCCHC4;KMT2A;ZNF2;SLC30A5;ERAP1;MT3;SEC24D;CYLD;ATAD3A;SIRT6;DPP3;SEC23A;P2RX4;PAPPA;TK1;MNAT1;WDFY1;ARIH1;TIMP2;GCH1;CHORDC1;CTCF;MYRIP;NPEPPS;FBXL19;ENPP1;CXXC4;LIMS1;PITRM1;CA2;SHMT1;TET2;MYCBP2;PAM;TMEM163;SEC24A;ENPP5;ACER3;RPH3A;KDM7A
prerank,mRNA binding (GO:0003729),0.36447237292766915,1.153453572746217,0.15947843530591777,0.8703678717220589,1.0,60/249,19.29%,IGF2BP1;DHFR;ZFP36;DHX33;IGF2BP3;AGO2;RBM14;TARDBP;TDRD7;RNF40;YTHDF1;ZC3H12C;DDX5;LARP1;RBMX;RSL1D1;DHX36;NCBP2;HNRNPK;SLPI;AUH;RBMS2;HNRNPM;DHX9;N4BP1;HNRNPA2B1;SF3B6;YTHDF2;HNRNPL;G3BP2;ZC3H12A;PUM3;MARF1;ZFP36L1;RNPS1;RBFOX1;HDLBP;EIF3A;CELF6;SECISBP2;ZC3H11A;DENR;EIF4G3;SHMT1;PCF11;DAZAP1;RBM15;RBFOX3;ETF1;NCBP1;NUDT16;SRSF4;METTL14;PCBP4;MRPL13;SRBD1;CPEB2;RBPMS;MRPS11;RC3H2
prerank,transition metal ion binding (GO:0046914),0.3601734400600894,1.153419618112556,0.10710710710710711,0.8655451419812132,1.0,81/397,15.95%,IFIH1;SAMHD1;TNFSF10;LOXL2;ADAM33;XYLT2;DHX58;GALT;SORD;BIRC2;ETHE1;CSRP1;SAP30L;ZFPL1;ADAMTS3;SOD2;ITGB1BP2;ASAH2;ZFP37;ADAM8;ENPP3;RNF5;SIAH1;RNF11;KPNB1;ZDHHC20;ZCCHC4;KMT2A;ZNF2;SLC30A5;NFU1;ERAP1;MT3;HMGCL;SEC24D;SLC11A2;CYLD;ATAD3A;FEN1;B4GALT1;ABCE1;SIRT6;DPP3;SEC23A;P2RX4;PAPPA;SCD5;PRNP;TK1;MNAT1;WDFY1;ARIH1;TIMP2;GCH1;CHORDC1;XXYLT1;CTCF;PIM1;DYRK2;MYRIP;NPEPPS;FBXL19;ENPP1;CXXC4;LIMS1;PAPOLA;PITRM1;CA2;SHMT1;FAM20C;TET2;MYCBP2;PAM;TMEM163;SEC24A;ENPP5;GALNT1;NUDT16;ACER3;RPH3A;KDM7A
prerank,poly-pyrimidine tract binding (GO:0008187),0.45793979998704265,1.1488591687540821,0.29936305732484075,0.8772498562108115,1.0,6/23,14.73%,PNPT1;HNRNPH1;RBMS2;ATXN1;DIS3L2;DAZAP1
prerank,adenyl ribonucleotide binding (GO:0032559),0.35855443816114785,1.1488505062121686,0.13827655310621242,0.8723561049116068,1.0,75/291,21.88%,OAS3;OAS2;HSPA1B;MSH2;ABCA1;DAPK3;ABCG1;MLKL;ACVR1;HASPIN;STK38L;DHX36;HSP90AB1;PEAK1;NOL9;SLC19A1;PFKM;MKNK1;RTEL1;PPIP5K1;ABCB9;AARS1;DHX9;AGAP2;RAPGEF2;ABCE1;EIF2B2;P2RX4;UBA2;INSR;SRPK1;ABCD1;HSPA8;PRKAG1;NUAK2;HSPA4;BCKDK;SIK1;LONP1;PIM1;ABCF1;NEK6;DYRK2;ENPP1;PAPOLA;MYO6;HSP90AA1;MINK1;BMPR1A;TDG;GLUD1;OXSR1;GCLC;TBCK;YARS2;SNRK;ACSS2;MYH9;HSPA14;MARK1;BRSK1;STK3;PDE4B;ERN1;TAP1;CNBD2;ACVRL1;ABCD4;TLK2;MAP4K2;MTPAP;STK11;PNPLA8;PDE4A;AKT3
prerank,ribonuclease activity (GO:0004540),0.39648250149646913,1.1474341991407455,0.2755102040816326,0.8727496748155059,1.0,12/56,14.04%,SAMHD1;AGO2;NOB1;ZC3H12C;CNOT7;RNASEH2A;N4BP1;RNASE7;ZC3H12A;RNASE1;DIS3L2;EXOSC9
prerank,excitatory extracellular ligand-gated ion channel activity (GO:0005231),0.4708415700356221,1.1470328930589422,0.29864864864864865,0.8693788343652887,1.0,3/21,15.10%,CHRNA9;P2RX4;CHRNB2
prerank,inorganic cation transmembrane transporter activity (GO:0022890),0.4091383765295731,1.1458023035156386,0.28157589803012745,0.8688142250956882,1.0,14/48,23.70%,TRPM5;TRPM2;TRPM6;SLC46A1;CALHM6;TRPM3;DMAC2L;TRPV4;TRPM7;ATP6V1B2;TRPC1;ABCC9;PIEZO1;TMEM165
prerank,ubiquitin protein ligase activity (GO:0061630),0.36230533852669505,1.1450835350023665,0.18328298086606243,0.8666250015403788,1.0,69/228,23.20%,TRIM14;IRF2BP1;DTX3L;TRIM25;BIRC2;NFX1;TMEM129;HLTF;TRIM21;RNFT1;RNF5;BFAR;SIAH1;RNF11;UBE3A;AREL1;LRSAM1;HERC2;TRIM39;VPS11;RNF114;AMFR;RNF19B;RBX1;PPP1R11;RING1;ARIH1;RNF122;TRIM26;RNF149;SMURF1;NEURL1B;NEURL3;RNF185;KCMF1;MYLIP;RNF25;BIRC3;UBE4B;NSMCE1;MYCBP2;NHLRC3;UBR4;GID4;RNF166;UBE2K;HECTD1;CBLL1;TRIM2;TRIM62;WWP1;RFFL;MGRN1;ASB1;RC3H2;RNFT2;VPS18;MKRN2;RNF180;TRIM13;MKRN1;RNF216;HUWE1;SMURF2;STUB1;UBR2;CUL3;PELI1;XIAP
prerank,calcium channel inhibitor activity (GO:0019855),0.5312749441527431,1.1447102011187225,0.30837004405286345,0.8632194219451734,1.0,2/11,5.28%,ITPR1;SLC30A1
prerank,organic anion transmembrane transporter activity (GO:0008514),0.37230450291455774,1.1423802165393535,0.23217922606924643,0.8670065154876992,1.0,35/134,22.20%,SLC25A22;ABCC2;SLC27A1;SLCO1C1;SLC38A2;SLC26A1;SLC38A1;SLC2A6;SLC25A1;SLC46A1;SLC19A1;SLC52A2;SLCO1B1;SLC38A3;SLC35B1;SLC38A6;PDPN;SLC25A25;ABCC1;SLC26A2;SFXN2;SLC35B4;CTNS;SLC35A3;SLC25A12;SLC36A4;SLC35D1;SFXN1;ABCG2;SLC25A15;ABCC5;SLC5A6;MFSD12;SLC6A6;SLC1A3
prerank,purine ribonucleoside triphosphate binding (GO:0035639),0.35443087821137764,1.141145545580307,0.112,0.8667722678470313,1.0,106/431,21.27%,OAS3;GBP4;OAS2;HSPA1B;MSH2;ABCA1;GBP5;DAPK3;TUBD1;ABCG1;ARF3;TUBB2B;ATL1;GBP3;MLKL;ACVR1;HASPIN;RAB21;STK38L;GBP2;RHOF;DHX36;HSP90AB1;PEAK1;RHEBL1;GBP7;NOL9;RRAGC;RHOJ;PFKM;MKNK1;LSG1;ARF5;RTEL1;PPIP5K1;ABCB9;AARS1;DHX9;RAB22A;AGAP2;RAB11B;SEPHS1;ABCE1;EIF2B2;P2RX4;UBA2;INSR;SRPK1;ABCD1;TUBE1;HSPA8;PRKAG1;GCH1;DNM2;NUAK2;HSPA4;RAB14;ARL1;BCKDK;SIK1;LONP1;PIM1;ABCF1;NEK6;DYRK2;ENPP1;ARL5C;PAPOLA;RAC1;HSP90AA1;NOA1;MINK1;BMPR1A;TUBB4B;NUDT16;TDG;GNL2;GLUD1;ARF4;OXSR1;RAB32;TBCK;YARS2;RANBP17;SNRK;RHOT2;MYH9;HSPA14;MARK1;BRSK1;MFHAS1;STK3;RAP2A;ERN1;TAP1;TGM2;ACVRL1;RND2;ABCD4;TLK2;MTG2;RIT1;MAP4K2;MTPAP;STK11;RHOH
prerank,low-density lipoprotein particle binding (GO:0030169),0.4910592423715649,1.1392439342422178,0.30165289256198347,0.8687657507865469,1.0,6/16,20.82%,STAB2;CDH13;LIPC;SORL1;LDLR;MSR1
prerank,clathrin adaptor activity (GO:0035615),0.4945963787385101,1.1381235334456121,0.3177304964539007,0.8676843110266145,1.0,6/15,17.69%,AP2A1;LDLRAP1;AP2S1;STON1;DAB2;STON2
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines (GO:0016813)",-0.446841287498989,-1.137623837919339,0.2961783439490446,1.0,1.0,4/11,32.12%,DDAH1;PADI4;DDAH2;ARG2
prerank,RNA polymerase core enzyme binding (GO:0043175),0.4247461892350176,1.131223584490271,0.2947761194029851,0.8877010801258931,1.0,17/33,27.93%,ESRRB;AGO2;UVSSA;DHX9;ELP2;WAC;WDR43;PCF11;RECQL5;ELOF1;SMYD2;RPRD2;ZNF326;SCAF8;AGO1;CDC73;HNRNPU
prerank,ubiquitin-specific protease binding (GO:1990381),0.4695921429239822,1.1305278862812513,0.330188679245283,0.8855419142281789,1.0,9/19,26.52%,AMFR;CHMP3;LCOR;SART3;SUMO1;VCP;DERL2;RAD23A;PTEN
prerank,MAP kinase phosphatase activity (GO:0033549),0.5030230404424062,1.1275669455419954,0.3387815750371471,0.8912000239199919,1.0,5/12,18.45%,DUSP3;DUSP29;DUSP10;DUSP16;DUSP8
prerank,sterol transfer activity (GO:0120015),0.4777606698691844,1.1238105719087867,0.34097035040431267,0.9006112307103342,1.0,7/17,19.16%,ABCA1;ABCG1;NPC2;GRAMD1C;OSBP;MTTP;OSBPL2
prerank,methylated histone binding (GO:0035064),0.3915893290452973,1.1220118570794264,0.2898550724637681,0.9020238324346129,1.0,20/62,23.78%,THAP7;LRWD1;RBBP5;MORC3;BPTF;WDR5;NCAPG2;CDYL;PYGO1;KDM8;ZCWPW1;KDM7A;KAT8;SGF29;SPIN1;ZCWPW2;ING5;DPF2;CHD8;TAF7
prerank,aminopeptidase activity (GO:0004177),0.4483087032853789,1.121920614309111,0.3248730964467005,0.8976960216637107,1.0,10/26,24.09%,LAP3;MMP14;ERAP1;CTSH;NPEPPS;KDM8;METAP2;MMP15;TRHDE;RNPEP
prerank,death domain binding (GO:0070513),0.5234412111614055,1.119876271652111,0.34294385432473445,0.9005331522932907,1.0,5/11,21.04%,IRGM;RACK1;BAX;CRADD;MCL1
prerank,gamma-tubulin binding (GO:0043015),-0.36105589671044047,-1.1191072811410865,0.265625,1.0,1.0,10/21,12.88%,PAK1;BLOC1S2;MARK4;TUBGCP3;NDRG1;TUBGCP4;TUBGCP6;TUBGCP2;OFD1;RACGAP1
prerank,transforming growth factor beta binding (GO:0050431),-0.34457225131072566,-1.1166059478905703,0.25892857142857145,1.0,1.0,4/23,6.24%,TGFBR3;LTBP1;ITGAV;TWSG1
prerank,telomerase RNA binding (GO:0070034),0.44951077161152253,1.1163438739066809,0.32591623036649214,0.908834428869662,1.0,6/22,11.57%,SMG7;DHX36;XRN1;DCP2;GAR1;SMG5
prerank,metal ion:proton antiporter activity (GO:0051139),-0.4157250098706263,-1.1149088630775195,0.32298136645962733,1.0,1.0,4/13,23.88%,SLC9A9;LETM1;SLC9A8;SLC9B2
prerank,titin binding (GO:0031432),0.5084913090126622,1.1132364965367765,0.36681222707423583,0.9149602775762173,1.0,2/13,3.82%,CAMK2D;ACTN2
prerank,PDZ domain binding (GO:0030165),-0.27210116744410334,-1.1130753901022366,0.16363636363636364,1.0,1.0,24/61,29.29%,DOCK4;SDC2;SRR;TGFBR3;DLG4;TBC1D10A;CCDC88C;CIT;SYNJ2;NSF;GNG5;FZD7;F11R;CRIM1;CXADR;SLC26A6;SNTG2;FZD4;KIF14;GRID2;ATP2B2;ATP2B4;FZD2;PRKN
prerank,pyrophosphate hydrolysis-driven proton transmembrane transporter activity (GO:0009678),-0.3501112060027652,-1.1125604945138154,0.3235294117647059,1.0,1.0,7/22,13.24%,ATP6V0A1;ATP6V1E1;ATP2A2;ATP6V1C1;ATP2C1;ATP6V1D;ATP6V1A
prerank,GTP binding (GO:0005525),0.3552221243313909,1.1120154493649654,0.2695829094608342,0.9148930897950887,1.0,37/172,16.74%,GBP4;GBP5;TUBD1;ARF3;TUBB2B;ATL1;GBP3;RAB21;GBP2;RHOF;RHEBL1;GBP7;RRAGC;RHOJ;LSG1;ARF5;RAB22A;AGAP2;RAB11B;SEPHS1;EIF2B2;INSR;TUBE1;GCH1;DNM2;RAB14;ARL1;ARL5C;RAC1;NOA1;TUBB4B;NUDT16;GNL2;GLUD1;ARF4;RAB32;RANBP17
prerank,carboxylic ester hydrolase activity (GO:0052689),0.3752759435034636,1.1118839928632875,0.288604898828541,0.9106925625075211,1.0,14/85,14.84%,AOAH;PNPLA2;ABHD2;PAFAH1B3;PLA2G12A;PTRH2;ABHD8;AARS1;LIPC;PGLS;LYPLA2;PNPLA6;CA2;ABHD3
prerank,glutamate receptor activity (GO:0008066),0.4633651341981066,1.1110971778563132,0.3493810178817056,0.9088514995675716,1.0,10/19,25.14%,GRIN2D;GRIK3;GRIA2;GRID1;GRIA4;GRIK4;GRM7;GRM4;GRIK5;GRIK2
prerank,cyclic nucleotide binding (GO:0030551),0.45307269584975757,1.1099742363229377,0.3424124513618677,0.9083023530805073,1.0,3/21,8.10%,CNGB1;SLC19A1;RAPGEF2
prerank,sodium-independent organic anion transmembrane transporter activity (GO:0015347),0.5334479871776568,1.1081988160646021,0.36666666666666664,0.9100477519802569,1.0,2/10,6.49%,SLCO1C1;SLCO1B1
prerank,cysteine-type endopeptidase inhibitor activity (GO:0004869),0.4195029040816056,1.101839245500813,0.358560794044665,0.9279997481870622,1.0,10/30,23.20%,NOL3;BIRC2;MT3;CST7;BIRC3;CD27;BIRC6;PTTG1;PRDX3;XIAP
prerank,amyloid-beta binding (GO:0001540),0.3696810179190194,1.1004450580574614,0.32867883995703545,0.9282902273250638,1.0,21/79,18.10%,ITGA2;CLU;CLSTN1;PFDN5;EPHA4;GRIA2;CACNA1A;INSR;PRNP;LDLRAP1;LRPAP1;SORL1;PFDN4;APOE;FCGR2B;APBB1;TLR2;PGRMC1;GRIA4;ITM2C;LDLR
prerank,voltage-gated calcium channel activity (GO:0005245),0.3996195946580131,1.100110717000499,0.3349397590361446,0.9250386643134264,1.0,3/37,2.42%,CATSPER4;CACNA2D4;TMC1
prerank,single-stranded DNA binding (GO:0003697),0.36250855620989286,1.0988057354700849,0.3311897106109325,0.9251203200820642,1.0,16/93,13.60%,SAMHD1;MSH2;POLR2G;MCM2;MCM7;DHX36;MCM4;MCM9;DHX9;ERCC4;HMGB1;TWNK;LONP1;HNRNPA1;DDX11;STN1
prerank,Hsp90 protein binding (GO:0051879),0.40755534927622483,1.0977350933543772,0.35178351783517836,0.924124306870984,1.0,14/33,25.02%,NOD2;KDR;CHORDC1;NR3C1;HDAC8;TELO2;UNC45A;PTGES3;AHSA1;TSC1;ERN1;STUB1;HDAC6;STIP1
prerank,microtubule plus-end binding (GO:0051010),-0.34861936166387686,-1.0964577929911534,0.31877729257641924,1.0,1.0,11/20,20.07%,STIM1;DST;CLIP1;CLASP2;FBXW11;APC;KIF18A;CLIP3;TTBK2;KNSTRN;CLASP1
prerank,RNA polymerase binding (GO:0070063),0.4603229668302189,1.0956073886561246,0.35983827493261455,0.9272956148101471,1.0,5/18,7.25%,ZFP36;PKN2;TCERG1L;CCNT2;DHX9
prerank,endopeptidase inhibitor activity (GO:0004866),0.36220799752272126,1.094343268249284,0.33475935828877007,0.9275775589330598,1.0,10/82,11.74%,AGT;BST2;SERPINC1;SLPI;UCHL5;CST7;APP;PRNP;TIMP2;USP14
prerank,nuclear receptor coactivator activity (GO:0030374),0.38773255102916215,1.0941891819879834,0.33183856502242154,0.9236553561949407,1.0,9/52,13.61%,HELZ2;ACTN1;RBM14;RNF4;NCOA1;SRA1;MED12;PPARGC1A;BUD31
prerank,calcium-release channel activity (GO:0015278),0.46454063110645333,1.093730914182421,0.3643835616438356,0.9209051212519027,1.0,3/17,12.43%,TRPM2;ITPR1;MCOLN2
prerank,DNA secondary structure binding (GO:0000217),0.411743478638801,1.0933554854424659,0.35580524344569286,0.9178402370771523,1.0,8/31,15.00%,MSH2;KMT2A;RAD51C;XRCC3;HMGB1;MEN1;HMGB3;GEN1
prerank,protein tyrosine/serine/threonine phosphatase activity (GO:0008138),0.43597100179797443,1.0928278043890873,0.3615894039735099,0.9153274661924576,1.0,6/22,13.34%,DUSP3;SBF1;DUSP29;PPM1F;DUSP10;DUSP16
prerank,RNA polymerase II transcription regulatory region sequence-specific DNA binding (GO:0000977),0.3384772914793347,1.0912606659184585,0.138,0.9164979551586626,1.0,131/831,16.02%,STAT1;STAT2;NLRC5;IRF7;PITX2;SIM1;LHX2;LMX1A;CIART;NR1H2;CC2D1B;ESR2;USF2;MEF2B;TCF24;ZNF483;TFAP2C;GMEB2;RBPJL;ZBTB17;ESRRB;RARG;NFX1;BBX;TEAD2;ZBTB2;NFKB2;STAT3;ZFP37;BATF3;RBL1;ZNF471;ELK3;RUNX1;BHLHE40;NACC1;NKX6-2;RBMX;KLF15;CIC;DHX36;MZF1;NFXL1;JUNB;ZSCAN12;ZNF23;SOX9;ZNF2;ZNF76;ZSCAN22;ZSCAN26;TCF7L2;TCF4;ZBTB43;NFKB1;BCL6;CREBRF;ZBTB38;BACH1;USF1;ZSCAN29;NFATC2;TFAP2B;SNAI2;UBP1;DHX9;SRF;ETV6;TBPL1;IKZF2;SMAD2;GLIS3;MEIS3;ATF6B;TFDP1;DNMT3A;AEBP1;ATF1;HOXA9;NFIB;POU3F1;SCX;DACH2;ELF4;IRF9;BPTF;ZSCAN20;NR2C1;RORA;PROX1;FOXK1;MAX;CTCF;ZBTB5;MITF;XBP1;SKIL;TFDP2;KLF10;ZNF423;CUX1;RELB;TEF;REL;HOXB6;NR3C1;RB1;PRDM4;E2F4;ZNF35;PGBD1;ST18;BCL11B;IKZF1;ZNF418;CASZ1;MYPOP;SOX2;RREB1;CREB5;MYB;POU6F1;ZBTB24;ZBTB34;KLF16;SOX5;GTF2IRD1;MEF2A;CARF;PROX2;PPARD
prerank,monocarboxylic acid binding (GO:0033293),-0.3581617940264843,-1.0884387989633961,0.33098591549295775,1.0,1.0,4/18,12.22%,NAPEPLD;RXRA;RARA;NR2F2
prerank,endopeptidase activator activity (GO:0061133),0.5150735846761907,1.0878547262094207,0.38144329896907214,0.9244387219208771,1.0,7/10,27.42%,PSME2;PSME3;APH1A;APH1B;ADRM1;PSENEN;VSIR
prerank,GTPase activity (GO:0003924),0.3451592773300705,1.0858882915956782,0.3081570996978852,0.9271991780046351,1.0,57/192,23.12%,GBP4;IRGM;GBP5;RAB8B;ATL1;GBP3;RAB21;GBP2;RHOF;GPN2;SRPRA;GSPT1;RHEBL1;GBP7;RRAGC;RHOJ;GNA15;GNA14;LSG1;RAB22A;AGAP2;GFM1;RAB43;RAB11B;RAB5C;RAP1GAP;GCH1;DNM2;RAB14;ARL1;RAB24;SEPTIN9;RAC1;EFTUD2;TBCC;GPN3;GNL2;GPN1;RAB11A;RAB32;HBS1L;RHOT2;RAP2A;RAB5B;RAB1A;RND2;DDX3X;MTG2;RIT1;MMUT;RHOH;RHEB;RRAGA;ENTPD7;RAB2A;OPA1;RAB29
prerank,ligand-gated ion channel activity (GO:0015276),0.41406433558241995,1.084224477341319,0.3575063613231552,0.9286550530041437,1.0,7/30,16.23%,CNGB1;GRIN2D;GRIK3;GRIA2;CHRNB2;GRID1;GRIA4
prerank,magnesium ion binding (GO:0000287),0.34793907929851897,1.0825592896743603,0.31983385254413293,0.9303294177292063,1.0,43/135,22.27%,XYLT2;MSH2;STK38L;DHX36;RRAGC;PDXP;NT5C3A;HMGCL;IDH1;NUDT5;FEN1;PGM1;UBA2;SRPK1;NUAK2;XXYLT1;HPRT1;SIK1;NEK6;DYRK2;EPHX2;PAPOLA;DIS3L2;GEN1;NUDT16;TDG;OXSR1;GCLC;EYA2;SNRK;ENDOV;MARK1;PPA1;BRSK1;STK3;RAP2A;ERN1;TKT;MTPAP;STK11;ABL2;RHEB;IDH3A
prerank,basal RNA polymerase II transcription machinery binding (GO:0001099),0.4048468979673719,1.0776360459404515,0.3477188655980271,0.9430783617823506,1.0,17/33,27.93%,ESRRB;AGO2;UVSSA;DHX9;ELP2;WAC;WDR43;PCF11;RECQL5;ELOF1;SMYD2;RPRD2;ZNF326;SCAF8;AGO1;CDC73;HNRNPU
prerank,protein phosphatase 1 binding (GO:0008157),0.43058069157008105,1.075940791558109,0.38382541720154045,0.9444652335642827,1.0,5/21,15.61%,PPP1R3E;PPP1R3D;AKAP11;PPP1R11;PHACTR4
prerank,GTPase regulator activity (GO:0030695),0.33874997948803864,1.0748862155705101,0.33031218529707956,0.9438694847467641,1.0,66/212,20.40%,WNT11;RASA4;RGPD1;TBC1D1;TAGAP;THY1;SYDE1;TBC1D8;AGAP2;RAPGEF2;CCDC88A;ABR;SEC23A;CDC42SE1;RAP1GAP;SYDE2;SIPA1L2;TBC1D8B;STARD8;ARHGAP25;SRGAP2;HACD3;RIN2;SOS1;ARHGAP10;RGS16;CHN1;ARHGAP11A;SIPA1L1;ALDH1A1;NRP1;RANBP1;ARHGAP39;ARHGAP30;SMAP1;ASAP3;RANBP3L;TBCD;SH3BP1;OPHN1;ARL2BP;TBCK;STXBP5L;LLGL1;OCRL;BCR;RUNDC3A;TBC1D2;RALGAPB;ARHGAP29;NF1;CPEB2;NPRL2;ARAP1;SIPA1L3;NPRL3;ARHGAP24;ARHGAP42;EIF5;ARHGAP18;SGSM1;SGSM3;SIRPA;TBC1D4;RGS10;ARHGAP31
prerank,N-acyltransferase activity (GO:0016410),0.40431789942064505,1.074377068669718,0.3834771886559803,0.9413552059560459,1.0,5/32,6.22%,SATL1;SAT1;NAA50;CERS6;SMARCE1
prerank,"oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor (GO:0016620)",-0.3506902452493948,-1.074313820998846,0.3103448275862069,1.0,1.0,5/18,10.45%,AKR1B1;ALDH2;ALDH18A1;ALDH3B1;FAR1
prerank,ligand-gated channel activity (GO:0022834),0.41407452879711476,1.0741694795577779,0.38333333333333336,0.9379105770191599,1.0,7/29,16.23%,CNGB1;GRIN2D;GRIK3;GRIA2;CHRNB2;GRID1;GRIA4
prerank,cation channel activity (GO:0005261),0.35637812683992826,1.0719213516232997,0.3708820403825717,0.9417366476131683,1.0,15/94,15.79%,TRPM5;TRPM2;TRPM6;CUL5;TMEM38A;CALHM6;TRPM3;PANX1;ANO10;KCNK3;PSEN1;TRPV4;TMEM38B;TRPM7;SLC24A3
prerank,NADPH binding (GO:0070402),0.4747119239472487,1.0703284329968916,0.4002828854314003,0.9428188724527372,1.0,2/13,1.99%,DHFR;GRHPR
prerank,R-SMAD binding (GO:0070412),0.4498030373753277,1.069638825099513,0.39470198675496687,0.9409656092978385,1.0,5/18,12.19%,DDX5;PMEPA1;SMAD2;MEN1;SMURF1
prerank,endopeptidase activity (GO:0004175),0.33526125237414084,1.0685546804728818,0.3293172690763052,0.940428427923346,1.0,38/257,15.96%,USP18;CASP4;CASP7;ADAM33;PSMB10;CTSS;PSMA5;PRSS12;ADAMTS3;USP25;MMP14;CASP6;USP15;USP40;PSMA3;ADAMTS19;CTSC;NLN;CTSH;PSMB9;USP34;PCSK7;KLK1;USP14;RHBDF2;PSEN1;ADAMTS2;PITRM1;PREP;MASP1;NAPSA;KDM8;PSMA4;USP37;ADAMTS6;HTRA3;ADAMTS12;SPRTN
prerank,histone-lysine N-methyltransferase activity (GO:0018024),0.37967872507989503,1.0685082337609204,0.38971428571428574,0.9364620199245219,1.0,16/44,22.76%,RBBP5;KMT2A;NSD3;SETD3;ASH1L;MEN1;WDR5;SETD5;SETDB2;EZH2;SMYD1;SMYD2;SMYD5;SETD7;KMT5C;KMT2D
prerank,transcription cis-regulatory region binding (GO:0000976),0.3327921787184559,1.066336085421981,0.306,0.9399718014851042,1.0,78/406,18.51%,PITX2;SIM1;LHX2;LMX1A;TCF24;TFAP2C;PER2;ZBTB17;ESRRB;NFX1;XRN2;BBX;AGO2;STAT3;ARID5B;ZFP37;RBBP5;RBL1;ELK3;RUNX1;KLF15;CIC;DHX36;MZF1;NFXL1;SOX9;TCF7L2;ZBTB43;NFKB1;CREBRF;TFAP2B;SNAI2;ETV6;SMAD2;ATF6B;TFDP1;CDK5RAP2;NONO;AEBP1;ATF1;TAF2;SCX;HMGB1;MEN1;HNRNPL;RORA;PROX1;NPM1;FOXK1;MAX;CTCF;ZBTB5;XBP1;TFDP2;LONP1;KLF10;CUX1;NR3C1;RB1;ZNF35;CASZ1;SOX2;RREB1;SOX5;MEF2A;TIPARP;SREBF1;ZBED4;ZBTB4;BRD7;POU2F2;DACH1;ZNF513;FOSL2;HDAC1;HINFP;GABPB1;GABPB2
prerank,pyrophosphatase activity (GO:0016462),0.3709213522437842,1.0646770240267183,0.4,0.9413251313672725,1.0,17/50,22.64%,TRPM2;ENTPD3;ENPP3;ENTPD6;DCP2;DHX9;NUDT5;ENTPD5;ENPP1;NUDT16;NUDT4;DCPS;PPA1;DDX3X;LHPP;ENTPD7;DOLPP1
prerank,calcium channel activity (GO:0005262),0.35505348004585124,1.0639880013814786,0.3786096256684492,0.9394873939127313,1.0,13/84,15.79%,TRPM5;CATSPER4;TRPM2;CACNA2D4;TMC1;CUL5;CACNA1A;P2RX4;PANX1;PSEN1;TRPV4;TRPM7;SLC24A3
prerank,transaminase activity (GO:0008483),0.48304374569373615,1.061992658714375,0.40454545454545454,0.9425294670983958,1.0,1/11,0.65%,AGXT
prerank,cholesterol transfer activity (GO:0120020),0.4587945341352948,1.0615936814378706,0.3958904109589041,0.9398037378836109,1.0,6/16,19.16%,ABCA1;ABCG1;NPC2;GRAMD1C;MTTP;OSBPL2
prerank,phospholipase activity (GO:0004620),-0.2463329780348469,-1.0607939946793694,0.2962962962962963,1.0,1.0,21/67,21.60%,PLCB2;ABHD16A;LYPLA1;PLAAT3;NAPEPLD;LIPH;SMPDL3A;SMPD3;LYPLAL1;PDIA3;PLBD1;PITPNM3;MGLL;ABHD12;PLD4;LPL;SEC23IP;PLA2G15;SMPD1;ABHD6;SMPD2
prerank,transcription coregulator binding (GO:0001221),0.37854560015043304,1.0603043579921223,0.3861271676300578,0.9398959600067139,1.0,16/50,20.04%,THAP7;PER2;ZBTB17;TEAD2;CTNNB1;CCNT2;LMO2;RORA;CTCF;NEK6;LCOR;EZH2;PPARD;ZBTB49;CTBP1;PER1
prerank,kinase binding (GO:0019900),0.33111613357201025,1.0595445568246888,0.309,0.9384205288011371,1.0,143/434,25.98%,SP100;IRGM;TRIM14;NOD2;MSH2;TPRKB;IL15RA;TRIB3;SPRY2;SOCS1;DAXX;ZFP36;UTRN;CHEK2;SASH1;STAT3;FBXO7;CDC25B;TRIM21;THY1;RHOF;CCND2;HSP90AB1;CDKN2D;CACUL1;DUSP3;CTNNB1;CCND1;FAM83H;PFKM;AP2A1;ARHGEF7;CAB39;TCF7L2;PIP5K1A;USF1;DOK7;MAP2K3;CYLD;MAPRE1;AGAP2;MTCP1;CNTLN;CDK5RAP2;BCAR1;CSPG4;BARD1;CNKSR2;SIKE1;NEK9;PRKAG1;UBQLN1;MOB1B;NPM1;CEP152;SIK1;IRAK4;GSN;NEK6;RELB;STAP1;PTPN11;NR3C1;RB1;TRPV4;RPS6;LIMS1;BAD;TELO2;LYST;RAC1;ACTB;SNAP91;JAK2;IFNAR2;DLG1;RB1CC1;TNIP2;USP37;CALM3;ERCC6L2;CRK;OXSR1;NBEA;IRAK1;CCNK;BLNK;LLGL1;ZBTB4;TRIP4;SPRED3;PTPRC;CDC37;MIDN;RFFL;SPRED1;BECN1;PER1;ACVRL1;PPP2R5A;RND2;ANKRA2;LCK;ADIPOR1;GADD45A;CADPS;RHOH;CKS2;TRIP6;PRKCD;STUB1;TOM1L2;PRDX3;GPRC5B;MAPRE3;MSN;RAD9A;IRF5;PPP1R12A;SYN1;AXIN1;KAT2B;ACSL3;EXOC2;PTPN6;PRKAB2;CALM2;FLNA;ANK2;TUBA4A;PTPN23;CEP192;WDCP;CDKN2A;DCTN1;PIH1D1;SHC1;CHP1;RAD23A;FERMT2;PTPN1;ADD2;CAV2
prerank,proton transmembrane transporter activity (GO:0015078),0.38328791721344946,1.0592907958020927,0.3978622327790974,0.9352051636016417,1.0,7/39,14.18%,UQCRQ;MFSD3;SLC46A1;SLC11A2;DMAC2L;UQCR10;CTNS
prerank,transition metal ion transmembrane transporter activity (GO:0046915),0.4075999477725155,1.0592868830183215,0.4093198992443325,0.9312641887733593,1.0,11/30,25.59%,SLC30A1;SLC30A5;SLC11A2;TTYH1;SLC39A10;SLC39A3;SLC31A1;SLC25A28;TMEM165;SLC39A13;ATP7B
prerank,m7G(5')pppN diphosphatase activity (GO:0050072),0.48921771552165916,1.0590442069726236,0.39461883408071746,0.9281668208818057,1.0,5/11,18.01%,DCP2;NUDT5;NUDT16;NUDT4;DCPS
prerank,GTPase activator activity (GO:0005096),0.33124609821107165,1.0589400324916411,0.34634634634634637,0.9246035469469265,1.0,94/313,20.51%,WNT11;RASA4;DOCK8;RGPD1;RGP1;TBC1D1;RINL;TAGAP;SPATA13;THY1;SYDE1;SBF1;RCC1L;ARHGEF7;HERC2;TBC1D8;GAPVD1;DENND1A;RAPGEF6;AGAP2;RAPGEF2;CCDC88A;ABR;EIF2B2;SEC23A;RAP1GAP;SYDE2;VAV1;SIPA1L2;TBC1D8B;STARD8;ARHGAP25;ANKRD27;ARHGEF11;SRGAP2;HACD3;RIN2;ARHGEF10;SOS1;ARHGAP10;LAMTOR3;ARFGEF2;RGS16;CHN1;ARHGAP11A;SIPA1L1;RIC1;FGD6;ALDH1A1;IQSEC2;AKAP13;RAPGEF1;NRP1;RANBP1;ARHGAP39;ARHGAP30;SMAP1;ASAP3;RANBP3L;DENND10;MYCBP2;DENND6B;TBCD;SH3BP1;DENND4A;OPHN1;TBCK;STXBP5L;LLGL1;OCRL;BCR;TBC1D2;WDR41;PLCE1;RALGAPB;ARHGAP29;NF1;EIF2B5;EIF2B3;NPRL2;ARAP1;SIPA1L3;DENND1B;NPRL3;ARHGAP24;ARHGAP42;ARHGAP18;SGSM1;SGSM3;TBC1D4;RGS10;LAMTOR4;ARHGAP31;DOCK10
prerank,quaternary ammonium group transmembrane transporter activity (GO:0015651),0.4889953259433185,1.0587864326551248,0.4116788321167883,0.921250571851111,1.0,3/11,26.95%,SLC25A47;SLC25A45;SLC22A4
prerank,protein serine/threonine kinase activity (GO:0004674),0.3310166436251288,1.0585022660953298,0.328,0.9183962560927316,1.0,93/334,22.44%,EIF2AK2;PKMYT1;TAOK3;DAPK3;SRPK3;CAMK2D;TP53RK;ALPK1;SGK3;SGK2;FASTK;CPNE3;BRD2;CAMK2B;CHEK2;ACVR1;MAPK6;MAP3K8;STK38L;PKN2;PNCK;CHEK1;IKBKE;CDK12;MKNK1;PAK3;NRBP2;CSNK2B;CSNK2A2;HTATIP2;VRK3;CLK3;SRPK1;PLK3;PIK3R4;BMPR2;MAST3;MAPK14;CDK19;TNIK;CDK10;NUAK2;CDK20;RIOK3;BCKDK;SIK1;PIM1;IRAK4;NEK6;DYRK2;PRKDC;PRKCE;CLK2;MAP3K4;PRKCH;FAM20C;MASTL;MINK1;BMPR1A;NRBP1;TAOK2;OXSR1;MTOR;IRAK1;CCNK;PHKG2;STK39;BCR;SNRK;ACVR2A;MARK1;BRSK1;TESK1;MAP3K15;NEK7;STK16;STK24;STK3;AAK1;ERN1;RIPK2;ACVRL1;TLK2;MAP4K2;STK11;SBK1;PRKCD;CDK9;AKT3;MAPK9;PIM3;CDK8;CDK16
prerank,vinculin binding (GO:0017166),-0.40713923814630887,-1.0569934758883919,0.39520958083832336,1.0,1.0,5/11,5.89%,SORBS3;CTNNA1;PXN;DMD;CORO2B
prerank,Toll-like receptor binding (GO:0035325),0.4870117598869621,1.0565235118716687,0.4206471494607088,0.9209010220974524,1.0,3/11,15.45%,UNC93B1;MYD88;TLR2
prerank,SH2 domain binding (GO:0042169),0.3998041488361049,1.0549931820800902,0.4240583232077764,0.922060994591712,1.0,11/31,20.60%,SLAMF1;IRS1;CCDC88A;TRPV4;RACK1;JAK2;CRK;BLNK;SH3PXD2B;PAG1;LCK
prerank,carbohydrate kinase activity (GO:0019200),0.4927551484142483,1.053271246141143,0.4221556886227545,0.9238200249208185,1.0,4/11,14.23%,HK1;FGGY;GNE;GALK2
prerank,calcium ion binding (GO:0005509),0.3279835605942019,1.0520658085938677,0.3727454909819639,0.9237463050153867,1.0,53/323,17.26%,NOL3;CABP4;LOXL2;AOAH;ASPH;COMP;TRPM2;CDH13;CANT1;RCN1;ASAH2;LRP2;ADAM8;SLC8A1;ENPP3;CABYR;ITPR1;TNNC1;PITPNM1;SYT7;RET;AIF1L;FBN1;CDH9;CETN3;BAIAP3;RAPGEF2;SMOC2;SYT3;PRNP;AGRN;CIB1;CRACR2A;ADGRV1;NOTCH4;SLIT3;SLIT1;GSN;ENPP1;CAPN1;MICU2;MASP1;DNER;SLC25A12;PAM;CALM3;ACER3;RPH3A;AIF1;PCDHA4;PCP4;SPARCL1;ANXA4
prerank,fatty acid synthase activity (GO:0004312),0.49744013852507835,1.0514082907529456,0.3991031390134529,0.9220089939757932,1.0,1/10,0.51%,MCAT
prerank,"DNA binding, bending (GO:0008301)",0.4556924956123878,1.0488700666433268,0.4298375184638109,0.9264896811825863,1.0,3/14,11.77%,SAP30L;HMGB1;HMGB3
prerank,death receptor activity (GO:0005035),-0.400436195463748,-1.0462254113505036,0.3824451410658307,1.0,1.0,9/11,51.12%,TNFRSF1B;TNFRSF19;FAS;TNFRSF25;TNFRSF4;NGFR;TNFRSF1A;EDA2R;TNFRSF11A
prerank,lysophospholipase activity (GO:0004622),-0.3423700803051933,-1.0451707963819425,0.412,1.0,1.0,5/20,13.47%,ABHD16A;LYPLA1;LYPLAL1;MGLL;ABHD12
prerank,glycerophospholipid flippase activity (GO:0140333),0.48152186843775635,1.0450931939037078,0.4330357142857143,0.9346513207921593,1.0,2/11,4.37%,ATP10A;ATP8A1
prerank,protein-arginine N-methyltransferase activity (GO:0016274),0.48516360466518527,1.0444990652501467,0.42424242424242425,0.932754393744921,1.0,5/11,25.41%,PRMT2;PRMT1;PRMT3;FBXO11;PRMT9
prerank,iron ion binding (GO:0005506),0.37273250300905947,1.0439930258935268,0.4178082191780822,0.9306912214678721,1.0,11/48,16.97%,ETHE1;FXN;EGLN2;NFU1;ALKBH1;ABCE1;SCD5;ALKBH2;TET2;KDM7A;FBXL5
prerank,protein kinase binding (GO:0019901),0.3256542300135277,1.0430630322260859,0.359,0.9296633592278284,1.0,107/479,17.39%,IRGM;TRIM14;NOD2;MSH2;TPRKB;IL15RA;TRIB3;SPRY2;IRS1;SOCS1;DAXX;ZFP36;UTRN;CHEK2;NELL2;ACVR1;SASH1;STAT3;FBXO7;CDC25B;TRIM21;THY1;MAD2L2;RHOF;CCND2;CDKN2D;CACUL1;DUSP3;SOX9;CCND1;FAM83H;AP2A1;EPHA4;ARHGEF7;TCF7L2;USF1;DOK7;MAP2K3;NBR1;CYLD;MAPRE1;AGAP2;MTCP1;CNTLN;MAPK8IP3;CDK5RAP2;CCDC88A;DACT1;BCAR1;CSPG4;PRKAR2B;CNKSR2;SIKE1;BMPR2;NEK9;PRKAG1;ROR2;TNIP1;GCH1;PRR7;NPM1;CEP152;SIK1;IRAK4;NEK6;RELB;STAP1;PTPN11;TJP2;NR3C1;DUSP10;TRPV4;RACK1;RPS6;LIMS1;BAD;DUSP16;TELO2;NELL1;LYST;RAC1;ACTB;SNAP91;JAK2;IFNAR2;DLG1;RB1CC1;TNIP2;HSP90AA1;USP37;CALM3;ERCC6L2;CRK;SPAG9;TAOK2;OXSR1;NBEA;IRAK1;CCNK;BLNK;LLGL1;ZBTB4;CSK;TRIP4;PRKAR2A;SPRED3;PTPRC
prerank,sulfuric ester hydrolase activity (GO:0008484),-0.37438549630154666,-1.04202269801711,0.42258064516129035,1.0,1.0,4/12,16.57%,ARSB;SULF1;ARSK;SGSH
prerank,retinoic acid receptor binding (GO:0042974),0.4452588297770085,1.0418845353336883,0.43072702331961593,0.9296420659354964,1.0,3/17,10.96%,PRMT2;RARG;SNW1
prerank,androgen receptor binding (GO:0050681),0.4047224011528752,1.0418821923719255,0.4368556701030928,0.9259611610772236,1.0,3/25,3.61%,DAXX;PRMT2;DDX5
prerank,carboxypeptidase activity (GO:0004180),-0.2904075890464884,-1.0409322276579143,0.38461538461538464,1.0,1.0,9/35,15.93%,AGBL4;BLMH;CTSA;AGTPBP1;AGBL5;AGBL3;CTSZ;CPE;CPA6
prerank,I-SMAD binding (GO:0070411),0.4774585471507772,1.040861396615559,0.42736248236953456,0.9255730884455574,1.0,3/13,12.19%,CTNNB1;SMAD2;SMURF1
prerank,hormone activity (GO:0005179),0.3697981804557309,1.0407646749826287,0.42536475869809204,0.9222930049252414,1.0,2/54,0.65%,GAL;AGT
prerank,insulin-like growth factor binding (GO:0005520),-0.36294545783950916,-1.0393725132760814,0.37809187279151946,1.0,1.0,9/15,23.36%,ITGAV;IGF2R;IGFBP5;IGFBP4;IGF1R;ITGB3;ITGB4;IGFBP6;IGFBP3
prerank,sequence-specific DNA binding (GO:0043565),0.3204037282454675,1.028390856665723,0.393,0.9571914643303203,1.0,96/590,17.09%,IRF7;PITX2;LMX1A;USF2;ETV3;MEF2B;MYBBP1A;TFAP2C;GMEB2;LRWD1;ESRRB;RARG;BBX;TEAD2;ZBTB2;NFKB2;MECP2;BATF3;ELK3;SMG7;BHLHE40;NKX6-2;KLF15;JUNB;ZNF23;SOX9;KMT2A;ZNF76;MBD2;TCF7L2;TCF4;ZBTB43;BCL6;ZBTB38;USF1;ZSCAN29;NFATC2;TFAP2B;SNAI2;UBP1;SRF;MEIS3;ATF6B;SLTM;HOXA9;NFIB;POU3F1;SCX;ELF4;IRF9;BPTF;NR2C1;RORA;PROX1;FOXK1;MAX;CTCF;XBP1;LONP1;SMG5;KLF10;ZNF423;CUX1;TEF;PPARGC1A;UPF2;HOXB6;NR3C1;UPF3A;FBXL19;PRDM4;E2F4;ZNF35;CXXC4;CHTOP;TELO2;STN1;ZBTB21;BCL11B;SOX2;CREB5;POU6F1;MBNL2;ERF;KLF16;ZCWPW1;MEF2A;PRMT1;PPARD;SREBF1;UPF1;ZBTB4;RBPJ;CHCHD2;ELF1;HMBOX1
prerank,triglyceride lipase activity (GO:0004806),0.4193406928836713,1.0263226358768889,0.4528301886792453,0.960152141338421,1.0,2/20,7.72%,PNPLA2;LIPC
prerank,protein tyrosine kinase binding (GO:1990782),0.34804903654749936,1.0246580046593552,0.43982494529540483,0.9613794087461953,1.0,16/71,16.49%,CPNE3;ACVR1;ELMO2;DUSP3;PITPNM1;EPHA4;NCK1;SOCS5;BMPR2;PRR7;PTPN11;TJP2;RACK1;HSP90AA1;CRK;BLNK
prerank,lipoprotein particle binding (GO:0071813),0.4245398326354901,1.0232803089146585,0.4448871181938911,0.9618925783985051,1.0,6/20,20.82%,STAB2;CDH13;LIPC;SORL1;LDLR;MSR1
prerank,myosin binding (GO:0017022),0.3589378882764926,1.0230616407230424,0.4402234636871508,0.9589122937432887,1.0,13/55,16.50%,CXCR4;TRAK1;MYOC;RAB11B;SPATA6;RAB14;GSN;MYRIP;MOBP;NCKIPSD;RAB11A;STXBP5L;LLGL1
prerank,chemokine binding (GO:0019956),0.38147446892644155,1.020099742625862,0.4440251572327044,0.9642461524796396,1.0,5/30,9.13%,CXCR4;ZFP36;ACKR3;PDPN;HMGB1
prerank,"acyltransferase activity, transferring groups other than amino-acyl groups (GO:0016747)",0.3497097588452198,1.019911815663722,0.4488697524219591,0.9611104850647966,1.0,26/69,27.29%,LIPT1;MCAT;ZDHHC21;ZDHHC20;CERS6;HHAT;LPGAT1;SOAT2;KAT8;ZDHHC13;SOAT1;ZDHHC8;CERS2;PLA2G4E;ZDHHC3;DBT;NMT1;ZDHHC18;KAT6A;AWAT2;KAT2B;ZDHHC17;ZDHHC16;PLA2G4A;ZDHHC7;EP300
prerank,phosphatase activator activity (GO:0019211),0.4490057350063026,1.0198221709190833,0.4523809523809524,0.9577165193117915,1.0,6/14,24.43%,PPP2R5C;PPP2R5D;CALM3;PHACTR4;PPP2R5A;CALM2
prerank,C-C chemokine binding (GO:0019957),0.4045908178730716,1.01912909100194,0.4630606860158311,0.9560587628858871,1.0,3/22,8.47%,CXCR4;ZFP36;ACKR3
prerank,acid-thiol ligase activity (GO:0016878),-0.378137785564135,-1.0161277171119667,0.4309210526315789,1.0,1.0,5/13,21.70%,ACSS3;AACS;ACSL1;ACSS1;SLC27A2
prerank,1-phosphatidylinositol binding (GO:0005545),0.448484674351848,1.0156317261501815,0.46685082872928174,0.9632832905309857,1.0,7/15,24.25%,SNX10;WDFY1;SNX9;SNAP91;ZFYVE1;EEA1;WDFY3
prerank,alcohol dehydrogenase (NADP+) activity (GO:0008106),0.4740753880238382,1.0155543550218102,0.4438122332859175,0.95990404556474,1.0,3/11,11.01%,RDH14;RDH11;AKR1B10
prerank,adenylate cyclase binding (GO:0008179),0.48268877447298786,1.0154794079239404,0.4583333333333333,0.9565347645331969,1.0,3/10,15.21%,ADCY5;AKAP12;CALM3
prerank,"oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (GO:0016616)",0.34498793516621257,1.0142865206646132,0.46012931034482757,0.9566410499527376,1.0,12/75,12.63%,SORD;GRHPR;HSD17B7;PHGDH;PGD;PTGR1;DHRS4;RDH11;LDHD;AKR1B10;DHRS11;LDHB
prerank,phosphatidylinositol monophosphate phosphatase activity (GO:0052744),-0.3398243333016733,-1.0140726404025682,0.4070175438596491,1.0,1.0,6/16,16.27%,INPP5F;MTMR1;MTMR4;MTMR9;MTMR10;MTM1
prerank,dipeptidyl-peptidase activity (GO:0008239),-0.401998771278704,-1.0137762080035904,0.4298780487804878,1.0,1.0,5/10,17.61%,DPP8;DPP4;DPP7;DPP9;FAP
prerank,metal ion binding (GO:0046872),0.313732965435084,1.0133198734404414,0.475,0.9557923325500338,1.0,109/477,21.87%,NOL3;CABP4;LOXL2;AOAH;XYLT2;ASPH;MSH2;COMP;TRPM2;CDH13;CANT1;RCN1;ASAH2;LRP2;ADAM8;SLC8A1;STK38L;ENPP3;CABYR;ITPR1;DHX36;TNNC1;RRAGC;PITPNM1;PDXP;MT3;NT5C3A;HMGCL;SYT7;RET;IDH1;AIF1L;FBN1;NUDT5;CDH9;FEN1;PGM1;CETN3;BAIAP3;RAPGEF2;SMOC2;SYT3;UBA2;SRPK1;PRNP;AGRN;CIB1;CRACR2A;NUAK2;ADGRV1;XXYLT1;NOTCH4;HPRT1;SLIT3;SLIT1;SIK1;GSN;NEK6;TRIM26;DYRK2;EPHX2;APOE;ENPP1;CAPN1;PAPOLA;MICU2;MASP1;DIS3L2;DNER;SLC25A12;GEN1;PAM;CALM3;NUDT16;TDG;OXSR1;ACER3;RPH3A;AIF1;GCLC;PCDHA4;PCP4;SPARCL1;EYA2;ANXA4;SNRK;MAN1C1;ENDOV;MARK1;PPA1;BRSK1;STK3;CAMKK2;RAP2A;PLA2G4E;ERN1;TGM2;RPE;EFHD2;TKT;SPARC;TPD52;MTPAP;STK11;MCTP1;ABL2;RHEB;ARSA;S100A13
prerank,sequence-specific double-stranded DNA binding (GO:1990837),0.31607495692696885,1.012855314605943,0.457,0.9534265747215831,1.0,78/597,12.97%,IRF7;PITX2;LMX1A;USF2;ETV3;MEF2B;TFAP2C;PER2;GMEB2;MCM2;ESRRB;RARG;BBX;DHX33;TEAD2;ZBTB2;NFKB2;STAT3;ARID5B;BATF3;RBBP5;ELK3;RUNX1;MCM7;BHLHE40;NKX6-2;KLF15;DHX36;MZF1;JUNB;MCM4;ZNF23;SOX9;KIF2C;ZNF76;MBD2;TCF7L2;TCF4;ZBTB43;NFKB1;BCL6;MCM9;USF1;ZSCAN29;NFATC2;TFAP2B;SNAI2;UBP1;DHX9;SRF;MEIS3;ATF6B;CDK5RAP2;NONO;HOXA9;NFIB;TAF2;POU3F1;HMGB1;ELF4;IRF9;MEN1;HNRNPL;NR2C1;PROX1;FOXK1;MAX;CTCF;XBP1;KLF10;CUX1;TEF;HOXB6;ORC3;NR3C1;DDX11;PRDM4;E2F4
prerank,cholesterol binding (GO:0015485),0.3629060866888816,1.0126921714002768,0.4659746251441753,0.9503518188857512,1.0,18/47,21.63%,ABCA1;ABCG1;OSBPL8;OSBPL7;OSBPL3;STARD3;TSPO;PTCH1;NPC1;ERLIN2;OSBP2;NPC2;GRAMD1C;SOAT2;SOAT1;OSBPL2;OSBPL10;VDAC2
prerank,phosphatidylinositol phosphate kinase activity (GO:0016307),0.4478390555126812,1.010187515428386,0.4805013927576602,0.9546404905423744,1.0,3/13,13.05%,PIK3CD;PIP5K1A;PIK3CB
prerank,heme binding (GO:0020037),0.34771042163135407,1.0088735556206507,0.4654983570646221,0.9549216979620467,1.0,13/65,18.29%,PXDNL;CYBB;THAP4;BACH1;CYB5B;CYP26B1;CYP27A1;CYB561D1;JAK2;PTGES2;PGRMC1;HMOX2;FLVCR1
prerank,RNA polymerase II cis-regulatory region sequence-specific DNA binding (GO:0000978),0.31313353017136325,1.008224198399701,0.459,0.9532671869967715,1.0,110/731,16.02%,STAT1;STAT2;NLRC5;IRF7;PITX2;CIART;NR1H2;CC2D1B;ESR2;USF2;MEF2B;ZNF483;TFAP2C;GMEB2;RBPJL;ZBTB17;ESRRB;RARG;TEAD2;ZBTB2;NFKB2;STAT3;BATF3;ZNF471;ELK3;RUNX1;BHLHE40;NACC1;NKX6-2;RBMX;KLF15;DHX36;MZF1;JUNB;ZSCAN12;ZNF23;SOX9;ZNF2;ZNF76;ZSCAN22;ZSCAN26;TCF7L2;TCF4;NFKB1;BCL6;ZBTB38;BACH1;USF1;ZSCAN29;NFATC2;TFAP2B;SNAI2;UBP1;DHX9;SRF;IKZF2;SMAD2;GLIS3;MEIS3;ATF6B;DNMT3A;ATF1;HOXA9;NFIB;POU3F1;SCX;DACH2;ELF4;IRF9;BPTF;ZSCAN20;NR2C1;RORA;PROX1;FOXK1;MAX;CTCF;ZBTB5;MITF;XBP1;SKIL;KLF10;ZNF423;RELB;TEF;REL;HOXB6;NR3C1;PRDM4;E2F4;PGBD1;ST18;BCL11B;IKZF1;ZNF418;MYPOP;SOX2;RREB1;CREB5;MYB;POU6F1;ZBTB24;ZBTB34;KLF16;SOX5;GTF2IRD1;MEF2A;CARF;PROX2;PPARD
prerank,"3',5'-cyclic-AMP phosphodiesterase activity (GO:0004115)",0.4558165889222472,1.007631602105883,0.47058823529411764,0.9517222072847471,1.0,5/12,21.82%,PDE7B;PDE8B;PDE3A;PDE4B;PDE4A
prerank,potassium:proton antiporter activity (GO:0015386),-0.41183257508132787,-1.007495774357429,0.47953216374269003,1.0,1.0,1/10,1.02%,SLC9A9
prerank,hyaluronic acid binding (GO:0005540),0.4749130391033217,1.007379468367642,0.46808510638297873,0.9489336310712407,1.0,2/10,8.20%,STAB2;IMPG2
prerank,cis-regulatory region sequence-specific DNA binding (GO:0000987),0.31257788965745303,1.007289193818267,0.469,0.945781989667197,1.0,109/732,16.02%,STAT1;STAT2;NLRC5;IRF7;PITX2;CIART;NR1H2;CC2D1B;ESR2;USF2;MEF2B;ZNF483;TFAP2C;GMEB2;RBPJL;ZBTB17;ESRRB;RARG;TEAD2;ZBTB2;NFKB2;STAT3;BATF3;ZNF471;ELK3;RUNX1;BHLHE40;NACC1;NKX6-2;RBMX;KLF15;DHX36;MZF1;JUNB;ZSCAN12;ZNF23;SOX9;ZNF2;ZNF76;ZSCAN22;ZSCAN26;TCF7L2;TCF4;NFKB1;BCL6;ZBTB38;BACH1;USF1;ZSCAN29;NFATC2;TFAP2B;SNAI2;UBP1;DHX9;SRF;IKZF2;SMAD2;GLIS3;MEIS3;ATF6B;DNMT3A;ATF1;HOXA9;NFIB;POU3F1;DACH2;ELF4;IRF9;BPTF;ZSCAN20;NR2C1;RORA;PROX1;FOXK1;CTCF;ZBTB5;MITF;XBP1;SKIL;KLF10;ZNF423;RELB;TEF;REL;HOXB6;NR3C1;PRDM4;E2F4;PGBD1;ST18;BCL11B;IKZF1;ZNF418;MYPOP;SOX2;RREB1;CREB5;MYB;POU6F1;ZBTB24;ZBTB34;KLF16;SOX5;GTF2IRD1;MEF2A;TIPARP;CARF;PROX2;PPARD
prerank,endopeptidase regulator activity (GO:0061135),0.3635861233088139,1.0039499342668408,0.4848837209302326,0.9521780731123923,1.0,8/40,15.31%,PSME2;SLPI;UCHL5;CST7;USP14;PSME3;APH1A;APH1B
prerank,U6 snRNA binding (GO:0017070),-0.36114446111865806,-1.0001798489556901,0.4565916398713826,1.0,1.0,6/14,22.88%,METTL16;LARP7;LSM3;LSM2;TUT1;RBM22
prerank,protein phosphorylated amino acid binding (GO:0045309),0.35953121359264323,0.9997574791937547,0.5,0.9612841039275583,1.0,17/42,25.64%,IRS1;HCK;FBXW7;SH3BP2;NCK2;LDLRAP1;VAV1;STAP1;PTPN11;CRK;PIN1;LCK;YES1;ABL2;PTPN6;YWHAE;SHC1
prerank,phosphoric diester hydrolase activity (GO:0008081),-0.26879264279022325,-0.9988232705769894,0.46236559139784944,1.0,1.0,10/35,16.15%,APEX2;PLCB2;MPPED2;NAPEPLD;SMPDL3A;SMPD3;PDIA3;PLD4;GPCPD1;SMPDL3B
prerank,actin monomer binding (GO:0003785),-0.3120534681828498,-0.9966177965458075,0.45414847161572053,1.0,1.0,4/22,9.52%,MTSS1;COBL;CORO1A;TMSB10
prerank,endodeoxyribonuclease activity (GO:0004520),0.4072988813350231,0.99524449637974,0.47638326585695007,0.9712488091711935,1.0,6/20,19.65%,APLF;FEN1;ERCC4;ZRANB3;ENDOV;DCLRE1C
prerank,peptidase activator activity (GO:0016504),0.397235643986401,0.9940888255236638,0.47797927461139894,0.9710078431610988,1.0,11/22,27.42%,PSME2;PSME4;PSME3;APH1A;APH1B;PCOLCE;TANK;ADRM1;VCP;PSENEN;VSIR
prerank,transcription corepressor binding (GO:0001222),0.3822345535261859,0.9914056351362119,0.49125,0.9752823670135622,1.0,8/27,20.04%,THAP7;PER2;RORA;NEK6;LCOR;EZH2;CTBP1;PER1
prerank,amino acid:sodium symporter activity (GO:0005283),0.46560846170435877,0.9909273265108416,0.4880952380952381,0.9731896380862868,1.0,2/11,3.40%,SLC38A2;SLC38A1
prerank,phosphatidic acid binding (GO:0070300),0.40465541340824274,0.9901813588340429,0.48874172185430464,0.9718629118753032,1.0,4/19,8.10%,PLEKHN1;PITPNM1;RAPGEF6;RAPGEF2
prerank,voltage-gated potassium channel activity (GO:0005249),-0.2216954282138098,-0.9898908989741857,0.4444444444444444,1.0,1.0,37/80,40.50%,KCNC2;KCNH1;KCNJ10;KCNQ5;KCND2;KCND1;KCND3;KCNK6;KCNA2;KCNC3;KCNG2;KCNC1;KCNT2;KCNT1;KCNJ6;HCN3;KCNJ13;KCNB2;KCNH5;KCNC4;KCNH2;KCNQ4;KCNJ12;HCN4;LRRC55;KCNJ16;KCNH4;KCNN1;KCNQ1;KCNIP2;KCNG1;KCNE3;KCNJ15;KCNG4;KCNA6;KCNE4;KCNG3
prerank,sodium:proton antiporter activity (GO:0015385),-0.3905794545114297,-0.989066701153436,0.4837758112094395,1.0,1.0,3/11,23.88%,SLC9A9;SLC9A8;SLC9B2
prerank,MAP kinase kinase kinase activity (GO:0004709),-0.3838665226454504,-0.9876786886150822,0.45425867507886436,1.0,1.0,3/11,11.96%,MAP3K20;EGFR;MAP3K13
prerank,ubiquitin-like protein conjugating enzyme binding (GO:0044390),0.36919972899833225,0.9876010429197611,0.4975609756097561,0.9760567250668508,1.0,8/33,12.90%,AUP1;RNF5;SIAH1;DCUN1D4;RNF19B;UBA2;ARIH1;RNF185
prerank,"oxidoreductase activity, acting on NAD(P)H, oxygen as acceptor (GO:0050664)",-0.35444842711889296,-0.9867867330561212,0.48771929824561405,1.0,1.0,5/14,15.09%,MICAL1;NOX1;AIFM1;NCF2;KMO
prerank,tRNA binding (GO:0000049),-0.256197290728577,-0.9867157231558598,0.46715328467153283,1.0,1.0,12/43,13.79%,FARS2;EEF1A1;EIF2A;TYW5;PSTK;TRNT1;MRPS27;TRMT10B;RPUSD4;YRDC;TRMT10A;NEMF
prerank,transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential (GO:1904315),0.38107795126527133,0.9857210975041207,0.49501246882793015,0.9778859869558129,1.0,9/28,25.14%,CHRNA9;GRIK3;CHRNB2;GRID1;GABRG1;GRIK4;GABRA3;GRIK5;GRIK2
prerank,estrogen receptor binding (GO:0030331),0.3733265190583702,0.9848458784981963,0.4926289926289926,0.9769445826990453,1.0,9/32,23.85%,PRMT2;NCOA1;CTNNB1;DDX54;LCOR;TRIP4;CCDC62;NRIP1;TACC1
prerank,K63-linked polyubiquitin modification-dependent protein binding (GO:0070530),0.3985588385929603,0.9825067471101954,0.49865229110512127,0.980289588601448,1.0,8/22,21.28%,PARP10;IKBKE;ZRANB3;ZRANB1;SPRTN;TAB3;ATRIP;OPTN
prerank,semaphorin receptor binding (GO:0030215),-0.3052385043499608,-0.9799196216419782,0.44155844155844154,1.0,1.0,13/23,29.01%,SEMA4C;SEMA4G;SEMA4A;SEMA6A;SEMA4B;SEMA3E;SEMA5B;SEMA6D;SEMA4F;SEMA6C;SEMA6B;SEMA3B;SEMA3F
prerank,neuropeptide hormone activity (GO:0005184),0.3939849790516992,0.9774173213423151,0.513375796178344,0.991567210648448,1.0,1/22,0.59%,GAL
prerank,retinoic acid binding (GO:0001972),-0.3644692933313084,-0.9762159810671687,0.4622356495468278,1.0,1.0,3/12,12.22%,RXRA;RARA;NR2F2
prerank,carboxy-lyase activity (GO:0016831),0.3880046567375274,0.974829908901361,0.5155440414507773,0.9956202855537296,1.0,6/23,18.07%,AZIN2;DDC;AZIN1;GGCX;ACOD1;GAD1
prerank,copper ion binding (GO:0005507),0.354068047194592,0.9745133854350128,0.5157526254375729,0.9930866407402666,1.0,13/42,25.59%,LOXL2;MT3;P2RX4;PRNP;PAM;LACC1;SUMF1;COX17;S100A13;CUTA;ANG;COMMD1;ATP7B
prerank,nuclear localization sequence binding (GO:0008139),0.4010604814765709,0.9711963328891855,0.5179558011049724,0.9987512830844835,1.0,3/18,4.97%,RANBP6;NUP153;KPNB1
prerank,SUMO transferase activity (GO:0019789),0.41248002643309467,0.9701437331696194,0.5075034106412005,0.9983416205620547,1.0,8/16,27.81%,CBX4;NSMCE2;PIAS1;PIAS2;HDAC4;TRIM28;PIAS4;RANBP2
prerank,"endoribonuclease activity, producing 5'-phosphomonoesters (GO:0016891)",0.37527656953856464,0.9698593151283936,0.5131744040150564,0.9958141140999769,1.0,11/28,22.98%,AGO2;RNASEH2A;FEN1;DBR1;NUDT16;DICER1;RPP30;ENDOV;RPP14;RNASEH1;RPP21
prerank,endonuclease activity (GO:0004519),0.33613798601552874,0.9697026890307204,0.5159817351598174,0.9928881026538943,1.0,8/49,12.48%,AGO2;APLF;NOB1;ZC3H12C;FEN1;ERCC4;ZC3H12A;ZRANB3
prerank,transmitter-gated ion channel activity (GO:0022824),0.37170551409927144,0.9687203781205336,0.5233881163084703,0.9922657443750967,1.0,12/29,25.14%,GRIN2D;GRIK3;GRIA2;GLRA2;GRID1;GRIA4;GABRG1;GABRB2;GRIK4;GABRA3;GRIK5;GRIK2
prerank,rRNA binding (GO:0019843),0.3494136561190378,0.9665084354037444,0.5177304964539007,0.9948778492888575,1.0,8/42,7.15%,SBDS;ERAL1;NOP53;NGRN;RCC1L;MRPL16;RRS1;PPAN
prerank,carboxylic acid binding (GO:0031406),-0.261944278620174,-0.9661279752621793,0.4808743169398907,1.0,1.0,8/38,11.69%,GRIN2B;SRR;GRIN1;GLRB;CASTOR2;HIF1AN;EPDR1;GLRA3
prerank,protease binding (GO:0002020),0.31717636313387665,0.9648500613950842,0.5642933049946866,0.9957883267555028,1.0,32/99,25.69%,NOL3;COMP;SERPINC1;BFAR;LONP2;CFLAR;ITGA3;AMFR;PRNP;TWNK;TIMP2;RIOK3;COL3A1;CHMP3;LCOR;TRIP4;CRADD;LDLR;RFFL;NFRKB;RIPK2;F3;ADRM1;SART3;SUMO1;INSL3;VCP;POLG;TNF;ANXA2;DERL2;RAD23A
prerank,Wnt-activated receptor activity (GO:0042813),-0.33296507010647547,-0.9643243166533363,0.5018050541516246,1.0,1.0,10/15,41.56%,RYK;TSPAN12;FZD7;FZD4;FZD6;FZD2;FZD5;FZD8;FZD1;FZD10
prerank,neutral amino acid transmembrane transporter activity (GO:0015175),0.36291668509974523,0.9642615510516436,0.5232419547079857,0.9940665531352967,1.0,9/32,21.95%,SLC38A2;SLC38A1;SLC38A3;SLC38A6;SFXN2;SLC36A4;SFXN1;MFSD12;SLC6A6
prerank,metalloexopeptidase activity (GO:0008235),0.3411636533667395,0.9631770002354244,0.5234375,0.9937061933332154,1.0,14/51,24.09%,LAP3;MMP14;AGBL2;ERAP1;CPQ;AEBP1;NPEPPS;NUDT16;METAP2;FOLH1;MMP15;TRHDE;VASH1;RNPEP
prerank,steroid hydroxylase activity (GO:0008395),0.40652652975601555,0.962376318729324,0.5258741258741259,0.992714906420823,1.0,3/16,20.65%,CH25H;CYP27A1;CYP39A1
prerank,hormone receptor binding (GO:0051427),0.43793862888178453,0.9609993340299604,0.53077975376197,0.9932826794731417,1.0,5/14,24.34%,NPPC;SOCS2;JAK2;CCK;JAK1
prerank,signaling receptor complex adaptor activity (GO:0030159),0.35282791450561146,0.9603576535043832,0.518562874251497,0.9918708676060658,1.0,11/38,16.49%,IRS1;MAGI2;MAPK8IP3;NCK1;NCK2;LDLRAP1;G3BP2;STAP1;PTPN11;SPAG9;BLNK
prerank,glucuronosyltransferase activity (GO:0015020),0.3965878150684532,0.9584979010938578,0.5086551264980027,0.9935562161207258,1.0,1/19,0.70%,EXT1
prerank,non-membrane spanning protein tyrosine kinase activity (GO:0004715),-0.26882394322678727,-0.9573729888653439,0.5310734463276836,1.0,1.0,7/35,11.69%,SYK;SLA;DYRK1A;FES;FGR;SRC;TNK2
prerank,protein tyrosine phosphatase activity (GO:0004725),0.32699027035441214,0.9562873373266128,0.574398249452954,0.9964399289724281,1.0,27/71,27.26%,EYA4;CDC25B;PTPN18;DUSP3;TIMM50;PTPN7;DUSP26;PTPN11;DUSP11;PTPN9;PTPRU;EYA2;PTPRC;PTPRB;PTPRF;PTP4A2;PTPRM;PTPN6;PTPRS;PTPN23;EYA3;PTPN1;PTEN;EYA1;CDC14A;PTPRN;PTPRE
prerank,protein serine/threonine phosphatase inhibitor activity (GO:0004865),-0.35927338275515097,-0.9539794791233844,0.4954682779456193,1.0,1.0,2/11,3.48%,PPP1R14C;PPP1R8
prerank,protein kinase inhibitor activity (GO:0004860),0.3454312985448508,0.9510365485402471,0.5420118343195266,1.0,1.0,9/42,13.87%,TAOK3;SPRY2;SOCS1;GMFB;NCK1;CIB1;NPM1;RACK1;DUS2
prerank,aminoacyl-tRNA ligase activity (GO:0004812),0.35033949503569184,0.9508392806662581,0.5338983050847458,1.0,1.0,10/37,18.28%,VARS1;RARS1;HARS2;IARS2;AARS1;IARS1;NARS1;PARS2;YARS2;TARS2
prerank,ion gated channel activity (GO:0022839),0.3743588789755259,0.9493053020523924,0.549492385786802,1.0,1.0,4/24,16.25%,TRPM5;TTYH1;ANO10;ANO5
prerank,sterol binding (GO:0032934),0.3315593211007639,0.9481736289233305,0.5658042744656918,1.0,1.0,18/56,17.01%,ABCA1;ABCG1;OSBPL8;OSBPL7;OSBPL3;RORA;STARD3;TSPO;PTCH1;NPC1;OSBPL9;ERLIN2;OSBP2;NPC2;GRAMD1C;SOAT2;OSBP;SOAT1
prerank,nuclear import signal receptor activity (GO:0061608),0.4085372081241101,0.9478667684498643,0.5457063711911357,1.0,1.0,3/15,13.46%,RANBP6;KPNB1;TNPO2
prerank,telomeric DNA binding (GO:0042162),0.3520317450246372,0.9473230797104065,0.5530864197530864,1.0,1.0,10/32,18.99%,SMG7;HNRNPA2B1;SMG5;UPF2;UPF3A;TELO2;STN1;UPF1;HMBOX1;TERF2
prerank,retinoid binding (GO:0005501),-0.2910050314824988,-0.9471435277844878,0.5377777777777778,1.0,1.0,4/22,12.22%,PTGDS;RXRA;RARA;NR2F2
prerank,cadherin binding (GO:0045296),0.2968134670078345,0.9441824799615692,0.6519558676028084,1.0,1.0,92/315,22.91%,STAT1;CHMP4B;ZC3HAV1;FMNL2;KDR;TRIM25;RARS1;CDH13;ACVR1;SH3GL1;FLNB;PKN2;LARP1;RSL1D1;HSP90AB1;GOLGA3;HNRNPK;CTNNB1;TNKS1BP1;SH3GLB1;IDH1;GAPVD1;ARGLU1;CDH9;MAPRE1;LASP1;RAB11B;NCK1;P2RX4;PLCB3;VAPB;BMPR2;HSPA8;FNBP1L;EIF4H;LYPLA2;SNX9;ATIC;HDLBP;FXYD5;CAPZB;TMOD3;PTPN11;PSEN1;TJP2;CTNNA3;KTN1;RACK1;RANBP1;CORO1B;SEPTIN9;UNC45A;CTNND2;DLG1;DBNL;BZW1;RPL23A;BAIAP2;BAIAP2L1;PPME1;KLC2;SNX1;IST1;TBC1D2;LRRFIP1;EPN2;AHSA1;CHMP5;MYH9;RPL24;CNN3;STK24;PTPRB;EIF5;ARHGAP18;RAB1A;PI4KA;TRPC4;EFHD2;DDX3X;CD46;RPL29;PSMB6;LDHA;USP8;RPL6;SNX2;CLIC1;ESYT2;RAB10;TWF1;EEF1G
prerank,5'-nucleotidase activity (GO:0008253),0.41433563533387896,0.943853948653273,0.5239477503628447,1.0,1.0,3/13,16.18%,NT5DC1;NT5C3A;NT5C3B
prerank,transmembrane receptor protein tyrosine kinase adaptor activity (GO:0005068),0.4285697188088159,0.9431768180989651,0.5334323922734027,1.0,1.0,7/12,28.72%,IRS1;STAP1;BLNK;GAB2;SHC1;SH2B1;PIK3R1
prerank,FAD binding (GO:0071949),0.3788966832951447,0.9430340149223204,0.5621827411167513,0.9986436512480317,1.0,3/24,8.05%,MTHFR;CYB5R2;CYB5R3
prerank,GABA-gated chloride ion channel activity (GO:0022851),-0.37198314889550615,-0.94289874217292,0.49666666666666665,1.0,1.0,5/12,20.95%,GABRG3;GABRB1;GABRA2;GABRB3;GABRA5
prerank,phosphotyrosine residue binding (GO:0001784),0.3481049064269077,0.9417515679104423,0.5808736717827627,0.9987500394330175,1.0,12/37,21.66%,IRS1;HCK;SH3BP2;NCK2;LDLRAP1;VAV1;STAP1;PTPN11;CRK;LCK;YES1;ABL2
prerank,protein tyrosine kinase activity (GO:0004713),0.3073644464920098,0.9416860346062025,0.6083769633507854,0.9957259408103385,1.0,30/108,23.18%,AXL;FLT1;KDR;HCK;PEAK1;EPHA4;FGFR2;RET;EPHA6;LTK;MET;LYN;INSR;ROR2;DYRK2;JAK2;FYN;FGFR3;CSK;CAMKK2;WEE1;DDR2;LCK;YES1;ROR1;ABL2;ERBB3;TWF1;PKDCC;AATK
prerank,nucleosomal DNA binding (GO:0031492),0.38858116504310397,0.9411294621746559,0.5525606469002695,0.9940071275659743,1.0,9/21,23.97%,MBD2;SMARCE1;SMARCC2;MTA2;ACTB;SMARCD2;HDAC1;HDAC2;ACTL6A
prerank,kinesin binding (GO:0019894),0.36804500638219395,0.9409103313347937,0.556390977443609,0.9914077479023672,1.0,8/27,16.48%,CLSTN1;MAPK8IP3;ARHGEF10;NEK6;PLEKHM2;ACTB;SPAG9;KLC2
prerank,insulin-like growth factor I binding (GO:0031994),-0.3420472225105362,-0.9394653313801031,0.4934210526315789,1.0,1.0,8/13,23.36%,ITGAV;IGFBP5;IGFBP4;IGF1R;ITGB3;ITGB4;IGFBP6;IGFBP3
prerank,ligand-gated anion channel activity (GO:0099095),-0.32567271798894243,-0.9386734662596055,0.49019607843137253,1.0,1.0,6/17,15.73%,GABRG3;GABRB1;GLRB;GABRA2;GLRA3;GABRB3
prerank,guanyl-nucleotide exchange factor activity (GO:0005085),0.30221543344056107,0.9386555452396967,0.6185567010309279,0.9939340134087402,1.0,42/147,21.14%,DOCK8;RGP1;RINL;SPATA13;SBF1;RCC1L;ARHGEF7;HERC2;GAPVD1;DENND1A;RAPGEF6;RAPGEF2;CCDC88A;ABR;EIF2B2;VAV1;ANKRD27;ARHGEF11;RIN2;ARHGEF10;SOS1;LAMTOR3;ARFGEF2;RIC1;FGD6;IQSEC2;AKAP13;RAPGEF1;DENND10;MYCBP2;DENND6B;DENND4A;BCR;WDR41;PLCE1;EIF2B5;EIF2B3;DENND1B;LAMTOR4;DOCK10;DENND2D;DENND4B
prerank,protein-lysine N-methyltransferase activity (GO:0016279),0.3483953683499682,0.9349967529666169,0.5525997581620314,0.9998657528802846,1.0,11/34,20.88%,METTL21A;NSD3;SETD3;EEF2KMT;MEN1;CAMKMT;EZH2;SMYD1;ATPSCKMT;SMYD2;SETD7
prerank,delayed rectifier potassium channel activity (GO:0005251),-0.25852647409760354,-0.9348465340337047,0.6171428571428571,1.0,1.0,18/32,40.50%,KCNC2;KCNH1;KCNQ5;KCNA2;KCNC3;KCNG2;KCNC1;KCNB2;KCNC4;KCNH2;KCNQ4;KCNQ1;KCNG1;KCNE3;KCNG4;KCNA6;KCNE4;KCNG3
prerank,protein heterodimerization activity (GO:0046982),0.2963020296703928,0.9307591908532826,0.6326942482341069,1.0,1.0,50/178,25.44%,SIM1;EXT1;USF2;ABCG1;TUBB2B;FBXO7;PAFAH1B3;CYBB;BHLHE40;ZHX3;TCOF1;RRAGC;TCF4;ITGA3;USF1;TFAP2B;NOLC1;BARD1;VAPB;UBA2;XBP1;GABBR2;MICU2;MEF2A;MIGA2;IRAK1;SNX1;MTTP;BAX;RALGAPB;LSM5;PAFAH1B1;BUD23;PSMF1;MCL1;GADD45A;TENM4;SNX2;RRAGA;ERBB3;BCL2L2;TAF7;CYBA;TENM1;YWHAE;EXT2;ATF6;GCA;EPAS1;KCNB1
prerank,histone demethylase activity (GO:0032452),0.3567404656271209,0.9306832466030258,0.5632183908045977,1.0,1.0,7/27,15.95%,KDM4D;HR;KDM3B;RIOX2;FBXL19;KDM8;KDM7A
prerank,methyltransferase activity (GO:0008168),0.3308520276685832,0.9305889084482534,0.586483390607102,1.0,1.0,12/46,18.74%,COMTD1;BCDIN3D;MRM2;NTMT1;MEPCE;COQ3;DNMT1;COMT;GCSH;PRMT1;PRMT3;BUD23
prerank,"DNA-binding transcription activator activity, RNA polymerase II-specific (GO:0001228)",0.2938044923116709,0.9290070287637119,0.6830985915492958,1.0,1.0,46/254,18.64%,NR1H2;MEF2B;TFAP2C;ZBTB17;ESRRB;NFKB2;STAT3;ELK3;RUNX1;KLF15;MZF1;SOX9;ZNF76;TCF4;NFKB1;CREBRF;TFAP2B;UBP1;SRF;SMAD2;MEIS3;ATF6B;TFDP1;ATF1;NFIB;SCX;ELF4;MITF;TFDP2;KLF10;REL;NR3C1;PRDM4;E2F4;CASZ1;RREB1;MYB;SMARCD2;MEF2A;RBPJ;ELF1;ZNF445;FOSL2;HINFP;HOXA5;PRRX1
prerank,sulfate transmembrane transporter activity (GO:0015116),0.41567595539502367,0.9282390426321423,0.5449358059914408,1.0,1.0,3/14,11.35%,SLC26A1;SLC25A10;SLC26A2
prerank,deoxyribonuclease activity (GO:0004536),0.4011622173437697,0.9256488179601999,0.5376044568245125,1.0,1.0,3/14,12.48%,APLF;ERCC4;ZRANB3
prerank,enoyl-CoA hydratase activity (GO:0004300),0.4357148329214634,0.9251797252515319,0.545727136431784,1.0,1.0,3/10,16.40%,AUH;ECHDC3;HADHA
prerank,receptor tyrosine kinase binding (GO:0030971),0.32056479652830927,0.9250424254526624,0.588500563697858,0.9998642655787844,1.0,9/56,12.93%,IRS1;CPNE3;ELMO2;DUSP3;PITPNM1;NCK1;SOCS5;STAP1;RACK1
prerank,"phosphatidylinositol-3,4,5-trisphosphate binding (GO:0005547)",-0.2520323152491407,-0.9245701265202618,0.6123595505617978,1.0,1.0,8/34,15.57%,MYO10;FCHSD2;MYO1G;IQGAP1;RACGAP1;AKT1;MYO1B;ARAP3
prerank,GTPase inhibitor activity (GO:0005095),-0.33024430105755265,-0.9220624058596586,0.543918918918919,1.0,1.0,6/13,20.66%,PDE6D;IQGAP1;ARL2;TNK2;GPS1;RTKN
prerank,lysophosphatidic acid acyltransferase activity (GO:0042171),0.39440608794645116,0.9194244905174851,0.5666666666666667,1.0,1.0,3/15,9.05%,AGPAT5;ABHD8;LPCAT2
prerank,protein phosphatase inhibitor activity (GO:0004864),0.36210750666490754,0.9181920569154043,0.5925,1.0,1.0,13/26,30.59%,ARPP19;PPP1R11;PPP1R1A;MGAT5;PPME1;SET;CABIN1;ENSA;BOD1;PPP1R14A;PPP1R2;PABIR1;LGALS3
prerank,metalloendopeptidase inhibitor activity (GO:0008191),0.4054229485327495,0.9131149903665807,0.6031294452347084,1.0,1.0,2/14,10.22%,BST2;TIMP2
prerank,voltage-gated chloride channel activity (GO:0005247),0.43756919763431523,0.9127182102541623,0.6117103235747303,1.0,1.0,2/10,5.81%,CLCN2;CLCN6
prerank,carbohydrate:cation symporter activity (GO:0005402),0.421047692111302,0.9098788209428553,0.5815295815295816,1.0,1.0,2/11,25.50%,SLC2A9;SLC17A5
prerank,protein kinase C activity (GO:0004697),-0.3276594821071014,-0.9092013865847389,0.5865724381625441,1.0,1.0,4/14,12.82%,PRKCQ;PRKCZ;CCL3;PRKCI
prerank,aspartic-type peptidase activity (GO:0070001),0.4285075421824336,0.9080698444984274,0.5939849624060151,1.0,1.0,3/10,18.94%,PSEN1;NAPSA;DDI2
prerank,phospholipase activator activity (GO:0016004),0.42489717474648053,0.9072797509991837,0.5897832817337462,1.0,1.0,5/10,23.42%,CCL5;STX4;FYN;LCK;PDPK1
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines (GO:0016814)",0.4343327703630375,0.906436873116303,0.5891238670694864,1.0,1.0,1/10,0.80%,APOBEC1
prerank,"phosphotransferase activity, phosphate group as acceptor (GO:0016776)",0.3596870383415889,0.9016217844714026,0.6010037641154329,1.0,1.0,5/24,12.14%,ITPKC;PPIP5K1;CMPK2;AK4;AK3
prerank,MHC class II protein complex binding (GO:0023026),-0.34840076281731625,-0.90073253192388,0.5421686746987951,1.0,1.0,4/11,10.56%,CD81;ATP1B1;PKM;ANXA11
prerank,"DNA-binding transcription repressor activity, RNA polymerase II-specific (GO:0001227)",0.2889091883959315,0.8994395775893179,0.7038539553752535,1.0,1.0,43/173,22.21%,TFAP2C;ZBTB17;NFX1;ZBTB2;ZFP37;BATF3;ELK3;BHLHE40;NACC1;MZF1;NFKB1;BCL6;BACH1;SNAI2;ETV6;AEBP1;PROX1;FOXK1;MAX;CTCF;ZBTB5;MITF;SKIL;NR3C1;ZBTB21;MYPOP;POU6F1;ZBTB34;ERF;GTF2IRD1;PPARD;ZBTB4;LRRFIP1;ZBTB49;DACH1;ZKSCAN3;ZEB1;ZFP90;SCRT1;ZBTB20;E2F6;ZNF692;PRDM1
prerank,G protein-coupled peptide receptor activity (GO:0008528),0.3040616110011691,0.8991374133685205,0.6438809261300992,1.0,1.0,10/73,19.39%,RXFP2;GPR37L1;FPR3;S1PR2;GPR37;GALR1;INPP5K;HCRTR1;NLRP6;ADCYAP1R1
prerank,CoA hydrolase activity (GO:0016289),0.37877630334904205,0.8976706745371872,0.6019553072625698,1.0,1.0,3/16,12.85%,ACOT9;ABCD1;ACOT13
prerank,protein kinase A catalytic subunit binding (GO:0034236),0.40915999773251777,0.8975889815190281,0.5957446808510638,1.0,1.0,4/13,17.07%,SOX9;PRKAR2B;CSK;PRKAR2A
prerank,MAP kinase kinase activity (GO:0004708),0.38863454298504224,0.8964968913566818,0.5968660968660968,1.0,1.0,4/15,11.82%,PAK3;MAP2K3;MAPK14;MAP2K2
prerank,lipase activity (GO:0016298),-0.23067999268565212,-0.8964132788738786,0.7028985507246377,1.0,1.0,14/43,21.60%,ABHD16A;LYPLA1;LIPH;SMPD3;PLBD1;PITPNM3;MGLL;ABHD12;LPL;FAAH;SEC23IP;PLA2G15;ABHD6;SMPD2
prerank,cardiolipin binding (GO:1901612),0.424279314873537,0.8956394845785903,0.6088888888888889,1.0,1.0,1/10,3.61%,PLEKHN1
prerank,RNA stem-loop binding (GO:0035613),0.40561783106750615,0.8948624641848377,0.6149341142020498,1.0,1.0,5/12,20.50%,DHX9;ZC3H12A;RC3H2;CSDE1;DDX3X
prerank,hydro-lyase activity (GO:0016836),0.32241232557642735,0.8945770421415883,0.6289752650176679,1.0,1.0,9/41,16.40%,CA4;AUH;ECHDC3;HACD3;CDYL;CA2;UROS;TGDS;HADHA
prerank,metallopeptidase activity (GO:0008237),0.29464755575751633,0.8941187656199976,0.6955161626694474,1.0,1.0,23/113,22.31%,ADAM33;LAP3;ADAMTS3;MMP14;ADAM8;ERAP1;ADAMTS19;NLN;PAPPA;ADAMTS2;PITRM1;ADAMTS6;NUDT16;ADAMTS12;SPRTN;METAP2;MPND;MIPEP;PSMD7;ADAMTS18;CHMP1A;IDE;MMP15
prerank,"3',5'-cyclic-nucleotide phosphodiesterase activity (GO:0004114)",0.362263277476191,0.8937984737483363,0.6097240473061761,1.0,1.0,7/21,21.82%,PDE7B;PDE8B;PDE3A;PDE1C;PDE4B;PDE9A;PDE4A
prerank,lysine N-methyltransferase activity (GO:0016278),0.36701908003901107,0.8930510582355311,0.613941018766756,1.0,1.0,8/20,26.44%,METTL21A;SETD3;EEF2KMT;ATPSCKMT;SMYD2;SETD7;EEF1AKMT1;EHMT2
prerank,GABA-A receptor activity (GO:0004890),-0.3064517509577467,-0.8925953228591127,0.5737704918032787,1.0,1.0,9/18,36.75%,GABRG3;GABRB1;GABRA2;GABRB3;GABRA5;GABRR2;GABRE;GABRA4;GABRQ
prerank,sodium ion transmembrane transporter activity (GO:0015081),-0.2608692726760624,-0.8920230010831627,0.5942622950819673,1.0,1.0,9/27,23.88%,SLC9A9;SLC8A3;SLC4A8;SLC3A2;PKD2L1;SLC9A8;CNNM4;SLC8A2;SLC9B2
prerank,cell adhesion mediator activity (GO:0098631),0.34782058393426957,0.8893028049385797,0.6214833759590793,1.0,1.0,7/24,19.95%,CD47;PLXNB3;NPTN;DSCAM;DSCAML1;JAM3;SIRPA
prerank,protein phosphatase activator activity (GO:0072542),0.40235035957519877,0.8888779451172439,0.6164978292329957,1.0,1.0,6/13,24.43%,PPP2R5C;PPP2R5D;CALM3;PHACTR4;PPP2R5A;CALM2
prerank,"exoribonuclease activity, producing 5'-phosphomonoesters (GO:0016896)",0.33491803146970767,0.8887339653523808,0.6303549571603427,1.0,1.0,7/33,14.04%,PNPT1;XRN2;CNOT7;XRN1;DCP2;DIS3L2;EXOSC9
prerank,UDP-galactosyltransferase activity (GO:0035250),0.4233273315947853,0.8863498304045068,0.6078147612156295,1.0,1.0,2/10,8.93%,B4GALT1;B4GALT5
prerank,TBP-class protein binding (GO:0017025),-0.2852526436036422,-0.8861608640993655,0.6626016260162602,1.0,1.0,6/21,17.49%,TAF12;ESR1;THRA;TAF1;PSMC1;AHR
prerank,myosin II binding (GO:0045159),0.421568970840548,0.8859954855638283,0.6255639097744361,1.0,1.0,3/10,16.50%,GSN;STXBP5L;LLGL1
prerank,acetylcholine receptor activity (GO:0015464),-0.273313352821201,-0.8856124863776803,0.6324786324786325,1.0,1.0,4/22,21.26%,CHRFAM7A;CHRNA7;CHRM2;CHRNA4
prerank,palmitoyltransferase activity (GO:0016409),0.3459158700761521,0.8848520417725118,0.6427672955974842,1.0,1.0,12/28,27.22%,GOLGA7;ZDHHC21;ZDHHC20;HHAT;ZDHHC13;ZDHHC8;ZDHHC3;ZDHHC18;ZDHHC22;ZDHHC17;ZDHHC16;ZDHHC7
prerank,inhibitory extracellular ligand-gated ion channel activity (GO:0005237),-0.32793167149312763,-0.8841340966344972,0.5855263157894737,1.0,1.0,4/13,11.69%,GABRG3;GLRB;GABRA2;GLRA3
prerank,histone demethylase activity (H3-K9 specific) (GO:0032454),0.39651359332890435,0.8821552252883434,0.6103703703703703,1.0,1.0,4/12,15.95%,KDM4D;HR;KDM3B;KDM7A
prerank,exonuclease activity (GO:0004527),0.3110339888759633,0.8814050550731625,0.6556442417331813,1.0,1.0,10/46,14.12%,XRN2;APLF;ENPP3;AEN;CNOT7;FEN1;ZC3H12A;ENPP1;EXOSC9;REXO1
prerank,ionotropic glutamate receptor activity (GO:0004970),0.37437013103349126,0.8813449920076162,0.623789764868603,1.0,1.0,3/17,6.56%,GRIN2D;GRIK3;GRIA2
prerank,thioesterase binding (GO:0031996),0.40313560579402047,0.880266889633431,0.6257142857142857,1.0,1.0,4/11,13.90%,TRAF4;TRAF3;TRAF5;RAC1
prerank,ubiquitin conjugating enzyme activity (GO:0061631),0.33083595730093124,0.8785704001815787,0.6415327564894932,1.0,1.0,9/31,17.95%,UBE2L6;UBE2W;UBE2B;UBE2E3;UBE2E1;UBE2L3;UBE2Q1;UBE2K;BIRC6
prerank,poly-purine tract binding (GO:0070717),0.33552545497312974,0.8749164012226548,0.653416149068323,1.0,1.0,13/27,29.63%,PNPT1;RBMS2;HNRNPDL;ATXN1;DAZAP1;RBPMS;DDX3X;ZC3H14;KHDRBS2;HNRNPU;KHDRBS1;PABPC1;PABPC4
prerank,Notch binding (GO:0005112),0.35040152098072647,0.8746408036827634,0.6429479034307497,1.0,1.0,8/22,23.81%,DLK2;MEGF10;SNW1;NOTCH4;DNER;AAK1;CUL3;NCOR2
prerank,cyclic-nucleotide phosphodiesterase activity (GO:0004112),0.3464759730221735,0.8743256409846237,0.6408268733850129,1.0,1.0,7/23,21.82%,PDE7B;PDE8B;PDE3A;PDE1C;PDE4B;PDE9A;PDE4A
prerank,gap junction channel activity (GO:0005243),0.35270605368455354,0.8737070415040701,0.6318471337579618,1.0,1.0,2/22,11.20%,PANX2;PANX1
prerank,phosphatase binding (GO:0019902),0.2890546028747925,0.8726525210538391,0.7086776859504132,1.0,1.0,21/105,14.68%,FCRL6;STAT3;ANAPC5;IKBKE;CTNNB1;ANK1;NFATC2;MAGI2;CTSC;PPP6R3;SMAD2;ANAPC4;VRK3;MET;MAPK14;TRAF3;CDC27;RACK1;BAD;DLG1;DZIP3
prerank,NADP binding (GO:0050661),0.33011147757301873,0.8711130427266646,0.6347087378640777,1.0,1.0,4/32,8.32%,DHFR;GRHPR;PGD;HSD11B1
prerank,metalloaminopeptidase activity (GO:0070006),0.37946419061972675,0.8704507191252459,0.6588720770288858,1.0,1.0,6/16,24.09%,MMP14;ERAP1;NPEPPS;MMP15;TRHDE;RNPEP
prerank,L-amino acid transmembrane transporter activity (GO:0015179),0.30673451455991146,0.8702542813282373,0.6820224719101123,1.0,1.0,13/53,22.20%,SLC25A22;SLC38A2;SLC38A1;SLC38A3;SLC38A6;SLC7A6;CTNS;SLC25A12;SLC36A4;SFXN1;SLC25A15;SLC7A7;SLC1A3
prerank,GDP binding (GO:0019003),0.29738760607566694,0.8687753783139474,0.6770601336302895,1.0,1.0,9/63,10.98%,RAB8B;RAB21;RHEBL1;RAB12;RRAGC;RAB22A;RAB11B;RAB5C;RAB14
prerank,ATPase regulator activity (GO:0060590),0.3221087264247679,0.8665812486357775,0.6865315852205006,1.0,1.0,10/38,20.78%,TOR1AIP2;TOR1AIP1;ATP1B3;DNAJB4;DNAJB6;BAG1;AHSA1;FNIP2;TSC1;HSPBP1
prerank,peptidase inhibitor activity (GO:0030414),0.3235818242323938,0.865567343467281,0.6501809408926418,1.0,1.0,5/33,11.74%,SLPI;UCHL5;CST7;TIMP2;USP14
prerank,heparan sulfate sulfotransferase activity (GO:0034483),-0.30593103291405704,-0.864328348757759,0.6398601398601399,1.0,1.0,6/15,19.75%,NDST3;HS6ST3;HS2ST1;HS3ST2;HS3ST3A1;HS3ST5
prerank,acyl-CoA hydrolase activity (GO:0047617),0.3640084770287121,0.8626828954299622,0.6657496561210454,1.0,1.0,3/17,12.85%,ACOT9;ABCD1;ACOT13
prerank,sodium channel activity (GO:0005272),0.31866555931552326,0.861658618090469,0.6726403823178017,1.0,1.0,11/37,26.99%,GRIK3;ASIC4;SCN2A;SCN1B;SCN8A;HCN2;GRIK4;GRIK5;GRIK2;SHROOM2;SCN4B
prerank,dynactin binding (GO:0034452),-0.32384681379338087,-0.8611819783312729,0.6292834890965732,1.0,1.0,3/12,8.69%,BICDL1;HTT;GSK3B
prerank,ferrous iron binding (GO:0008198),0.3525048839770878,0.8590621740757475,0.6564495530012772,1.0,1.0,5/21,14.84%,FXN;EGLN2;ALKBH1;ALKBH2;TET2
prerank,monocarboxylic acid transmembrane transporter activity (GO:0008028),0.33750474707415207,0.8584913030345837,0.6619897959183674,1.0,1.0,8/26,24.58%,SLC27A1;SLC16A13;SLC16A14;SLC16A6;ABCG2;SLC5A6;SLC6A6;SLC16A4
prerank,cation:chloride symporter activity (GO:0015377),-0.34303685950329244,-0.8560302511840591,0.6374622356495468,1.0,1.0,2/10,2.43%,SLC12A6;SLC12A2
prerank,inward rectifier potassium channel activity (GO:0005242),-0.263377339455083,-0.8545791900278867,0.7110091743119266,1.0,1.0,9/24,33.79%,KCNJ10;KCNK6;KCNJ6;KCNJ13;ABCC8;KCNH2;KCNJ12;KCNJ16;KCNN1
prerank,tropomyosin binding (GO:0005523),-0.28589739830834,-0.8530172494548972,0.6750902527075813,1.0,1.0,12/16,50.25%,CALD1;NEBL;TMOD1;TNNT3;SMTNL2;LMOD3;TMOD2;PYCARD;LMOD1;TNNT2;TMOD4;TNNT1
prerank,sialyltransferase activity (GO:0008373),0.34886393113685055,0.8529441662254215,0.6582109479305741,1.0,1.0,4/20,9.70%,ST6GALNAC4;ST6GALNAC6;ST6GAL1;ST3GAL1
prerank,"phosphatidylinositol-3,4-bisphosphate binding (GO:0043325)",0.33538660209989585,0.8521666952780375,0.6710013003901171,1.0,1.0,10/25,26.73%,ADAP2;KIF16B;PLEKHA1;PLEKHA4;PHLDA3;PLA2G4E;ZFYVE1;COMMD1;GAB2;PLEKHA2
prerank,phosphatidylinositol-3-phosphatase activity (GO:0004438),-0.3004959980988789,-0.8491289234373975,0.6784452296819788,1.0,1.0,5/14,16.27%,MTMR1;MTMR4;MTMR9;MTMR10;MTM1
prerank,"phosphatidylinositol-4,5-bisphosphate binding (GO:0005546)",0.28897190306277654,0.8487980654724462,0.7161430119176598,1.0,1.0,16/72,19.67%,CGAS;ACTN2;GRAMD2A;SYT7;ADAP2;LDLRAP1;GSN;PLEKHA4;SNAP91;RPH3A;KCNJ2;PHLDA3;TULP3;MARK1;OSBPL2;PLA2G4E
prerank,"endodeoxyribonuclease activity, producing 5'-phosphomonoesters (GO:0016888)",-0.3157591648710874,-0.8485103507549814,0.6877076411960132,1.0,1.0,4/13,11.27%,DNASE1L1;ZGRF1;SLX4;DNA2
prerank,cadherin binding involved in cell-cell adhesion (GO:0098641),-0.2783984586636076,-0.8476108957632136,0.6403162055335968,1.0,1.0,6/18,21.76%,PDLIM5;PDLIM1;S100A11;CDC42EP1;ANXA1;STXBP6
prerank,anion channel activity (GO:0005253),-0.21440269838061538,-0.8466908077098676,0.7211538461538461,1.0,1.0,17/61,22.28%,GABRG3;VDAC1;CLCN5;GABRB1;GLRB;GABRA2;GPR89B;GPR89A;GLRA3;SLC1A4;GABRB3;SLC26A8;GABRA5;LRRC8A;CLCN4;ANO6;FXYD1
prerank,endoribonuclease activity (GO:0004521),0.31608922201744355,0.8457692634931249,0.6852540272614622,1.0,1.0,7/32,19.75%,AGO2;NOB1;ZC3H12C;ZC3H12A;DICER1;ENDOV;ERN1
prerank,death receptor binding (GO:0005123),0.3616424728883039,0.8446513579110617,0.6680972818311874,1.0,1.0,2/15,3.91%,BDNF;FEM1B
prerank,protein-cysteine S-palmitoyltransferase activity (GO:0019706),0.33741874500120356,0.8414342475830208,0.6898326898326899,1.0,1.0,3/24,5.21%,GOLGA7;ZDHHC21;ZDHHC20
prerank,C4-dicarboxylate transmembrane transporter activity (GO:0015556),0.36556718211368694,0.840259687108547,0.6810228802153432,1.0,1.0,3/16,14.79%,SLC25A22;SLC25A10;SLC25A12
prerank,translation elongation factor activity (GO:0003746),-0.30141201331181844,-0.8394332517238146,0.7071428571428572,1.0,1.0,6/14,24.66%,EEF1A1;EEF1B2;TSFM;EIF5A2;GTPBP1;EEF1A2
prerank,cytokine receptor activity (GO:0004896),0.279766629373242,0.8371619899211693,0.7583243823845328,1.0,1.0,17/83,21.45%,CRLF1;IL15RA;IL21R;IL17RC;IL10RA;IL12RB2;LEPR;GFRA2;IL10RB;IFNAR2;IL1RAP;CSF2RA;IFNGR2;IFNGR1;EBI3;IL4R;F3
prerank,nucleobase-containing compound kinase activity (GO:0019205),0.34983084214314497,0.8368191663256078,0.6734417344173442,1.0,1.0,4/17,12.14%,NOL9;CMPK2;AK4;AK3
prerank,phosphatidylinositol 3-kinase activity (GO:0035004),-0.31844995089939127,-0.8366173062449579,0.6721311475409836,1.0,1.0,4/12,9.21%,PIK3C2A;IPMK;PIK3C3;PIK3CG
prerank,active ion transmembrane transporter activity (GO:0022853),0.307404936133023,0.8359486859409027,0.699177438307873,1.0,1.0,3/37,6.49%,UQCRQ;SLCO1C1;SLCO1B1
prerank,retinoid X receptor binding (GO:0046965),0.39003677542884774,0.8347167560247447,0.6705539358600583,1.0,1.0,1/11,2.12%,RARG
prerank,ubiquitin-like protein conjugating enzyme activity (GO:0061650),0.30892768987506086,0.8327902946380824,0.7144578313253012,1.0,1.0,9/34,17.95%,UBE2L6;UBE2W;UBE2B;UBE2E3;UBE2E1;UBE2L3;UBE2Q1;UBE2K;BIRC6
prerank,wide pore channel activity (GO:0022829),0.3364798285290874,0.8325312775804455,0.686624203821656,1.0,1.0,2/23,11.20%,PANX2;PANX1
prerank,solute:anion antiporter activity (GO:0140323),0.36661292500654574,0.8322260048939806,0.6874095513748191,1.0,1.0,3/14,16.45%,SLC26A1;SLC26A2;SLC4A2
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides (GO:0016812)",-0.32726797288355747,-0.8316859886917422,0.6718266253869969,1.0,1.0,2/10,11.57%,DPYSL3;CRMP1
prerank,ubiquitin conjugating enzyme binding (GO:0031624),0.3193103039962094,0.8315368769040739,0.6915422885572139,1.0,1.0,5/27,10.13%,AUP1;SIAH1;DCUN1D4;RNF19B;ARIH1
prerank,phosphatase activity (GO:0016791),0.28190336606075705,0.8294898932167007,0.7453347969264544,1.0,1.0,27/73,26.64%,DUSP3;PDXP;SBF1;LPIN2;DUSP28;DUSP26;EPHX2;DUSP10;DUSP16;DUSP11;INPP5K;NUDT16;OCRL;DUSP8;MINPP1;SACM1L;LHPP;PGAM5;PLPP2;PLPPR2;PLPPR1;FRA10AC1;MDP1;PLPP6;PLPP1;NT5C;NOCT
prerank,metalloendopeptidase activity (GO:0004222),0.2801165008687525,0.8285724092575866,0.7527114967462039,1.0,1.0,11/76,17.51%,ADAM33;ADAMTS3;MMP14;ADAMTS19;NLN;ADAMTS2;PITRM1;ADAMTS6;ADAMTS12;SPRTN;MIPEP
prerank,amino acid transmembrane transporter activity (GO:0015171),0.29447466246552834,0.8279499312790347,0.7025171624713958,1.0,1.0,6/47,9.33%,SLC38A2;SLC38A1;SLC38A3;SLC38A6;PDPN;SLC7A6
prerank,transforming growth factor beta-activated receptor activity (GO:0005024),0.38251243330197526,0.8262189161246558,0.7009735744089013,1.0,1.0,4/12,20.16%,ACVR1;BMPR2;BMPR1A;ACVRL1
prerank,voltage-gated cation channel activity (GO:0022843),0.2706054336332577,0.8248696232823614,0.7768421052631579,1.0,1.0,8/97,9.69%,CATSPER4;CACNA2D4;GRIN2D;TMC1;KCNH8;KCNS3;CACNA1A;KCNA4
prerank,mitogen-activated protein kinase kinase kinase binding (GO:0031435),-0.31437867042798096,-0.8243360314268143,0.6798679867986799,1.0,1.0,4/11,9.13%,STK38;MAP3K11;TRAF6;DAB2IP
prerank,"hydrolase activity, hydrolyzing O-glycosyl compounds (GO:0004553)",0.31743414507652823,0.8231258283487479,0.7077114427860697,1.0,1.0,8/29,19.33%,HEXD;NEU1;GANC;HPSE;HPSE2;ACER3;GBA2;ABHD10
prerank,transmembrane receptor protein serine/threonine kinase activity (GO:0004675),0.3494815447325997,0.8224776121572648,0.7383798140770252,1.0,1.0,5/18,20.16%,ACVR1;BMPR2;BMPR1A;ACVR2A;ACVRL1
prerank,microtubule binding (GO:0008017),0.2590275319206782,0.819167102250412,0.8678102926337034,1.0,1.0,52/222,19.35%,SBDS;KIF26A;KIF3C;KIF7;REEP2;POLB;KIF2C;KIF3B;HOOK2;SAXO2;MAPRE1;CETN3;CEP57L1;RAE1;CDK5RAP2;CCDC88A;NEFM;VAPB;KIF16B;PRNP;HOOK1;SPEF1;CCDC88B;DNM2;CCDC181;SUN2;UXT;MAP1LC3B;TOGARAM2;TRPV4;FGF13;CLIP2;WHAMM;REEP3;HOOK3;CCDC61;CEP295;MAP4;KIF2A;GAS2L3;CCDC66;RAB11A;CLIP4;RMDN1;CAMSAP2;PAFAH1B1;KIF19;SVBP;FNTA;NUMA1;MAP1B;CCDC69
prerank,pseudouridine synthase activity (GO:0009982),0.36433735643329423,0.818496893500612,0.7011834319526628,1.0,1.0,4/13,21.53%,PUS7L;PUS7;RPUSD1;PUS10
prerank,pre-mRNA binding (GO:0036002),0.31408545836002283,0.8159266409009145,0.7045735475896168,1.0,1.0,6/28,12.68%,DDX5;TARBP2;RNPC3;HNRNPL;HNRNPA1;RBM41
prerank,protein serine/threonine/tyrosine kinase activity (GO:0004712),-0.2423499064406045,-0.8150563168899303,0.8382352941176471,1.0,1.0,10/28,21.89%,MAP2K6;SGK1;MAP3K9;RPS6KA2;TNK2;AKT1;MAP2K5;MAPKAPK5;PRKCG;RPS6KA1
prerank,diacylglycerol kinase activity (GO:0004143),-0.3131080316533459,-0.8149203145074745,0.6987577639751553,1.0,1.0,4/11,12.32%,DGKH;DGKZ;DGKD;DGKE
prerank,transcription coactivator binding (GO:0001223),0.3383886626476921,0.81372261356618,0.7234600262123198,1.0,1.0,6/20,17.68%,ZBTB17;TEAD2;CCNT2;RORA;PPARD;ZBTB49
prerank,Tat protein binding (GO:0030957),0.380935150474582,0.81320483930368,0.6787790697674418,1.0,1.0,3/10,13.99%,MDFIC;NPM1;ACTB
prerank,motor activity (GO:0003774),0.2813659158951831,0.8131266670141438,0.7621681415929203,1.0,1.0,14/60,20.62%,KIF26A;KIF3C;KIF7;KIF2C;KIF3B;KIF16B;MYO6;KIF2A;APPBP2;DYNC2H1;MYH9;KIF19;PIN1;STARD9
prerank,general transcription initiation factor binding (GO:0140296),-0.2459923710839627,-0.8124804168260324,0.7757847533632287,1.0,1.0,7/25,13.07%,AR;TAF12;ESR1;THRA;TBP;TAF1;PSMC1
prerank,solute:sodium symporter activity (GO:0015370),-0.23552197909662578,-0.8123779588684004,0.806930693069307,1.0,1.0,10/27,41.53%,SLC20A1;SLC4A8;SLC28A2;SLC4A9;SLC4A10;SLC4A7;SLC13A5;SLC5A3;SLC28A1;SLC4A5
prerank,"inositol 1,4,5 trisphosphate binding (GO:0070679)",0.3816215285788139,0.8103262371954412,0.7192192192192193,1.0,1.0,4/11,22.36%,ITPR1;RPH3A;TRPC4;TRPC1
prerank,platelet-derived growth factor binding (GO:0048407),-0.31428257017266836,-0.8091937968678602,0.7134328358208956,1.0,1.0,6/11,31.89%,COL1A2;COL4A1;PDGFRA;COL6A1;PDGFRB;COL5A1
prerank,fibroblast growth factor binding (GO:0017134),0.3309428827729847,0.8059718407675495,0.7169811320754716,1.0,1.0,7/21,26.15%,FGFR2;FGFR3;FIBP;FGFRL1;S100A13;GLG1;CEP57
prerank,exopeptidase activity (GO:0008238),0.2872810735173696,0.8047082816778821,0.7537058152793614,1.0,1.0,16/50,26.05%,LAP3;DPEP2;ERAP1;CTSH;DPP3;NPEPPS;KDM8;NUDT16;METAP2;FOLH1;CNDP2;TRHDE;RNPEP;DPP10;DPP6;CPM
prerank,calcium channel regulator activity (GO:0005246),0.2993207040008455,0.800687492373131,0.7461077844311377,1.0,1.0,4/37,6.02%,SGK3;ITPR1;SLC30A1;INAFM1
prerank,protein serine/threonine kinase inhibitor activity (GO:0030291),0.3151534876672706,0.80066374229162,0.7391304347826086,1.0,1.0,11/29,28.11%,SPRY2;CDKN2D;PRKAR2B;CIB1;PRKAR2A;SPRED1;YWHAG;KAT2B;CDKN2A;PKIB;PRKAR1A
prerank,S-adenosylmethionine-dependent methyltransferase activity (GO:0008757),0.28833754891709784,0.8004221111197648,0.7508610792192881,1.0,1.0,5/40,9.13%,COMTD1;MEPCE;SETD3;DNMT3A;DNMT1
prerank,histone methyltransferase activity (GO:0042054),0.30210884562312346,0.7984969476382208,0.7410501193317423,1.0,1.0,9/32,20.88%,PRMT2;NTMT1;NSD3;MEN1;EZH2;PRMT1;SMYD1;SMYD2;SETD7
prerank,potassium ion leak channel activity (GO:0022841),-0.27666919748661845,-0.7975034651944007,0.7818791946308725,1.0,1.0,7/15,36.16%,KCNK6;KCNK12;KCNK9;KCNK5;KCNK4;KCNK13;KCNK7
prerank,calcium-dependent phospholipase A2 activity (GO:0047498),0.34619975819011084,0.7968207830094323,0.7361702127659574,1.0,1.0,1/15,4.57%,PLA2G12A
prerank,protein binding involved in heterotypic cell-cell adhesion (GO:0086080),0.365767094915288,0.7967274823666328,0.7109375,1.0,1.0,1/10,3.99%,CD47
prerank,mitogen-activated protein kinase binding (GO:0051019),0.3063262935563737,0.7958788631691822,0.7468827930174564,1.0,1.0,8/29,18.45%,NBR1;MAPK14;TNIP1;GCH1;DUSP10;DUSP16;PRMT1;DUSP8
prerank,transforming growth factor beta receptor binding (GO:0005160),0.3301866957716368,0.7947945462456233,0.7350993377483444,1.0,1.0,3/18,8.50%,USP15;SMAD2;BAMBI
prerank,protein kinase C binding (GO:0005080),0.29202597841746153,0.7945699629757575,0.7899649941656943,1.0,1.0,7/43,13.46%,IRS1;NELL2;CCDC88A;DACT1;TRPV4;RACK1;NELL1
prerank,tau protein binding (GO:0048156),0.2845334368622394,0.7943532154485957,0.7708095781071835,1.0,1.0,11/40,19.46%,CLU;HSP90AB1;SMAD2;APOE;ACTB;FYN;HSP90AA1;TAOK2;MARK1;BRSK1;PIN1
prerank,transcription regulatory region nucleic acid binding (GO:0001067),0.25424129226084186,0.7942331830663116,0.8787878787878788,1.0,1.0,22/188,11.05%,PITX2;PER2;STAT3;ARID5B;RBBP5;RUNX1;KLF15;DHX36;MZF1;TCF7L2;NFKB1;DHX9;ATF6B;CDK5RAP2;NONO;TAF2;HMGB1;MEN1;HNRNPL;PROX1;FOXK1;CTCF
prerank,L-glutamate transmembrane transporter activity (GO:0005313),0.34657295331385035,0.7938402537157346,0.7226775956284153,1.0,1.0,1/14,0.81%,SLC25A22
prerank,myosin V binding (GO:0031489),0.34525745963949994,0.7915016689157185,0.7363387978142076,1.0,1.0,6/15,26.50%,RAB11B;RAB14;RAB11A;RAB10;RAB3A;RAB3D
prerank,tRNA (guanine) methyltransferase activity (GO:0016423),0.355773701608409,0.7908074902766445,0.7492877492877493,1.0,1.0,6/13,20.91%,TRMT1;WDR4;TRMT10C;THUMPD3;METTL1;TARBP1
prerank,ubiquitin-ubiquitin ligase activity (GO:0034450),0.3721765437255312,0.7900632389351979,0.7307692307692307,1.0,1.0,7/11,27.69%,AMFR;RBX1;UBE4B;UBE2K;STUB1;PRPF19;ANAPC11
prerank,extracellular ligand-gated ion channel activity (GO:0005230),-0.3258194077388391,-0.7898921994209892,0.7222222222222222,1.0,1.0,2/10,9.15%,GABRG3;GABRA2
prerank,superoxide-generating NAD(P)H oxidase activity (GO:0016175),0.3742289398581451,0.7898831111296991,0.7407407407407407,1.0,1.0,1/10,3.67%,CYBB
prerank,beta-tubulin binding (GO:0048487),0.2983966492385121,0.789725166417534,0.7276073619631902,1.0,1.0,7/31,15.36%,DLEC1;VAPB;TTLL7;UXT;TRPV4;FGF13;TBCD
prerank,aldehyde dehydrogenase (NAD+) activity (GO:0004029),0.34921796142562844,0.787827214058008,0.7339055793991416,1.0,1.0,3/13,13.22%,ALDH7A1;ALDH1A2;ALDH1A1
prerank,"hydrolase activity, hydrolyzing N-glycosyl compounds (GO:0016799)",-0.27587349653115134,-0.7871632142456232,0.717391304347826,1.0,1.0,2/16,1.17%,MACROD2;CD38
prerank,"N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity (GO:0008532)",-0.2969567070749167,-0.7863601398774342,0.7666666666666667,1.0,1.0,6/12,33.78%,B3GNT2;B3GALT5;B3GALT2;B3GNT7;B3GNT8;B3GNT6
prerank,cell-cell adhesion mediator activity (GO:0098632),0.2841174959797668,0.7849969713408729,0.8004694835680751,1.0,1.0,14/42,25.45%,CD47;PLXNB3;TMOD3;NPTN;DSCAM;BAIAP2;DSCAML1;BAIAP2L1;JAM3;CNN3;SIRPA;RAB10;CNTN2;ANXA2
prerank,phosphatidylinositol phospholipase C activity (GO:0004435),0.31362002699872665,0.7846298791551019,0.7581274382314694,1.0,1.0,3/23,9.28%,PLCB4;CCL5;PLCB3
prerank,2-oxoglutarate-dependent dioxygenase activity (GO:0016706),0.29580039690085963,0.7841298238613528,0.7723970944309927,1.0,1.0,9/32,18.73%,EGLN2;ALKBH1;RIOX2;ALKBH2;KDM8;TET2;KDM7A;JMJD4;P4HTM
prerank,"phosphotransferase activity, for other substituted phosphate groups (GO:0016780)",-0.30692943176936616,-0.7823289538010604,0.7464387464387464,1.0,1.0,6/11,24.60%,SAMD8;AASDHPPT;SGMS2;SGMS1;PIGO;PTDSS2
prerank,"phosphatidylinositol-3,5-bisphosphate binding (GO:0080025)",0.3103870183073584,0.7803172071696575,0.7601043024771839,1.0,1.0,6/23,19.67%,KIF16B;PLEKHA4;SH3PXD2B;PHLDA3;GBF1;PLA2G4E
prerank,NF-kappaB binding (GO:0051059),0.3073779424753514,0.779860331587213,0.7678571428571429,1.0,1.0,6/24,18.23%,TAF4B;COMMD7;NPM1;RNF25;ANXA4;HDAC1
prerank,inorganic anion transmembrane transporter activity (GO:0015103),0.30646533337742876,0.7790112236844662,0.7596996245306633,1.0,1.0,4/27,11.35%,SLC26A1;ANKH;SLC25A10;SLC26A2
prerank,potassium ion transmembrane transporter activity (GO:0015079),0.29477557053596176,0.7776149057401857,0.8017565872020075,1.0,1.0,5/31,14.30%,TMEM38A;SLC12A5;SLC12A8;KCNK3;TMEM38B
prerank,anion:anion antiporter activity (GO:0015301),0.3267868071206236,0.776729047643311,0.7587168758716876,1.0,1.0,4/17,16.45%,SLC26A1;SLC19A1;SLC26A2;SLC4A2
prerank,acidic amino acid transmembrane transporter activity (GO:0015172),0.33349637125628545,0.776259378602809,0.7266666666666667,1.0,1.0,1/15,0.81%,SLC25A22
prerank,phosphatidylinositol phosphate binding (GO:1901981),0.2522063177016436,0.7761195119491481,0.8411703239289446,1.0,1.0,30/100,24.98%,SAP30L;PLEKHN1;GAP43;OSBPL8;DENND1A;RUBCNL;ADAP2;ZFYVE26;KIF16B;ANKFY1;RUBCN;PLEKHA4;PLEKHA3;RPH3A;OSBP;SH3PXD2B;SNX24;PHLDA3;GBF1;GOLPH3L;ARAP1;DENND1B;PLA2G4E;CERT1;IQGAP2;ZFYVE1;SNX12;ARAP2;COMMD1;GAB2
prerank,tubulin binding (GO:0015631),0.24223447108539334,0.7737085056906778,0.9377510040160643,1.0,1.0,100/295,27.63%,GPAA1;SBDS;KIF26A;B9D2;KIF3C;KIF7;REEP2;POLB;KIF2C;ARHGEF7;KIF3B;HOOK2;SAXO2;EFHC2;DLEC1;CETN3;CEP57L1;STMN4;RAE1;CDK5RAP2;CCDC88A;NEFM;VAPB;KIF16B;PRNP;HOOK1;SPEF1;TPPP3;GIT1;STMN3;CCDC88B;DNM2;CCDC181;SUN2;TTLL7;UXT;MAP1LC3B;TOGARAM2;TRPV4;FGF13;CLIP2;WHAMM;REEP3;HOOK3;CCDC61;CEP295;FYN;MAP4;KIF2A;GAS2L3;TBCD;CCDC66;RAB11A;DNAL1;STMN2;RMDN1;PAFAH1B1;KIF19;SVBP;FNTA;BRSK1;NUMA1;MAP1B;CCDC69;DDX3X;STARD9;TRAPPC14;CRIPT;DIXDC1;MAP6D1;RAB11FIP5;MAPRE3;OPA1;KIF21A;MDM1;DNM3;HDAC6;ARL4C;BBS4;HAUS6;DCTN1;RAD51D;EML5;CHP1;MAPRE2;ABRAXAS2;CEP57;CDK5R1;KIF13B;MAST2;TUBGCP5;KIF1A;DNM1;SNPH;LRPPRC;ATF5;MAP1S;CDK5;CCDC170;IRAG2
prerank,phosphatidylinositol kinase activity (GO:0052742),0.3338169365872075,0.7713765558429843,0.7565698478561549,1.0,1.0,3/15,13.05%,PIK3CD;PI4KB;PIK3CB
prerank,"oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor (GO:0016655)",-0.2812682565086866,-0.7694159478814199,0.7445482866043613,1.0,1.0,6/12,26.11%,CRYZL1;AIFM2;CBR1;NQO2;DCXR;CRYZ
prerank,ankyrin binding (GO:0030506),-0.24535090758297629,-0.7680669907287038,0.8157894736842105,1.0,1.0,4/19,17.31%,SPTB;SPTBN4;PLEC;NRCAM
prerank,bicarbonate transmembrane transporter activity (GO:0015106),0.3299617951161442,0.7651440789337227,0.7610872675250357,1.0,1.0,2/15,11.35%,SLC26A1;SLC26A2
prerank,small GTPase binding (GO:0031267),0.24369098766556307,0.7627055874865551,0.9084435401831129,1.0,1.0,52/169,25.20%,ABCA1;DAPK3;RGP1;MYO1C;GOLGA5;TNFAIP1;RILP;CYFIP1;GGA3;KIF3B;RAPGEF6;UNC13D;RAP1GAP;SIKE1;SPHK2;CIB1;ANKFY1;ANKRD27;SRGAP2;SORL1;RIC1;FGD6;AKAP13;WHAMM;RANBP1;DENND10;MYCBP2;LZTR1;PEX5;OCRL;PLCE1;RANBP9;SGSM1;NCKAP1;SGSM3;STRN3;GCC1;RHOH;OPTN;USP33;BRK1;CCDC186;IQGAP2;RAB29;ARHGAP1;BICD2;EXOC2;RAF1;FLNA;RIN3;EVI5L;TBC1D20
prerank,potassium ion antiporter activity (GO:0022821),-0.2745909553158929,-0.7626204168903381,0.8027210884353742,1.0,1.0,1/15,1.02%,SLC9A9
prerank,kinase inhibitor activity (GO:0019210),0.28673615184072987,0.7624217348759712,0.7795371498172959,1.0,1.0,6/33,13.87%,TAOK3;SOCS1;GMFB;NCK1;NPM1;DUS2
prerank,alpha-tubulin binding (GO:0043014),0.2859508429326331,0.7615639981774152,0.7938271604938272,1.0,1.0,12/31,26.36%,EFHC2;DLEC1;TTLL7;TRPV4;FYN;DNAL1;FNTA;TRAPPC14;HDAC6;ARL4C;BBS4;CDK5R1
prerank,peptide alpha-N-acetyltransferase activity (GO:0004596),0.35128763242299116,0.7587556881291222,0.7741007194244605,1.0,1.0,2/11,16.20%,NAA50;NAA25
prerank,phosphatidylinositol bisphosphate binding (GO:1902936),0.2517783796361835,0.7575176967758623,0.8609062170706007,1.0,1.0,19/91,19.67%,CGAS;ACTN2;GRAMD2A;SYT7;ADAP2;KIF16B;LDLRAP1;GSN;PLEKHA4;SNAP91;RPH3A;KCNJ2;SH3PXD2B;PHLDA3;TULP3;GBF1;MARK1;OSBPL2;PLA2G4E
prerank,peptide hormone receptor binding (GO:0051428),-0.28565499934949073,-0.7565623352611576,0.8032258064516129,1.0,1.0,5/11,40.34%,ADCYAP1;PTHLH;GNRH1;PSMC5;VIP
prerank,NADH dehydrogenase (quinone) activity (GO:0050136),0.282184976314795,0.7562209934467866,0.8038277511961722,1.0,1.0,9/34,19.64%,NDUFA5;NDUFB9;NDUFS1;NDUFB5;NDUFS4;NDUFA10;NDUFB6;NDUFS8;NDUFS7
prerank,NADH dehydrogenase (ubiquinone) activity (GO:0008137),0.282184976314795,0.7562209934467866,0.8038277511961722,1.0,1.0,9/34,19.64%,NDUFA5;NDUFB9;NDUFS1;NDUFB5;NDUFS4;NDUFA10;NDUFB6;NDUFS8;NDUFS7
prerank,growth factor receptor binding (GO:0070851),0.24904533370630025,0.7544455127355858,0.8569903948772679,1.0,1.0,18/95,22.13%,TGFA;ERAP1;CCDC88A;TIMM50;VEGFD;FGF9;PSEN1;JAK2;FYN;IL1RAP;PIBF1;ARF4;SNX1;CD300LF;ERN1;TRIP6;FGF2;SNX2
prerank,BMP binding (GO:0036122),0.354083477692972,0.7528517598839148,0.7842857142857143,1.0,1.0,1/11,9.53%,BMPR2
prerank,ribosome binding (GO:0043022),0.2701300134670295,0.7500334589332505,0.8244186046511628,1.0,1.0,10/46,18.41%,SBDS;YTHDF1;MTIF3;ZC3H12A;EIF6;RACK1;EIF2S1;ETF1;NOMO1;CPEB2
prerank,potassium channel activity (GO:0005267),0.24706701413886845,0.7483258606330326,0.864693446088795,1.0,1.0,8/89,11.76%,KCNMB3;GRIK3;TMEM38A;KCNH8;KCNS3;KCNA4;CCDC51;KCNK3
prerank,nuclear export signal receptor activity (GO:0005049),0.34837906355259907,0.7480785644644338,0.7874818049490538,1.0,1.0,2/11,16.74%,CSE1L;RANBP17
prerank,ribonuclease P activity (GO:0004526),-0.2883778868952277,-0.7475271912256255,0.8029411764705883,1.0,1.0,7/11,29.61%,RPP38;RPP40;POP4;POP5;POP7;PRORP;POP1
prerank,epidermal growth factor receptor binding (GO:0005154),0.2947102650701089,0.7470480787190904,0.7995049504950495,1.0,1.0,8/25,27.01%,TGFA;CCDC88A;ARF4;SNX1;SNX2;LINGO1;SHC1;FER
prerank,peptide N-acetyltransferase activity (GO:0034212),0.3549550332601811,0.7466072848644195,0.7958579881656804,1.0,1.0,2/10,16.20%,NAA50;NAA25
prerank,1-phosphatidylinositol-3-kinase activity (GO:0016303),0.35819723264595676,0.7463925131347711,0.7920353982300885,1.0,1.0,2/10,13.05%,PIK3CD;PIK3CB
prerank,metallocarboxypeptidase activity (GO:0004181),-0.22146909403671125,-0.7447084329913336,0.8767772511848341,1.0,1.0,6/26,15.93%,AGBL4;AGTPBP1;AGBL5;AGBL3;CPE;CPA6
prerank,cation transmembrane transporter activity (GO:0008324),0.26314479522794376,0.7443668704780532,0.8378378378378378,1.0,1.0,10/48,21.95%,SLC38A2;SLC38A1;SLC38A3;SLC38A6;SFXN2;SLC36A4;SFXN1;SLC25A15;MFSD12;SLC6A6
prerank,pyridoxal phosphate binding (GO:0030170),0.3052352653685242,0.7440558722046275,0.7738896366083445,1.0,1.0,1/20,0.65%,AGXT
prerank,lipase activator activity (GO:0060229),0.3511459660018161,0.7438364169415562,0.7841614906832298,1.0,1.0,4/10,23.42%,CCL5;FYN;LCK;PDPK1
prerank,Hsp70 protein binding (GO:0030544),0.2780789106266698,0.7435204191844641,0.8245398773006135,1.0,1.0,3/31,6.59%,NOD2;METTL21A;GPR37
prerank,mechanosensitive ion channel activity (GO:0008381),0.33974831686495344,0.7419912430804168,0.8122270742358079,1.0,1.0,1/12,2.42%,TMC1
prerank,mRNA methyltransferase activity (GO:0008174),0.333714502459528,0.7414998447607238,0.7935578330893118,1.0,1.0,4/12,16.70%,TRMT61B;RNMT;TRMT10C;METTL14
prerank,acetylgalactosaminyltransferase activity (GO:0008376),-0.2223594554425288,-0.7412973020450206,0.864406779661017,1.0,1.0,6/26,16.62%,CHSY1;CSGALNACT1;B3GNT2;B3GALT5;B3GALT2;B4GALNT1
prerank,snoRNA binding (GO:0030515),-0.21691671817753005,-0.7408386544476288,0.8804347826086957,1.0,1.0,11/30,22.83%,XRCC5;NOP56;NUDT7;NOP58;TBL3;IMP3;NUDT16L1;NOP14;NUDT1;BYSL;NUFIP1
prerank,phosphatidylinositol-4-phosphate binding (GO:0070273),0.2950308240048011,0.7395074167150937,0.8167539267015707,1.0,1.0,7/24,22.39%,OSBPL8;RUBCNL;PLEKHA3;OSBP;GOLPH3L;PLA2G4E;CERT1
prerank,zinc ion transmembrane transporter activity (GO:0005385),0.30298577405667143,0.7385303904117626,0.7972972972972973,1.0,1.0,5/20,23.75%,SLC30A1;SLC30A5;SLC39A10;SLC39A3;SLC39A13
prerank,GTPase binding (GO:0051020),0.23496425298148535,0.7385110336434058,0.9442190669371197,1.0,1.0,55/194,24.52%,ABCA1;DAPK3;RGP1;MYO1C;GOLGA5;TNFAIP1;RILP;RRAGC;CYFIP1;GGA3;KIF3B;RAPGEF6;UNC13D;RAP1GAP;SIKE1;SPHK2;FNBP1L;CIB1;ANKFY1;ANKRD27;SRGAP2;SORL1;IARS1;RIC1;FGD6;AKAP13;WHAMM;RANBP1;DENND10;HSP90AA1;MYCBP2;LZTR1;PEX5;OCRL;PLCE1;BECN1;RANBP9;SGSM1;NCKAP1;SGSM3;STRN3;GCC1;RHOH;OPTN;USP33;BRK1;CCDC186;IQGAP2;RAB29;ARHGAP1;BICD2;EXOC2;RAF1;FLNA;RIN3
prerank,snRNA binding (GO:0017069),0.26535266549867187,0.7382848784636084,0.8273381294964028,0.998250875415283,1.0,12/42,23.56%,NCBP2;CCNT2;MEPCE;RNPC3;RBM41;EFTUD2;DDX39B;SNRPB2;CDK9;SART3;LSM4;SNRPD3
prerank,transmembrane receptor protein tyrosine phosphatase activity (GO:0005001),-0.25466781199607613,-0.7374163328939315,0.8686131386861314,1.0,1.0,3/16,9.07%,PTPRK;PTPRA;PTPRG
prerank,transmembrane receptor protein phosphatase activity (GO:0019198),-0.25466781199607613,-0.7374163328939315,0.8686131386861314,1.0,1.0,3/16,9.07%,PTPRK;PTPRA;PTPRG
prerank,voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization (GO:0086008),-0.2642942650685923,-0.7368313202127836,0.8193979933110368,1.0,1.0,9/14,46.84%,KCND3;KCNH2;KCNQ1;KCNIP2;KCNE3;KCNE4;KCNJ5;KCNJ8;KCNE2
prerank,nucleotidase activity (GO:0008252),0.3135044372653645,0.7329582903053391,0.7977839335180056,1.0,1.0,2/15,6.71%,NT5DC1;NT5C3A
prerank,MAP-kinase scaffold activity (GO:0005078),0.336077602033941,0.7322566785645569,0.7911111111111111,1.0,1.0,4/11,15.56%,MAPK8IP3;MAP2K2;AKAP13;SPAG9
prerank,microtubule motor activity (GO:0003777),0.2583083979984145,0.7303728840844089,0.8608305274971941,1.0,1.0,6/51,9.39%,KIF26A;KIF3C;KIF7;KIF2C;KIF3B;KIF16B
prerank,high voltage-gated calcium channel activity (GO:0008331),0.33881816934104425,0.7291938352661793,0.7937219730941704,1.0,1.0,1/10,8.44%,CACNA1A
prerank,phospholipase C activity (GO:0004629),0.28539418744509476,0.7274878442665347,0.820480404551201,1.0,1.0,3/25,9.28%,PLCB4;CCL5;PLCB3
prerank,GABA receptor activity (GO:0016917),-0.23312565160284174,-0.7237558100677168,0.8565573770491803,1.0,1.0,3/21,9.15%,GABRG3;GABRB1;GABRA2
prerank,calcium ion transmembrane transporter activity (GO:0015085),0.2547866715145343,0.7191145563918745,0.8635851183765502,1.0,1.0,8/55,15.79%,TRPM2;CUL5;ITPR1;PANX1;PSEN1;TRPV4;TRPM7;SLC24A3
prerank,AMP binding (GO:0016208),0.32858525731329746,0.7173137522450864,0.8045454545454546,1.0,1.0,3/11,17.98%,PFKM;PRKAG1;ACSS2
prerank,protein tyrosine kinase activator activity (GO:0030296),-0.23486799732572416,-0.7167160775354402,0.8438661710037175,1.0,1.0,8/19,30.02%,PAK2;AFAP1L2;CD24;EGF;NRG3;ABI1;DGKQ;GREM1
prerank,phospholipase A2 activity (GO:0004623),0.28453218228192184,0.7160671094406762,0.8207070707070707,1.0,1.0,6/26,21.55%,PLA2G12A;ABHD3;PLA2G4E;PNPLA3;PLA2G6;PNPLA8
prerank,glucose transmembrane transporter activity (GO:0005355),0.30755459647601957,0.7159624300587862,0.8164642375168691,1.0,1.0,1/17,4.15%,SLC2A6
prerank,signal sequence binding (GO:0005048),0.2658366640763874,0.71527331277445,0.8521212121212122,1.0,1.0,7/35,18.03%,RANBP6;NUP153;KPNB1;KDELR1;TNPO2;PEX5;BABAM2
prerank,DNA-(apurinic or apyrimidinic site) endonuclease activity (GO:0003906),0.33426934411394205,0.7138360665502508,0.8132530120481928,1.0,1.0,4/11,20.09%,APLF;ALKBH1;NEIL2;HMCES
prerank,C-C chemokine receptor activity (GO:0016493),0.2868542183316003,0.7131759825913022,0.8398384925975774,1.0,1.0,2/21,8.47%,CXCR4;ACKR3
prerank,nucleotide diphosphatase activity (GO:0004551),-0.2533533102553115,-0.7128737026775657,0.8819444444444444,1.0,1.0,3/14,16.16%,FHIT;NUDT6;ENPP4
prerank,acylglycerol O-acyltransferase activity (GO:0016411),-0.22328775138073204,-0.7115840593013054,0.8795180722891566,1.0,1.0,9/20,26.13%,MOGAT3;DGAT1;AGPAT4;AGPAT2;PLA2G15;GPAT4;GPAT3;LCLAT1;DGAT2
prerank,aldehyde dehydrogenase [NAD(P)+] activity (GO:0004030),0.30780891811421085,0.7113605749301579,0.8289290681502086,1.0,1.0,3/15,13.22%,ALDH7A1;ALDH1A2;ALDH1A1
prerank,sulfotransferase activity (GO:0008146),0.26581881956772363,0.7090758742595323,0.8617788461538461,1.0,1.0,1/33,0.26%,TPST1
prerank,gated channel activity (GO:0022836),0.3094339155721878,0.7076208530760375,0.8450899031811895,1.0,1.0,2/14,9.43%,TMC1;TMEM266
prerank,syntaxin-1 binding (GO:0017075),-0.21674200362059048,-0.7075724375224888,0.898989898989899,1.0,1.0,6/22,20.45%,DAPK1;NSF;VAMP3;STXBP5;UNC13A;SYT1
prerank,cAMP response element binding (GO:0035497),-0.28110733197290777,-0.7051164368281049,0.8449848024316109,1.0,1.0,5/10,30.22%,ATF7;HMGA2;CREB1;ATF2;CREB3L1
prerank,actin binding (GO:0003779),0.22505052724828561,0.704470505631325,0.951417004048583,1.0,1.0,42/170,23.82%,MYOZ2;NOD2;CXCR4;UTRN;FLNB;PARVB;BCL7B;MRTFA;CCDC88A;SSH3;SPEF1;FXYD5;CORO7;GSN;CAPZB;MYRIP;SYNPO;PRKCE;TRPV4;MOBP;PLEKHH2;MYO6;RUSC1;GAS2L3;DBNL;PHACTR4;PDLIM3;TNNI2;MYH9;ABITRAM;MAP1B;KLHL1;MSRB1;ABL2;NRAP;IQGAP2;TWF1;FHL3;VASH1;PARVG;MAEA;ANG
prerank,phospholipase binding (GO:0043274),-0.2629469979913579,-0.7042078002407995,0.842443729903537,0.9938541968371345,1.0,7/13,29.78%,SYK;SRC;WAS;BTK;ARHGAP6;PRKN;DGKQ
prerank,poly(A) binding (GO:0008143),0.2864812540119405,0.7040644709777945,0.8558322411533421,1.0,1.0,10/21,29.63%,RBMS2;HNRNPDL;RBPMS;DDX3X;ZC3H14;KHDRBS2;HNRNPU;KHDRBS1;PABPC1;PABPC4
prerank,phosphatase inhibitor activity (GO:0019212),0.2890043423342431,0.7033452492896471,0.851006711409396,1.0,1.0,9/20,30.59%,ARPP19;MGAT5;PPME1;SET;CABIN1;ENSA;BOD1;PPP1R2;LGALS3
prerank,cyclin-dependent protein serine/threonine kinase activity (GO:0004693),0.28092222254433585,0.7027420520631226,0.8481675392670157,0.9992250725747148,1.0,10/21,27.46%,CDK12;CDK19;CDK10;CDK20;CCNK;CDK9;CDK8;CDKL4;CDK7;CDK5
prerank,cyclin-dependent protein kinase activity (GO:0097472),0.28092222254433585,0.7027420520631226,0.8481675392670157,0.9992250725747148,1.0,10/21,27.46%,CDK12;CDK19;CDK10;CDK20;CCNK;CDK9;CDK8;CDKL4;CDK7;CDK5
prerank,hexose transmembrane transporter activity (GO:0015149),0.320645969647691,0.7002099383250295,0.8446043165467626,1.0,1.0,1/12,4.15%,SLC2A6
prerank,MAP kinase activity (GO:0004707),0.3110604452802176,0.7001986532261798,0.819364161849711,0.9979984501416128,1.0,2/14,9.63%,MAPK6;MAPK14
prerank,"oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen (GO:0016709)",0.27522858442141407,0.6977558626443779,0.8764044943820225,0.9986101191289103,1.0,3/25,12.22%,CH25H;CYP26B1;CYP27A1
prerank,acetylglucosaminyltransferase activity (GO:0008375),0.2484866762422292,0.6967975843800429,0.8928571428571429,0.997569679743105,1.0,5/46,11.70%,EXT1;GCNT4;B3GLCT;MGAT4C;B3GALNT1
prerank,neuropeptide binding (GO:0042923),0.29389494432237195,0.6927153660558893,0.8592493297587132,0.9998956416164967,1.0,2/18,11.64%,GPR37;SORL1
prerank,SH3 domain binding (GO:0017124),0.2417020630147329,0.6919836134300876,0.9107142857142857,0.9986691457683181,1.0,7/62,10.61%,ZNF106;CNTNAP1;SYNJ1;CABYR;EVL;SH3BP2;DNM2
prerank,chemokine receptor activity (GO:0004950),0.2720347751492619,0.6916414615568516,0.8622516556291391,0.9969951981050518,1.0,3/24,12.50%,CXCR4;ACKR3;GPR35
prerank,GABA receptor binding (GO:0050811),0.3203141855943147,0.6915044850886631,0.8489208633093526,0.9950991699210469,1.0,2/11,12.80%,TRAK1;ARFGEF2
prerank,neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential (GO:0099529),0.2875019081089427,0.6913350091903171,0.8590785907859079,0.9932590877275562,1.0,8/19,27.23%,GRIK3;GRID1;GABRG1;GRIK4;GABRA3;GRIK5;GRIK2;GABRG2
prerank,metal ion transmembrane transporter activity (GO:0046873),0.2680412150184912,0.6913138269387449,0.8806532663316583,0.9912633487927345,1.0,3/27,6.94%,ITPR1;ASIC4;SLC11A2
prerank,histone demethylase activity (H3-K36 specific) (GO:0051864),0.3247557137190778,0.6904453607595157,0.837593984962406,0.9900689500845763,1.0,3/10,15.95%,RIOX2;KDM8;KDM7A
prerank,G protein-coupled receptor activity (GO:0004930),-0.14649665634084383,-0.6894014402399443,1.0,1.0,1.0,110/239,42.35%,GRM3;GPR183;CNR2;CALCRL;LPAR1;PTAFR;ADGRL1;OPRM1;C5AR2;CX3CR1;GPR45;GPR34;HRH1;ADGRL3;GPR149;P2RY14;XPR1;GPR173;ADGRB3;ADGRA1;CMKLR1;GRM8;TAPT1;S1PR1;GLP2R;ADGRG3;HCRTR2;NTSR2;F2R;QRFPR;PDGFRL;S1PR5;GPR135;ADGRB2;NPR3;ADRA2A;PAX8;P2RY1;DRD2;OPRL1;OPRK1;GPR85;OPN3;GPR75;LPAR6;PDGFRB;GPR26;CRHR1;GPR61;GPR101;TSHR;PTH2R;GPR18;ADRB2;GRPR;F2RL2;ADGRB1;NPR1;OPRD1;MRGPRE;NPFFR2;GPR65;GPR161;GPR27;GPR88;LANCL1;MC5R;HCAR2;SSTR2;FFAR1;NMUR2;BDKRB2;ADGRE5;NPY;GPR171;ADGRG5;S1PR3;DRD3;GPR174;LTB4R;LPAR4;CXCR5;LPAR2;KISS1R;FFAR4;VIPR2;APLNR;CXCR6;CYSLTR1;PTH1R;NTSR1;NMBR;GLP1R;GPR17;RRH;SCTR;S1PR4;ADORA2A;AVPR2;LGR5;ADGRL2;ADGRG6;MC4R;GPR52;LPAR3;ADGRG7;P2RY10;FPR2;GPR62;GPR4
prerank,chloride channel activity (GO:0005254),0.2382810742855746,0.6891302058653865,0.9025755879059351,0.9894314465410127,1.0,18/59,27.23%,CLIC4;CLCN2;CLCN6;TTYH1;GLRA2;CLCN7;ANO5;CLCN1;GABRG1;GLRA1;GABRB2;CLIC1;GABRA3;SLC26A7;CFTR;ANO4;ANO3;GABRG2
prerank,1-acylglycerol-3-phosphate O-acyltransferase activity (GO:0003841),0.30486387577137336,0.6883437765778984,0.8643578643578643,0.9881811430840305,1.0,2/13,9.05%,AGPAT5;LPCAT2
prerank,purinergic nucleotide receptor activity (GO:0001614),0.29440962537501114,0.6881761145263706,0.838150289017341,0.9863632494434237,1.0,2/15,8.96%,P2RY13;P2RX4
prerank,3'-5' exonuclease activity (GO:0008408),0.24656933412983306,0.6881302260338766,0.9063583815028902,0.9844180965964273,1.0,4/45,4.80%,PNPT1;XRN2;APLF;CNOT7
prerank,nucleoside monophosphate kinase activity (GO:0050145),0.2805069646839953,0.6837657009739846,0.8550135501355014,0.9869566809999185,1.0,5/20,14.43%,CMPK2;AK4;AK3;TJP2;DLG1
prerank,calcium-dependent phospholipid binding (GO:0005544),0.24423785393884412,0.6837621631098572,0.9144508670520232,0.984974840275019,1.0,17/49,27.13%,CPNE3;SYT7;SYT3;RPH3A;ANXA4;PLA2G4E;MCTP1;CPNE9;ESYT2;C2CD5;PCLO;SYT11;SYT12;ANXA2;SYT4;PLA2G4A;ANXA9
prerank,basic amino acid transmembrane transporter activity (GO:0015174),-0.246802710849772,-0.6836619273036656,0.8931034482758621,1.0,1.0,2/13,2.69%,SLC66A1;SLC7A2
prerank,calcium:sodium antiporter activity (GO:0005432),0.3281062794011391,0.6828821314141384,0.8485804416403786,0.9838962415150397,1.0,2/10,15.79%,SLC8A1;SLC24A3
prerank,purine ribonucleotide transmembrane transporter activity (GO:0005346),0.31416754957701787,0.6800116516460517,0.8582089552238806,0.9848718907175822,1.0,2/11,11.07%,SLC19A1;SLC25A25
prerank,ubiquitin-dependent protein binding (GO:0140036),0.3173633842144711,0.6790120703012245,0.84399375975039,0.9839125999681805,1.0,4/10,24.12%,USP15;IDE;DNAJB2;DNAJC2
prerank,MAP kinase tyrosine/serine/threonine phosphatase activity (GO:0017017),0.3155189525693046,0.6775704569015332,0.8540031397174255,0.981541974765863,1.0,3/10,18.45%,DUSP10;DUSP16;DUSP8
prerank,protein tyrosine/threonine phosphatase activity (GO:0008330),0.3155189525693046,0.6775704569015332,0.8540031397174255,0.981541974765863,1.0,3/10,18.45%,DUSP10;DUSP16;DUSP8
prerank,poly(A)-specific ribonuclease activity (GO:0004535),0.30881744962620317,0.674517094954536,0.8610315186246418,0.9824595329121623,1.0,4/12,26.64%,CNOT7;PAN3;CNOT2;NOCT
prerank,vascular endothelial growth factor receptor binding (GO:0005172),0.30020177758503397,0.6710238943980551,0.8698224852071006,0.9838818833159968,1.0,2/12,11.22%,CCDC88A;VEGFD
prerank,3'-5'-exoribonuclease activity (GO:0000175),0.25123295058688216,0.6704160579956415,0.9018181818181819,0.9825483880296862,1.0,3/34,4.80%,PNPT1;XRN2;CNOT7
prerank,histone methyltransferase activity (H3-K9 specific) (GO:0046974),0.3124278101802198,0.6699309662406269,0.8531976744186046,0.9810682269222086,1.0,3/10,11.23%,ASH1L;SETD5;SETDB2
prerank,oxidoreduction-driven active transmembrane transporter activity (GO:0015453),0.232093219848237,0.6697573758392273,0.9232480533926585,0.9793189427634744,1.0,11/57,19.64%,UQCRQ;NDUFA5;NDUFB9;NDUFS1;UQCR10;NDUFB5;NDUFS4;NDUFA10;NDUFB6;NDUFS8;NDUFS7
prerank,postsynaptic neurotransmitter receptor activity (GO:0098960),-0.21692885797282296,-0.6657602745457801,0.9428571428571428,1.0,1.0,3/21,21.26%,CHRFAM7A;CHRNA7;CHRNA4
prerank,FMN binding (GO:0010181),0.30185186435249134,0.6647633617137588,0.8717579250720461,0.9820114863896683,1.0,3/11,23.72%,DUS2;PPCDC;NDOR1
prerank,RNA polymerase II CTD heptapeptide repeat kinase activity (GO:0008353),0.3050163433424456,0.6645765312645128,0.8822652757078987,0.980241033678228,1.0,5/12,22.38%,CDK12;CDK19;CCNK;CDK9;CDK8
prerank,secondary active transmembrane transporter activity (GO:0015291),0.2371380473639884,0.6636629090982347,0.9362416107382551,0.9791588411727186,1.0,6/51,10.43%,SLCO1C1;SLC25A16;SLCO1B1;ANKH;SLC25A10;TMEM241
prerank,H4 histone acetyltransferase activity (GO:0010485),0.3102201140205233,0.661060851376267,0.8710644677661169,0.9796013482192754,1.0,2/10,16.69%,NAA50;KAT8
prerank,phosphatidylinositol-3-phosphate binding (GO:0032266),0.2415855702854768,0.6588322066102261,0.9135802469135802,0.97970579578677,1.0,10/38,23.73%,DENND1A;RUBCNL;ZFYVE26;KIF16B;PLEKHA4;SH3PXD2B;PHLDA3;PLA2G4E;ZFYVE1;SNX12
prerank,vitamin D receptor binding (GO:0042809),0.28858997328425795,0.657066619005579,0.8810511756569848,0.9792843379608542,1.0,6/14,24.80%,MED12;SNW1;MED16;MED24;TAF7;TAF11
prerank,actinin binding (GO:0042805),0.26741352046922356,0.6511287172055635,0.8955823293172691,0.982633583582787,1.0,2/21,6.29%,CSRP1;NFKB1
prerank,ribonuclease P RNA binding (GO:0033204),-0.2581754483812471,-0.6488630794971629,0.8974358974358975,1.0,1.0,6/10,29.61%,RPP38;RPP40;POP4;POP5;POP7;POP1
prerank,"racemase and epimerase activity, acting on carbohydrates and derivatives (GO:0016857)",-0.25705631872560447,-0.6472726195238666,0.8923076923076924,1.0,1.0,3/10,17.88%,GALM;DSEL;GFUS
prerank,leak channel activity (GO:0022840),-0.211993702305456,-0.6432249349269846,0.948339483394834,1.0,1.0,8/18,36.16%,NALCN;KCNK6;KCNK12;KCNK9;KCNK5;KCNK4;KCNK13;KCNK7
prerank,tRNA-specific ribonuclease activity (GO:0004549),0.281550159062472,0.6425841034425359,0.8879432624113475,0.9881413199590964,1.0,5/14,22.98%,TSEN2;RPP30;TSEN34;RPP14;RPP21
prerank,platelet-derived growth factor receptor binding (GO:0005161),-0.23349666524324084,-0.641010273055053,0.934931506849315,0.9959782240607694,1.0,6/13,30.39%,IL1R1;ITGB3;PDGFRA;PDGFC;PDGFRB;PDGFD
prerank,intracellular calcium activated chloride channel activity (GO:0005229),0.27439614342523255,0.6402270610832757,0.9049586776859504,0.9863008375308568,1.0,3/16,16.25%,TTYH1;ANO10;ANO5
prerank,intracellular chloride channel activity (GO:0061778),0.27439614342523255,0.6402270610832757,0.9049586776859504,0.9863008375308568,1.0,3/16,16.25%,TTYH1;ANO10;ANO5
prerank,acylglycerol lipase activity (GO:0047372),0.2904294796371868,0.6373864102861057,0.8895522388059701,0.9866543556090654,1.0,2/11,14.84%,ABHD2;ABHD3
prerank,exoribonuclease activity (GO:0004532),0.28550074967090644,0.6370114920635729,0.891970802919708,0.9850610995542601,1.0,3/12,14.04%,CNOT7;ZC3H12A;EXOSC9
prerank,histone deacetylase activity (GO:0004407),0.2583748246804996,0.6362318426835107,0.9001367989056087,0.9838268132496559,1.0,11/19,30.44%,SIRT6;MIER1;HDAC8;HDAC1;HDAC2;HDAC4;HDAC6;SIRT2;HDAC5;SIRT3;HDAC11
prerank,alanine transmembrane transporter activity (GO:0022858),0.2844871671887015,0.6344450695132551,0.8979310344827586,0.9832839040344593,1.0,4/12,25.51%,SLC38A3;SLC36A4;SLC6A6;SLC36A1
prerank,transmembrane-ephrin receptor activity (GO:0005005),0.2661958345553357,0.6295909138319253,0.9174825174825175,0.9832548425080763,1.0,2/17,7.50%,EPHA4;EPHA6
prerank,ephrin receptor activity (GO:0005003),0.2661958345553357,0.6295909138319253,0.9174825174825175,0.9832548425080763,1.0,2/17,7.50%,EPHA4;EPHA6
prerank,amino acid binding (GO:0016597),0.23610769393427408,0.6292246412306167,0.922882427307206,0.9816323735997754,1.0,5/31,16.13%,AGXT;AARS1;GLRA2;SHMT1;GCLC
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides (GO:0016811)",0.2148270412748348,0.6243942179614868,0.9588100686498856,0.9834407782001315,1.0,18/54,28.62%,ASAH2;SIRT6;NGLY1;MIER1;HDAC8;HINT3;ACER3;HDAC1;TGM2;NIT1;HDAC2;HDAC4;HDAC6;SIRT2;NTAN1;GLS2;KLK3;HDAC5
prerank,single-stranded telomeric DNA binding (GO:0043047),0.28415103530208274,0.6232047713335792,0.8974739970282318,0.9824945031553208,1.0,4/11,18.99%,HNRNPA2B1;HNRNPA1;STN1;TERF2
prerank,adenine nucleotide transmembrane transporter activity (GO:0000295),0.27968049966312036,0.6227519891789408,0.9237410071942446,0.9809566072346004,1.0,2/12,11.07%,SLC19A1;SLC25A25
prerank,G protein-coupled serotonin receptor activity (GO:0004993),-0.1947765563277175,-0.6222401320379092,0.9720930232558139,0.985398549597032,1.0,6/22,28.03%,HRH2;HRH1;CHRM2;HTR7;HTR1D;HTR1B
prerank,serotonin receptor activity (GO:0099589),-0.1947765563277175,-0.6222401320379092,0.9720930232558139,0.985398549597032,1.0,6/22,28.03%,HRH2;HRH1;CHRM2;HTR7;HTR1D;HTR1B
prerank,G protein-coupled amine receptor activity (GO:0008227),-0.1947765563277175,-0.6222401320379092,0.9720930232558139,0.985398549597032,1.0,6/22,28.03%,HRH2;HRH1;CHRM2;HTR7;HTR1D;HTR1B
prerank,antiporter activity (GO:0015297),0.2544344765700164,0.6220413451489737,0.9248407643312102,0.979636142432612,1.0,6/20,22.93%,SLC25A16;SLC25A10;TMEM241;SLC35D1;SLC35C2;SLC25A30
prerank,phosphatidylglycerol binding (GO:1901611),0.2782087891271494,0.6201288157712422,0.907563025210084,0.9791112727747062,1.0,1/13,3.61%,PLEKHN1
prerank,5'-3' RNA polymerase activity (GO:0034062),0.24095776557647486,0.6190185993657614,0.9213917525773195,0.9780990461874062,1.0,2/27,6.34%,POLR2G;POLR3B
prerank,voltage-gated anion channel activity (GO:0008308),0.26734334989497643,0.6189877839920958,0.9016620498614959,0.9762817495387067,1.0,2/15,5.81%,CLCN2;CLCN6
prerank,ephrin receptor binding (GO:0046875),0.24782767217862336,0.6120088002121611,0.93048128342246,0.9792248562099672,1.0,4/21,15.43%,LYN;CHN1;FYN;CRK
prerank,phospholipid transfer activity (GO:0120014),0.25193959304229824,0.6115146678094608,0.9239842726081258,0.9777565211923912,1.0,8/21,23.36%,PITPNM1;PLEKHA3;MTTP;OSBPL2;GLTP;TNFAIP8L3;CERT1;PITPNA
prerank,voltage-gated sodium channel activity (GO:0005248),-0.18315546494359386,-0.6010910511976378,0.979253112033195,0.9897413733086566,1.0,9/22,31.85%,SCN3A;SCN3B;SCN9A;HCN3;SCN7A;SCN2B;CACNA1G;HCN4;CACNA1H
prerank,DNA-directed 5'-3' RNA polymerase activity (GO:0003899),0.23368301560564592,0.6001925429819982,0.946360153256705,0.9832563005743119,1.0,2/27,6.34%,POLR2G;POLR3B
prerank,adrenergic receptor binding (GO:0031690),0.2543487782403553,0.6000492715351683,0.9178470254957507,0.9815119231083027,1.0,2/16,8.10%,MAGI2;RAPGEF2
prerank,histone acetyltransferase activity (GO:0004402),0.22805942698928444,0.5971871053947182,0.946078431372549,0.9814379308806972,1.0,12/30,28.45%,NAA50;KAT14;TADA2A;KAT8;KAT7;MCM3AP;KAT6A;KAT5;KAT2B;EP300;SRCAP;USP22
prerank,GDP-dissociation inhibitor activity (GO:0005092),-0.21348527311331372,-0.5856802715075407,0.9472049689440993,0.98970737290631,1.0,4/13,17.31%,ARHGDIB;RGS14;GDI1;ITGB1BP1
prerank,"proton-transporting ATPase activity, rotational mechanism (GO:0046961)",0.24892398647255887,0.5836077656508323,0.9323204419889503,0.9853474070759956,1.0,4/16,22.41%,ATP6V0D1;TCIRG1;ATP6V1B2;ATP5F1B
prerank,"ATPase activity, coupled to transmembrane movement of ions, rotational mechanism (GO:0044769)",0.24892398647255887,0.5836077656508323,0.9323204419889503,0.9853474070759956,1.0,4/16,22.41%,ATP6V0D1;TCIRG1;ATP6V1B2;ATP5F1B
prerank,store-operated calcium channel activity (GO:0015279),0.2743992830019482,0.5799541505543054,0.9323308270676691,0.9854378933057981,1.0,6/10,31.81%,TRPC4;TRPC1;ORAI1;TRPC7;STIM2;TRPC3
prerank,cAMP binding (GO:0030552),0.26940138919584894,0.5788463456269071,0.9446870451237264,0.9842162679592509,1.0,4/11,21.82%,RAPGEF2;PDE4B;CNBD2;PDE4A
prerank,O-acyltransferase activity (GO:0008374),0.21832115561257026,0.5768220421796381,0.9621026894865525,0.9834122326323134,1.0,4/30,17.01%,PIGW;LPCAT2;SOAT2;SOAT1
prerank,serine-type peptidase activity (GO:0008236),0.18775857487061173,0.5731359351593145,0.9937369519832986,0.9833866256830268,1.0,8/96,15.81%,PRSS12;CTSH;PCSK7;KLK1;RHBDF2;PREP;MASP1;HTRA3
prerank,cyclin-dependent protein serine/threonine kinase inhibitor activity (GO:0004861),0.2731509975758096,0.568861015014399,0.9393491124260355,0.9835744462469165,1.0,1/10,5.07%,CDKN2D
prerank,serine-type endopeptidase activity (GO:0004252),0.1895127474861475,0.5673438315750426,0.9892125134843581,0.9824990015004572,1.0,6/80,13.75%,PRSS12;CTSH;PCSK7;KLK1;RHBDF2;MASP1
prerank,Lys48-specific deubiquitinase activity (GO:1990380),0.2478272958723299,0.5641134064034169,0.9526462395543176,0.9822363220368023,1.0,2/14,13.84%,USP15;MINDY3
prerank,G protein-coupled photoreceptor activity (GO:0008020),0.256873822975518,0.5607090173745488,0.9532846715328467,0.9819652152510276,1.0,12/12,74.33%,ELOVL4;GNAT2;OPN1SW;RHO;OPN4;OPN5;OPN1MW;OPN1MW3;GPR52;RRH;GPR88;OPN3
prerank,nucleoside diphosphate kinase activity (GO:0004550),-0.19549403630902162,-0.5511009570367975,0.9660377358490566,0.9952269171664683,1.0,8/14,36.19%,CMPK1;DTYMK;NME1;NME2;AK7;AK9;NME4;AK1
prerank,"exodeoxyribonuclease activity, producing 5'-phosphomonoesters (GO:0016895)",0.2506203817222531,0.5463346107998289,0.9613180515759312,0.9859343699992081,1.0,3/10,19.65%,FEN1;DCLRE1A;DCLRE1C
prerank,phosphate ion binding (GO:0042301),-0.221858882493057,-0.5443190222558433,0.9556962025316456,0.9899151405691824,1.0,1/10,5.60%,PNP
prerank,symporter activity (GO:0015293),0.25665327642480573,0.541288880758806,0.9606060606060606,0.9860484936653752,1.0,10/10,74.35%,SLC5A6;SLC4A4;SLC28A3;SLC5A8;SLC5A12;SLC5A5;SLC28A1;MFSD2A;SLC46A2;SLC28A2
prerank,Lys63-specific deubiquitinase activity (GO:0061578),0.2533253985145101,0.5376407337914121,0.9529411764705882,0.9854918378340004,1.0,4/10,29.15%,CYLD;OTUD5;STAMBPL1;ATXN3
prerank,organic cation transmembrane transporter activity (GO:0015101),0.22327019993505737,0.5213848202366739,0.9859943977591037,0.9888327987662036,1.0,15/16,62.44%,SLC44A1;SLC25A26;SLC22A4;SLC5A7;SLC22A5;SLC44A4;SLC22A16;SLC22A1;SLC7A8;SLC29A4;SLC22A2;SLC44A2;SLC22A3;SLC18A3;SLC25A17
prerank,phospholipase inhibitor activity (GO:0004859),-0.20841208575577413,-0.5206329788158109,0.9738372093023255,0.9884795686644268,1.0,4/10,32.22%,SNCA;ANXA1;APOC1;SNCB
prerank,calcium-dependent cysteine-type endopeptidase activity (GO:0004198),0.22394595599379663,0.5083755681808104,0.9702549575070821,0.9903792526828454,1.0,3/14,15.80%,CAPNS1;CAPN1;CAPN5
prerank,fibroblast growth factor receptor binding (GO:0005104),0.19462004361278784,0.48493730279437275,0.9959568733153639,0.9934634306466252,1.0,3/21,21.95%,FGF9;NPTN;FGF2
prerank,phosphatidate phosphatase activity (GO:0008195),0.21335297433474057,0.47689720897628146,0.9855072463768116,0.9930809386204095,1.0,5/13,25.45%,LPIN2;PLPP2;PLPPR2;PLPPR1;PLPP1
prerank,"intramolecular oxidoreductase activity, transposing C=C bonds (GO:0016863)",0.20529434011975198,0.4567812224726256,0.99,0.9941765143468333,1.0,2/13,17.74%,IDI1;EBP
